Announcements

23 May 2024
Transfer Service in MDPI

We are pleased to announce MDPI’s Transfer Service.

This service provides a convenient method of transferring your manuscript file, along with any reviewer comments, to another journal within our publishing portfolio.

We are committed to helping authors find the right home for their research, and we will provide authors with guidance and technical support through all stages of the transfer process. Authors will be able to choose to transfer in the following two situations:

1. Select alternative journals on submission.

2. Authors are encouraged to transfer manuscripts to other MDPI journals.

More details about the Transfer Service can be found at the following link:

https://www.mdpi.com/authors/transfer-service

17 May 2024
Tu Youyou Award—Open for Nominations

In acknowledgment of the groundbreaking achievements of Professor Tu Youyou, the Nobel laureate credited with the discovery of artemisinin, MDPI is proud to announce the Tu Youyou Award. This award, inaugurated in 2016, seeks to honor scholars who excel in the fields of natural products chemistry and medicinal chemistry.

Prize:

  • CHF 100,000 in total (If there is more than one winner, the prize will be divided equally amongst the winners);
  • An award medal for each winner.

Who should be nominated?

  • Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Who can submit a nomination?

  • Academic research institutes
  • Universities
  • Academic societies

Any personal nominations are not accepted.

How do I submit a nomination?
Candidates’ institutional affiliations need to submit their nominations for final candidates to the Tu Youyou Award Team directly by email after internal screening, and each institution can only nominate a maximum of two candidates for each edition of the Tu Youyou Award. Please note that the nominations cannot be modified once they are submitted and confirmed by the Tu Youyou Award Team.

Required nomination materials:
Nomination Form (Download)

Schedule:
Nomination deadline: 31 December 2024;
Winner announcement: 30 April 2025.

Contact:
Tu Youyou Award Team ([email protected])

More information can be found on the Tu Youyou Award official website. For any inquiries, do not hesitate to contact the Tu Youyou Award Team.

17 May 2024
Toxins Webinar | Recent Insights Into Fusarium Mycotoxins, 28 May 2024


Fusarium fungi attack a wide range of plants, particularly cereals, thereby reducing yield and contaminating them with mycotoxins harmful to human and animal health. These toxins, including commonly detected trichothecenes such as deoxynivalenol (DON), HT-2, and T-2 toxin, have many harmful effects on human health. Additionally, toxins such as DON have been shown to be phytotoxic, enhancing the virulence of producer Fusarium fungi. A better understanding of the prevalence and mode of action of these toxins is imperative if we are to control their occurrence. This webinar will provide an overview of some important recent developments regarding our understanding of these toxins, their phytotoxic effects, and the implications of impending EU legislation regarding their maximal levels of foodstuffs.

Date: 28 May 2024 at 9:30 a.m. CEST | 3:30 p.m. CST Asia
Webinar ID: 841 4540 5869
More information: https://sciforum.net/event/Toxins-8

Register now for free!

After registering, you will receive a confirmation email about how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway, and we will let you know when the recording is available to watch.

Speakers/Presentation Time in CEST Time in CST Asia
Dr. Marc Maresca & Dr. Fiona Doohan
Chair Introduction
9:30–9:40 a.m. 3:30–3:40 p.m.
Prof. Simon Edwards
HT2+T2 Mycotoxins–Preparing for European Legislation
9:40–10:20 a.m. 3:40–4:20 p.m.
Prof. Rainer Schuhmacher
Metabolism of Deoxynivalenol in Wheat and Its Effect on the Plant Metabolome
10:20–11:00 a.m. 4:20–5:00 p.m.
Dr. María Agustina Pavicich
Fusarium Toxins and Other Mycotoxins in Vegetarian Food
11:00–11:20 a.m. 5:00–5:20 p.m.
Ms. Bernadette Willoquet
Roles of Cytochromes P450 and Ribotoxicity in the Interaction Between Two Preoccupying Mycotoxins, Aflatoxin B1 and Deoxynivalenol
11:20–11:40 a.m. 5:20–5:40 p.m.
Q&A Session 11:40–11:50 a.m. 5:40–5:50 p.m.
Dr. Marc Maresca & Dr. Fiona Doohan
Closing of Webinar
11:50–12:00 a.m. 5:50–6:00 p.m.

Webinar Chairs and Keynote Speakers:

  • Dr. Marc Maresca, Institut des Sciences Moléculaires de Marseille (ISM2) – BiosCiences – UMR 7313 CNRS Aix Marseille Université, France;
  • Dr. Fiona Doohan, University College Dublin, Dublin, Ireland;
  • Prof. Simon Edwards, Agriculture and Environment Department, Harper Adams University, UK;
  • Prof. Rainer Schuhmacher, Institute of Bioanalytics and AgroMetabolomics (iBAM), Department of Agrobiotechnology (IFA-Tulln), BOKU University, Vienna, Austria;
  • Dr. María Agustina Pavicich, 1 Centre of Excellence in Mycotoxicology & Public Health, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; 2 Laboratory of Applied Mycology and Phenomics, Department of Plants and Crops, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium;
  • Ms. Bernadette Willoquet, Toxalim – Research centre in food toxicology, Toulouse, France.

 Relevant Topic:
Fungal Metabolites: From Toxins to Therapeutics

16 May 2024
MDPI Romania Author Training Academic Events in April

MDPI Romania sponsored four events over the month of April, contributing author training sessions to each event.

The NutriSciLabs 2024 conference was held at the Carol Davila University of Medicine and Pharmacy on 12 April 2024. Organized by the Association of Students from the Faculty of Pharmacy Studies, the conference aimed to enhance students’ academic writing and research skills, and bolster their confidence in participating in the academic world. Ioana Paunescu, journal relations specialist for MDPI Romania, led the training session. Paunescu first outlined MDPI’s history and core values, then explained academic writing techniques, ethics, and similarity percentages. The presentation covered the entire editorial process, highlighting the amount of attention paid to details throughout manuscript processing. Paunescu also discussed common errors that authors make while writing, and how to avoid such errors.


On 13 April 2024, the NextGEN 2.0 Student Conference took place at the Babes-Bolyai University of Cluj-Napoca. NextGen Healthcare organized this event with the university’s European Students’ Society to discuss European and international current affairs. MDPI Romania contributed an author training session called Steps of the Publication Process. Irina Codruta Zaharia, journal relations specialist, began the session with a general introduction of MDPI before diving into different article types, different layout formats, possible journals to submit to, the MDPI submission checklist, and the MDPI editorial process. By explaining the fundamentals of writing and publishing academic papers, Zaharia imparted valuable industry knowledge to the curious minds present. Participants were eager to engage with Zaharia in the subsequent Q&A session.


Celebrating its 20th anniversary this year, the International Conference “Students for Students” has long been a gathering place for undergraduate and postgraduate students of all nationalities to present their work and exchange ideas with each other. This year’s conference was held on 18 April 2024, with MDPI Romania contributing an author training session called The World of Open Access. Key speakers included Dr. Norbert Kiss from MDPI Romania and Prof. Dragos Horvath from Strasbourg University. Dr. Kiss discussed the history of open access, differences between open access publishing and traditional publishing, and implications for open access in the future. Attendees expressed keen interest in the subject, approaching Dr. Kiss with questions about academic publishing as well as his career trajectory.


Most recently, on 26 April 2024, MDPI Romania sponsored the National Symposium of Students from Geology and Geophysics Faculties. The AAPG Students Chapter at the Babes-Bolyai University organized this event as an opportunity for geology students from all Romanian universities to present their work and confer with other researchers. Dr. Kiss gave his lecture The World of Open Access at this event as well.


MDPI is thankful to all the participants, speakers, and organizers who attended these events. Through their enthusiasm and dedication, these events were great successes.

2 May 2024
MDPI Insights: The CEO's Letter #11 – 2023 Annual Report, MDPI Awards, STM

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2023 Annual Report

This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.


Stefan Tochev (CEO, MDPI)

Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.

Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.

2023 Top-line MDPI Numbers

An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).

2023 Open Access Numbers

For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.

MDPI is the trusted and preferred OA publisher for the scholarly community

However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.

Download 2023 MDPI Annual Report.
Access 2023 Digital Report.

Impactful Research

Recognizing Scholars – MDPI Awards

MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.

For more information about MDPI awards, applications, and winners, please click here

The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.

MDPI Awards – The following awards require an application or a nomination.

Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.

Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.

Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.

Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.

These awards exemplify the excellent contributions made by our authors, reviewers, and editors

Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.

Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.

MDPI also offers awards for specific topics in various research fields:

Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.

Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.

Granted: World Sustainability Awards

Inside MDPI

MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.

MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher


Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.

Reflecting on his role, Claude shared that he is:

“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.

Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.

Coming Together for Science

4th MMCS: Harnessing the Power of New Drug Modalities

Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.


From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).

The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.

We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.

Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).

Upcoming In-Person Event

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.

Find more upcoming MDPI events here.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

A Report from the Future – STM US Annual Conference 2024


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.

MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.

Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.

In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.

Launch of STM Trends 2028 Panel

I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.

MDPI has joined the STM Integrity Hub. Click here to learn more.

While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.

Memorial Park in Washington, DC

On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.

"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."

– Excerpted from a letter to Samuel Kercheval, July 12, 1816.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 April 2024
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.

With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.


Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.

OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.


MDPI CEO Visits Seoul, Korea

In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.

Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."

Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

For further inquiries, please contact our Seoul office directly.


About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

26 January 2024
Acknowledgment of the Reviewers of Toxins in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Toxins. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Toxins received 2664 review reports, from 1689 reviewers. This past year, we worked with reviewers from 64 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Toxins family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

Abdelnaser Elzaawely Larisa Shcherbakova
Abhiroop Chowdhury Laura Valdez
Abhishek Dwivedy Leandro Castro
Abraham Méndez-Albores Leontina Grigore-Gurgu
Adam Okorski Li Wu
Ádám Tölgyesi Licia Pantano
Adányi Nóra Liming Zhang
Adham Al-Sagheer Lindsay McDermott
Adina Roceanu Lin-Fu Liang
Adrian Macri Lingchen Yang
Adriana Grigoraș Lingjing Jin
Adriana Paucean Liviu Giurgiulescu
Adrijana Leonardi Ljilja Torovic
Agostino Casapullo Lorena María Durán-Riveroll
Agustin Ariño Lorraine Mcintyre
Ahmed Fayed Lothar Brecker
Ahmed Hammam Lucia Citores
Ahmed Sherif Attia Luigi Brunetti
Maria A. Andersson Luis Miguel Gonzalez-Perez
Ajit Kumar Navin Luís Roberto Gonçalves
Akebe Luther King Abia Łukasz Zielonka
Akihiko Yamamoto Maciej Woźny
Ákos Pethő Madhu Kamle
Alejandra Bravo Magdalena Polak-Śliwińska
Alejandro Islas-Jácome Mahmoud F. Seleiman
Aleksandra Bocian Mahmoud S. M. Mohamed
Alex Merrick Maksim Burkin
Alexander Berestetskiy Małgorzata Kulesa-Mrowiecka
Alexandr Ceasovschih Malgorzata Miazga-Karska
Alexey Safonov Marcin Różewicz
Alfred Ngenge Tamfu Marco Iammarino
Ali Shafiee Marco Invernizzi
Amany Abdel-Rahman Marco Villanueva
Amin Mousavi Khaneghah Margarita Fernandez-Tejedor
Amir Souissi Maria Angeles Rojo
Amit Ranjan Maria Del Rosario Iglesias
Ammar Saleem María Guadalupe Frías-De-León
Amro Amara Maria João Sousa
Ana Isabel Prieto Maria Joao Silva
Ana Juan-Garcia María José Ruiz
Ana Mornar Maria Luisa Dindo
Ana Tomić Maria Michela Salvatore
Andreas Breidbach Maria P. Ntalouka
Andreea Iren Serban Maria Serena Fabbrini
Andrzej Hutorowicz Mariana Radkova
Anil Chuturgoon Marija Kovač Tomas
Anna Baturo-Cieśniewska Marina Isaeva
Anna Goncharenko Mark Nelson
Anon Thammasittirong Mark Wiser
Anthimia Batrinou Marta Hryniewicka
Antía Lestido-Cardama Marta Laranjo
Antonio Abad-Fuentes Martin Michel
Antonio Gonzalez-Casado Martin Svoboda
Anusorn Cherdthong Martin Welker
Apurva Lad Martina Loi
Araceli Escudeiro Rossignoli Masashi Mizuno
Aram Megighian Massimo Blandino
Arshad Javaid Massimo Bortolotti
Arturo Gerardo Valdivia-Flores Matan Geron
Ashish Kabra Matthew Beard
Ashley Cluck Mauro Martínez
Athanasios Papakyriakou Mauro Vilar
Atul Pandey Mazen Nazal
Balázs Zoltán Zsidó Md Abdul Hakim
Baohua Chen Medhat A. ElNaggar
Barbara Novak Meiji Soe Aung
Behrokh Beiranvand Mélanie Roué
Ben De Lacy Costello Melisa Benard-Valle
Benito Soto-Blanco Mengliang Zhang
Benjamin Cull Michael Fasullo
Bingmiao Gao Michael Weller
Bingnan Han Michel Treilhou
Binu Jacob Michela Mitchell
Bogdan Lewczuk Miguel A. Alonso
Boonhiang Promdonkoy Miguel Hueso
Brahim Oudra Mihaela Pertea
Camilo Ayra-Pardo Miklós Poór
Carlene Moore Miran Brvar
Carlos Alberto-Silva Mirko Filippetti
Carlos de Oliveira Mithun Rudrapal
Carmen Rubio Armendariz Mohammad Sadraeian
Carolina Sabença Montamas Suntravat
Carsten Holzmann Morgan Brisse
Cátia Ramalhete Mostafa El-Sheekh
Cesar Mattei Muhammad Awais
Charlotte Preston Muhammad Nawaz
Cheng Wang Muhammad Ubaid Hafeez
Cho Yeow Koh Mahadevamurthy Murali
Choo Hock Tan Nadezhda Berezina
Christian Müller Naeem Abbas
Christine Rasetti-Escargueil Natalia Piekuś-Słomka
Chung-Cheng Wang Natalia Statsyuk
Chuyen Hoang Nataly Gruntenko
Ciprian Silaghi Negrea Monica
Delgadillo Puga Claudia Nemat Ali
Claudio Caprari Newton Verbisck
Dan Jeffers Niels Ole Gerslev Jørgensen
Daniel Costache Nikolaos Solomakos
Daniel Novakovic Nilmani Singh
Daniel Rodriguez Nina Kudumija
Dario Calafiore Niya Zhang
Dariusz Pawlak Norrie Pearce
David Sergeevichev Oana Mîrza
Davide Bizzoca Olga Gavrilova
Debasish Dey Olga Koksharova
Delavar Shahbazzadeh Olga Pershina
Denis Servent Olga Tsivileva
Dimitrios G. Georgakopoulos Palanisamy Ravichandiran
Dimosthenis Kizis Panagiotis Karakaidos
Dolly Khona Pankaj Singh
Domenico Davolos Partha Narayan Dey
Donna Hill Patricio Díaz
Douglas Kane Patrizia Pagliara
Raja Chinnappan Paul Daly
Eduardo Fox Paulo Ribeiro
Egor Turovsky Paulo Vale
Egor Verbitskiy Pavan Kumar
Eiji Arakawa Paweł Kubica
Eishin Morita Pedro Costa
Ekaterina F. Kolesanova Pedro Infante-Cossio
Elena González Peñas Peter Croot
Elena Leychenko Peter Dubovskii
Elena-Suzana Biris-Dorhoi Ping-Chung Kuo
Eleonóra Spekker Piya Temviriyanukul
Eliana Badiale-Furlong Ponlapat Rojnuckarin
Elio Romano Prabhat Talukdar
Elisabetta Caprai Pradeep Kumar
Elva Morretta Przemysław Kosobucki
Eman Khalifa Qingsen Shang
Emelyn Salazar Ravi Pandiselvam
Emmanouil Dermitzakis Radu Racovita
Enrique Torres Rafał Frański
Érica Martins-Duarte Ralf Gerhard
Erick Nuñez-Vazquez Rama Rao Tata
Ericsson Coy-Barrera Ramachandran Srinivasan
Eugenia Irene Davidescu Ramon Silva Rocha
Evgenia Benova Raphael Eberle
Excel Rio Maylem Reham El-trabili
Fabián Acuña Remington Poulin
Fabio Di Nardo Reynaldo Patiño
Fabio Zobi Riccardo Leinardi
Fabrizio Anniballi Richard Harris
Faez Amokrane Nait Mohamed Richard J. Lewis
Fajun Chen Rimma Kalina
Farhan Mahmood Shah Rita Cordeiro
Fatima El Khalloufi Roberta Di Lecce
Fatma El-Demerdash Roland Kerpes
Federico Gastón Baudou Roman Begunov
Felipe Masiero Salvarani Romana Roje-Busatto
Felipe Penagos-Tabares Rosa Elena Cardoza
Fernanda Cosme Rosa María Oliart-Ros
Fernanda Vieira Portaro Rosario Nicoletti
Fernando Cardoso Rosilda Mussury
Filippo Rossi Roua Popescu
Fiona Radcliff Roy Kirsch
Fiorella Tonello Ruojun Wang
Flora Tsvetanova Russolina Zingali
Francesco Giuseppe Galluzzo Rūta Kananavičiūtė
Francisc Boda Sabine Pellett
Francisco Espejo Alcaide Sabrina Oliva
Frédéric Goormaghtigh Safa Oufensou
Fuguo Xing Salman Ahmed
Furong Tian Salvatore De-Simone
Gabriela Egly Feresin Sami Ul-Allah
Gabrijela Tavcar-Kalcher Samina Akbar
Gang Li Samy Sayed
Gaurav Sharma Sandeep Kondakala
Georgescu Emil Sandra Cabo Verde
Gergana Zahmanova Sandra Garrigues
Gheorghe Solcan Sandra Sousa
Gill Diamond Santiago Gutierrez
Gisela Degen Santiago Pedro Aubourg Martínez
Gleiston Dias Saul Gomez-Manzo
Gniewko Wieckiewicz Sebastian Ulrich
Goran Gajski Sebastian Werneburg
Goran Kis Sergio Minucci
Gordana Wozniak Knopp Shahid Ali Rajput
Greta Gaiani Shin-Ichiro Miyashita
Grzegorz Zieliński Shozo Yano
Guanglin Zhang Shu-Feng Zhang
Guillermin Agüero-Chapin Silvia Bando
Guillermo de la Rosa Silvia Pichardo
Guoyou Zhang Silvio Sosa
Guy Hans Silvio Veiga
Hafiz Muhammad Umer Farooqi Song Yu
Haifei Wang Songhai Tian
Hak Jun Kim Spiros Paramithiotis
Hang-kin Kong Srinivas Sura
Heather Hallen-Adams Stefano Accoroni
Héctor Mora-Montes Stephen Duke
Hélène Niculita-Hirzel Stephen Inbaraj
Holger Zetzsche Stephen Melville
Horst Posthaus Stoycho Stoev
Hugh Byrne Sumita Dutta
Humberto Hernandez-Sanchez Suresh Verma
Hyun-Woo Park Svetlana V. Malysheva
Ignacio Leyva Valencia Svetoslav Todorov
Igor Maksimov Sylwester Ciećwież
Ilona Sadok Tadashi Kimura
Ioana Ionut Tadeusz Kaminski
Ioannis-Dimosthenis Adamakis Takeshi Fujino
Ionel Alexandru Checherita Tao Li
Isabel Sierra Tapani Yli-Mattila
Ivan Pecorelli Tarana Arman
Ivan Savic Tariq Mukhtar
Ivo Fridolin Teresa D'Amore
Iwona Poziomkowska-Gęsicka Theodoros Mavridis
Izabela Podgórska-Kryszczuk Thierry Cens
Izabela Zakrocka Tiago Nazareth
Jacek Rybka Tibor Fülöp
Jai Singh Patel Tihana Kurtović
Jaime Bustos-Martinez Tina Wismer
Jan Langenberg Toby Sanan
Jaroslaw Dulski Tomasz Szablewski
Jay Fox Tomasz Szymborski
Jean Mukherjee Tommaso Ercoli
Jean-Marie Exbrayat Tracy Daniels-Wells
Jean-Michel Savoie Tünde Pusztahelyi
Jelka Pleadin Tzu-Ping Ko
Jesús Marín-Sáez Umair Muhammad
Jesus Morón-López Valeria Di Dato
Jian-Fang Gao Vera Costa
Jiangbing Qiu Vera Kostikova
Jianhua Wang Véronique Fontaine
Jianlin Li Vinay Shivanna
Jinlong Liu Viridiana Magaña Dueñas
Joana Damásio Vitalii Timofeev
Joanna Rudnicka Vladimir Dvoretsky
Jochen D. Schipke Wanchun Guan
Jolanta Wawrzyniak Wansu Park
Jon Woods Weijiang Zheng
Jonatan Dorca-Arévalo Wiebke Albrecht
Jorge Javier Alfonso Wiesław Bielas
José Ascención Martínez Álvarez William Hayes
Jose Malaquias William Lawrence
José Miguel Ferreras Wilson Rumbeiha
José Rafael de Almeida Xiao Shen
Joshua Jue Xingjun Feng
Juan Blanco Xueqing Xu
Juan Carlos Angeles-Hernandez Yajun Yang
Juan Carlos Moltó Yanyang Xu
Juan Ferre Yaroslav Andreev
Juliana Pavan Zuliani Yasmina Abd-Elhakim
Julien Barbier Yida Gao
Jürgen Frevert Ying Jia
Justyna Libera Yingang Feng
Kai Wang Yongpeng Guo
Kaloyan Petrov Yongsik Sin
Kari Stone Younes Rashad
Karolina Kowalska Yu Cai
Kazuya Murata Yunhai Cui
Keith Warriner Yuta Kudo
Khalid Masoodi Željko Jakopović
Kimio Fukami Zhanna Pisarenko
Kirthiram Sivakumar Zhiming Guo
Konstantin Moiseenko Zhiyong Zhao
Krastena Nikolova Zia-ud-Din Sindhu
Krishnarjuna Bankala Zivana Nincevic
Kunlong Yang Zoltán Győri
Kusol Pootanakit Zoltán Pethő
Lanfranco Troncone Zorana Katanic
Lara Manyes Тatyana Odintsova

2 January 2024
MDPI Insights: The CEO’s Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

30 November 2023
MDPI Insights: The CEO’s Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Spain Summit


Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members


Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!


MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session


Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home


Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month


Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.

Mindfulness

Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer
MDPI AG

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023


We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!


Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Van Mierlo, Joeri
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

1 November 2023
MDPI Insights: The CEO’s Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access Week 2023 – the Global Drive to Open Continues

As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.

International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.

Core principles of OA publishing

Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.

One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.

OA holds the potential to democratize knowledge, advance science, and drive positive societal change.

Policy driving change

Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the USEU and China

OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.

For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.

MDPI is proud to lead the transition to open access.

Read more:

Impactful Research

Spotlight on Smart Cities

Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.

As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.

Highly cited papers in Smart Cities

Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.

1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.

2. “A Review on Electric Vehicles: Technologies and Challenges
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.

3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.

4. “Artificial Intelligence Techniques in Smart Grid: A Survey
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.

5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.

Testimonial

“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators. – Dr. Luís Rosa, University of Minho

Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility

Inside MDPI

MDPI Manchester office, UK Visit


Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.

In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.

Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.

I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.

The UK by numbers

The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.

As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.

According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.

We are currently hiring EEs in various locations worldwide.

English Editing at MDPI

Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.

While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.

Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.

Testimonials

“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam

“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño

Read more:

Coming Together for Science

STM and Frankfurt Book Fair

Attending STM

MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.

Meeting with Web of Science

On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.

“We discussed ways to improve our communication and collaboration.”

I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.

75th Frankfurt Book Fair


Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.

For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.

MDPI Books

Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?

The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.

Closing Thoughts

MDPI Strategy Meeting

As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.

Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.

“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”

As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!

Stefan Tochev
Chief Executive Officer
MDPI AG

19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues


MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the USEU and China

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

10 October 2023
Toxins | Highly Cited Reviews in 2021–2022


It is our great honor to present some of the review papers with more than 10 citations published by Toxins (ISSN: 2072-6651) in 2021 and 2022. We would like to take this opportunity to acknowledge the outstanding individuals and teams whose work inspires fellow researchers and profoundly influences the field of toxins system science. We welcome you to read these outstanding works listed below

1. “Zearalenone and Its Metabolites—General Overview, Occurrence, and Toxicity”
by Karolina Ropejko and Magdalena Twarużek
Toxins 2021, 13(1), 35; https://doi.org/10.3390/toxins13010035
Full text available online: https://www.mdpi.com/2072-6651/13/1/35

2. “The Food Poisoning Toxins of Bacillus cereus
by Richard Dietrich, Nadja Jessberger, Monika Ehling-Schulz, Erwin Märtlbauer and Per Einar Granum
Toxins 2021, 13(2), 98; https://doi.org/10.3390/toxins13020098
Full text available online: https://www.mdpi.com/2072-6651/13/2/98

3. “Botulinum Toxin in Movement Disorders: An Update”
by Charenya Anandan and Joseph Jankovic
Toxins 2021, 13(1), 42; https://doi.org/10.3390/toxins13010042
Full text available online: https://www.mdpi.com/2072-6651/13/1/42

4. “Zearalenone and the Immune Response”
by Cristina Valeria Bulgaru, Daniela Eliza Marin, Gina Cecilia Pistol and Ionelia Taranu
Toxins 2021, 13(4), 248; https://doi.org/10.3390/toxins13040248
Full text available online: https://www.mdpi.com/2072-6651/13/4/248

5. “Phytotoxic Secondary Metabolites from Fungi”
by Dan Xu, Mengyao Xue, Zhen Shen, Xiaowei Jia, Xuwen Hou, Daowan Lai and Ligang Zhou
Toxins 2021, 13(4), 261; https://doi.org/10.3390/toxins13040261
Full text available online: https://www.mdpi.com/2072-6651/13/4/261

6. “Old World Vipers—A Review about Snake Venom Proteomics of Viperinae and Their Variations”
by Maik Damm, Benjamin-Florian Hempel and Roderich D. Süssmuth
Toxins 2021, 13(6), 427; https://doi.org/10.3390/toxins13060427
Full text available online: https://www.mdpi.com/2072-6651/13/6/427

7. “Chronic Kidney Disease-Associated Pruritus”
by Puneet Agarwal, Vinita Garg, Priyanka Karagaiah, Jacek C. Szepietowski, Stephan Grabbe and Mohamad Goldust
Toxins 2021, 13(8), 527; https://doi.org/10.3390/toxins13080527
Full text available online: https://www.mdpi.com/2072-6651/13/8/527

8. “The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming”
by José María Gutiérrez, Laura-Oana Albulescu, Rachel H. Clare, Nicholas R. Casewell, Tarek Mohamed Abd El-Aziz, Teresa Escalante and Alexandra Rucavado
Toxins 2021, 13(7), 451; https://doi.org/10.3390/toxins13070451
Full text available online: https://www.mdpi.com/2072-6651/13/7/451

9. “Uremic Toxins and Blood Purification: A Review of Current Evidence and Future Perspectives”
by Stefania Magnani and Mauro Atti
Toxins 2021, 13(4), 246; https://doi.org/10.3390/toxins13040246
Full text available online: https://www.mdpi.com/2072-6651/13/4/246

10. “An Updated Review of Bioactive Peptides from Mushrooms in a Well-Defined Molecular Weight Range”
by Nicola Landi, Angela Clemente, Paolo V. Pedone, Sara Ragucci and Antimo Di Maro
Toxins 2022, 14(2), 84; https://doi.org/10.3390/toxins14020084
Full text available online: https://www.mdpi.com/2072-6651/14/2/84

11. “Algal Toxic Compounds and Their Aeroterrestrial, Airborne and other Extremophilic Producers with Attention to Soil and Plant Contamination: A Review”
by Georg Gӓrtner, Maya Stoyneva-Gӓrtner and Blagoy Uzunov
Toxins 2021, 13(5), 322; https://doi.org/10.3390/toxins13050322
Full text available online: https://www.mdpi.com/2072-6651/13/5/322

12. “Anabaenopeptins: What We Know So Far”
by Patrick Romano Monteiro, Samuel Cavalcante do Amaral, Andrei Santos Siqueira, Luciana Pereira Xavier and Agenor Valadares Santos
Toxins 2021, 13(8), 522; https://doi.org/10.3390/toxins13080522
Full text available online: https://www.mdpi.com/2072-6651/13/8/522

13. “Immunotoxic Effects Induced by Microcystins and Cylindrospermopsin: A Review”
by Leticia Diez-Quijada, Maria del Monte Benítez-González, María Puerto, Angeles Jos and Ana M. Cameán
Toxins 2021, 13(10), 711; https://doi.org/10.3390/toxins13100711
Full text available online: https://www.mdpi.com/2072-6651/13/10/711

14. “The Natterin Proteins Diversity: A Review on Phylogeny, Structure, and Immune Function”
by Carla Lima, Geonildo Rodrigo Disner, Maria Alice Pimentel Falcão, Ana Carolina Seni-Silva, Adolfo Luis Almeida Maleski, Milena Marcolino Souza, Mayara Cristina Reis Tonello and Monica Lopes-Ferreira
Toxins 2021, 13(8), 538; https://doi.org/10.3390/toxins13080538
Full text available online: https://www.mdpi.com/2072-6651/13/8/538

15. “Ochratoxin A in Slaughtered Pigs and Pork Products”
by Mikela Vlachou, Andreana Pexara, Nikolaos Solomakos and Alexander Govaris
Toxins 2022, 14(2), 67; https://doi.org/10.3390/toxins14020067
Full text available online: https://www.mdpi.com/2072-6651/14/2/67

2 October 2023
MDPI Insights: The CEO’s Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access in China

It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.

Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!

Open Access Policy in China

As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.

Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.

In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.

In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.

MDPI Offices in China

 While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.


Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.

In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

Our Strength is in Our People

With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.

In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.

Impactful Research

MDPI Awards

To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.

In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.

Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.

To learn more about MDPI Awards and to find out which are currently available, please click here.

MDPI Awards to Scholars from China

Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.

MDPI’s Tu Youyou Award


Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.

The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.

2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu

Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.

Highly Cited Articles by Chinese Scholars Published in MDPI

Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.

Read more:

Inside MDPI

Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.

Marketing Department in China

During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.

I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.

Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.

Coming Together for Science

Collaborations, Scholarships and Meetings

MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.

Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.

Scholarships in China

Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).

Meeting with the Society of Chinese University Journals (CUJS)


Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.

I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.

We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.

MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.

Meeting with National Science Library, Chinese Academy of Sciences (NSLC)


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.

We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our  IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.

In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.

The Numbers

As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.

At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.

Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.

Closing Thoughts

Final Reflections on our MDPI Offices in Beijing and Wuhan


Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.

I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.

Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.

95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).

91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.

Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.

Hospitality and Service

Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.

I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.

Stefan Tochev
Chief Executive Officer
MDPI AG

25 September 2023
Toxins | Highly Cited Articles in 2021–2022


It is our great honor to present some of the articles with more than 10 citations published by Toxins (ISSN: 2072-6651) in 2021 and 2022. We would like to take this opportunity to acknowledge the outstanding individuals and teams whose work inspires fellow researchers and profoundly influences the field of toxins system science. We welcome you to read these outstanding works listed below:

1. “Multi-Mycotoxin Contamination of Maize Silages in Flanders, Belgium: Monitoring Mycotoxin Levels from Seed to Feed”
by Jonas Vandicke, Katrien De Visschere, Maarten Ameye, Siska Croubels, Sarah De Saeger, Kris Audenaert and Geert Haesaert
Toxins 2021, 13(3), 202; https://doi.org/10.3390/toxins13030202
Full text available online: https://www.mdpi.com/2072-6651/13/3/202

2. “Occurrence of Fusarium Mycotoxins and Their Modified Forms in Forage Maize Cultivars”
by Tim Birr, Tolke Jensen, Nils Preußke, Frank D. Sönnichsen, Marthe De Boevre, Sarah De Saeger, Mario Hasler, Joseph-Alexander Verreet and Holger Klink
Toxins 2021, 13(2), 110; https://doi.org/10.3390/toxins13020110
Full text available online: https://www.mdpi.com/2072-6651/13/2/110

3. “Staphylococcus aureus Extracellular Vesicles: A Story of Toxicity and the Stress of 2020
by Xiaogang Wang, Paul F. Koffi, Olivia F. English and Jean C. Lee
Toxins 2021, 13(2), 75; https://doi.org/10.3390/toxins13020075
Full text available online: https://www.mdpi.com/2072-6651/13/2/75

4. “Co-Occurrence of 35 Mycotoxins: A Seven-Year Survey of Corn Grain and Corn Silage in the United States”
by Alexandra C. Weaver, Daniel M. Weaver, Nicholas Adams and Alexandros Yiannikouris
Toxins 2021, 13(8), 516; https://doi.org/10.3390/toxins13080516
Full text available online: https://www.mdpi.com/2072-6651/13/8/516

5. “Aflatoxin B1 Toxicity in Zebrafish Larva (Danio rerio): Protective Role of Hericium erinaceus
by Davide Di Paola, Carmelo Iaria, Fabiano Capparucci, Marika Cordaro, Rosalia Crupi, Rosalba Siracusa, Ramona D’Amico, Roberta Fusco, Daniela Impellizzeri, Salvatore Cuzzocrea et al.
Toxins 2021, 13(10), 710; https://doi.org/10.3390/toxins13100710
Full text available online: https://www.mdpi.com/2072-6651/13/10/710

6. “An Update on Ciguatoxins and CTX-like Toxicity in Fish from Different Trophic Levels of the Selvagens Islands (NE Atlantic, Madeira, Portugal)
by Pedro Reis Costa, Pablo Estévez, Lucía Soliño, David Castro, Susana Margarida Rodrigues, Viriato Timoteo, José Manuel Leao-Martins, Carolina Santos, Neide Gouveia, Jorge Diogène et al.
Toxins 2021, 13(8), 580; https://doi.org/10.3390/toxins13080580
Full text available online: https://www.mdpi.com/2072-6651/13/8/580

7. “A Neurotoxic Snake Venom without Phospholipase A2: Proteomics and Cross-Neutralization of the Venom from Senegalese Cobra, Naja senegalensis (Subgenus: Uraeus)”
by Kin Ying Wong, Kae Yi Tan, Nget Hong Tan and Choo Hock Tan
Toxins 2021, 13(1), 60; https://doi.org/10.3390/toxins13010060
Full text available online: https://www.mdpi.com/2072-6651/13/1/60

8. “Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease
by Satoshi Kumakura, Emiko Sato, Akiyo Sekimoto, Yamato Hashizume, Shu Yamakage, Mariko Miyazaki, Sadayoshi Ito, Hideo Harigae and Nobuyuki Takahashi
Toxins 2021, 13(1), 50; https://doi.org/10.3390/toxins13010050
Full text available online: https://www.mdpi.com/2072-6651/13/1/50

9. “An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients”
by Carmela Cosola, Maria Teresa Rocchetti, Ighli di Bari, Paola Maria Acquaviva, Valentina Maranzano, Simone Corciulo, Agostino Di Ciaula, Domenica Maria Di Palo, Flavia Maria La Forgia, Sergio Fontana et al.
Toxins 2021, 13(5), 334; https://doi.org/10.3390/toxins13050334
Full text available online: https://www.mdpi.com/2072-6651/13/5/334

10. “Acute Toxicity of Gambierone and Quantitative Analysis of Gambierones Produced by Cohabitating Benthic Dinoflagellates”
by J. Sam Murray, Sarah C. Finch, Jonathan Puddick, Lesley L. Rhodes, D. Tim Harwood, Roel van Ginkel and Michèle R. Prinsep
Toxins 2021, 13(5), 333; https://doi.org/10.3390/toxins13050333
Full text available online: https://www.mdpi.com/2072-6651/13/5/333

11. “Ageratina adenophora Disrupts the Intestinal Structure and Immune Barrier Integrity in Rats”
by Yujing Cui, Samuel Kumi Okyere, Pei Gao, Juan Wen, Suizhong Cao, Ya Wang, Junliang Deng and Yanchun Hu
Toxins 2021, 13(9), 651; https://doi.org/10.3390/toxins13090651
Full text available online: https://www.mdpi.com/2072-6651/13/9/651

12. “Populations of Helicoverpa zea (Boddie) in the Southeastern United States are Commonly Resistant to Cry1Ab, but Still Susceptible to Vip3Aa20 Expressed in MIR 162 Corn
by Ying Niu, Isaac Oyediran, Wenbo Yu, Shucong Lin, Marcelo Dimase, Sebe Brown, Francis P. F. Reay-Jones, Don Cook, Dominic Reisig, Ben Thrash et al.
Toxins 2021, 13(1), 63; https://doi.org/10.3390/toxins13010063
Full text available online: https://www.mdpi.com/2072-6651/13/1/63

13. “Prevalence and Characterization of PVL-Positive Staphylococcus aureus Isolated from Raw Cow’s Milk”
by Asmaa Sadat, Radwa Reda Shata, Alshimaa M. M. Farag, Hazem Ramadan, Adel Alkhedaide, Mohamed Mohamed Soliman, Mohamed Elbadawy, Amira Abugomaa and Amal Awad
Toxins 2022, 14(2), 97; https://doi.org/10.3390/toxins14020097
Full text available online: https://www.mdpi.com/2072-6651/14/2/97

14. “Antimicrobial, Insecticidal and Cytotoxic Activity of Linear Venom Peptides from the Pseudoscorpion Chelifer cancroides
by Jonas Krämer, Tim Lüddecke, Michael Marner, Elena Maiworm, Johanna Eichberg, Kornelia Hardes, Till F. Schäberle, Andreas Vilcinskas and Reinhard Predel
Toxins 2022, 14(1), 58; https://doi.org/10.3390/toxins14010058
Full text available online: https://www.mdpi.com/2072-6651/14/1/58

15. “Article Potential of Trichoderma spp. for Biocontrol of Aflatoxin-Producing Aspergillus flavus
by Xianfeng Ren, Maria Teresa Branà, Miriam Haidukowski, Antonia Gallo, Qi Zhang, Antonio F. Logrieco, Peiwu Li, Shancang Zhao and Claudio Altomare
Toxins 2022, 14(2), 86; https://doi.org/10.3390/toxins14020086
Full text available online: https://www.mdpi.com/2072-6651/14/2/86

18 September 2023
Meet Us at the 4th Conference on Food Bioactives & Health, 18–21 September 2023, Prague, Czech Republic


MDPI will be attending the 4th Conference on Food Bioactives & Health, which will be held from 18 to 21 September 2023 in Prague, Czech Republic.

The conference has already established itself as an important international forum for the presentation of the latest research results in the field of food bioactives, such as (poly)phenols, glucosinolates, carotenoids, peptides, (poly)saccharides, lipids, and other beneficial food constituents, but also of food contaminants and toxins. Contributions to the development of functional foods and food supplements, nutrition policy, personalized nutrition, and the bioavailability, absorption, and metabolism of food constituents and their interaction with gut microbiota are especially welcome. Researchers, practitioners, and policy makers with different professional backgrounds (e.g., physiologists, nutritionists, pharmacologists, plant scientists, and toxicologists) are welcome in order to create a multidisciplinary discussion forum typical of Food Bioactives & Health conferences.

The following MDPI journals will be represented:

  • Nutrients;
  • Foods;
  • CIMB;
  • Toxins;
  • Dietetics.

If you are planning to attend this conference, please feel free to stop by our booth and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://fbhc2023.com/.

6 September 2023
Recap of Awards Granted to Scholars in 2022


MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

30 August 2023
MDPI Insights: The CEO’s Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Our Commitment to Sustainability

As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.

In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.

MDPI and the Sustainable Development Goals (SDGs)

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.

“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]

As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:

MDPI journals specializing in sustainability-related topics:

  • 2009: Sustainability
  • 2012: Resources
  • 2013: Climate
  • 2014: Environments
  • 2016: Recycling
  • 2019: Clean Technologies
  • 2020: Sustainable Chemistry
  • 2021: Wind, Biomass, Conservation, Pollutants, Solar
  • 2022: Waste, Microplastics

Read more:

Impactful Research

Highly Cited Articles in Sustainability

In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.

We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.

“Sustainability received a 2022 CiteScore of 5.8”

While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.

Highly Cited Papers in Sustainability

Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.

1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?
Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)

This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.

2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety
Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)

This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.

3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review
Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)

This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.

4. Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions
Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)

This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.

Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).

Read more:

Inside MDPI

President of Ireland Authors Editorial in MDPI Journal Sustainability

It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:

This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.

The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.

As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.

Read the completed editorial here:

Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683

Coming Together for Science

The World Sustainability Forum 2023

The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.

This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:

  • The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
  • The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
  • The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.

MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research

The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:

  1. The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
  2. The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.

The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.

2023 World Sustainability Award Winners

  1. Professor Michael R. Templeton
  2. Professor Tom Lyon
  3. Dr Krithi K. Karanth

Interviews with 2023 Emerging Sustainability Leader Award Finalists

  • Dr. Bahareh Kamranzad
  • Dr. Youjin Kim
  • Dr. Julia Lohmann

As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.

Read more:

Closing Thoughts

“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier

I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.

MDPI’s Interaction with Elsevier

In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.

“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”

Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.

It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.

‘Fully OA’ Organizations Dedicated to Open Access

MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.

This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.

As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”

Stefan Tochev
Chief Executive Officer
MDPI AG

14 August 2023
MDPI’s 2022 Young Investigator Awards in Biology and Life Sciences—Winners Announced


MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in biology and life sciences. The winners were selected by the journals’ Award Evaluation Committee.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Agriculture:

  • Thomas Hartinger, University of Veterinary Medicine Vienna, Austria

Agronomy:

  • Leontina Lipan, Universidad Miguel Hernández, Spain

Animals:

  • Daniel Stec, Polish Academy of Sciences, Poland

Brain Sciences:

  • Dibyadeep Datta, Yale Medical School, USA
  • Giacomo Valle, ETH Zurich, Switzerland
  • Morgan H. James, Rutgers University, USA

Foods:

  • Xiaonan Lu, McGill University, Canada

Genes:

  • Alfredo Iacoangeli, King's College London, UK
  • Elisa De Franco, University of Exeter, UK
  • Riccardo Pecori, German Cancer Research Center, Germany
  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Horticulturae:

  • Massimiliano Renna, University of Bari Aldo Moro at Bari, Italy

Insects:

  • Adam G. Dolezal, University of Illinois Urbana-Champaign, United States

Microorganisms:

  • Carla Rodrigues, Institut Pasteur, France
  • Lorena Rodriguez-Rubio, University of Barcelona, Spain
  • Kevin Solomon, University of Delaware, USA

Nutrients:

  • Colleen Deane, University of Southampton, UK

Toxins:

  • Paz Otero Fuertes, University of Vigo, Spain

Pathogens:

  • Marta Giovanetti, National Reference Laboratory of Flavivirus in the Oswaldo Cruz Foundation, Brazil
  • Carrie M. Long, National Institute of Allergy and Infectious Diseases (NIAID), USA

Vaccines:

  • Carina Joe, University of Oxford, UK

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Travel Awards in Biology and Life Sciences—Winners Announced


We are proud to recognize the winners of MDPI’s 2022 Travel Awards in biology and life sciences for their outstanding presentations.

MDPI journals regularly offer travel awards to encourage junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the winners of the 2022 Travel Awards and wish them the greatest success in their future research endeavors. MDPI will continue to enhance communication among scientists.

Brain Sciences:

  • Liloia Donato, University of Turin, Italy
  • Roberta Bettoni, University of Milano Bicocca, Italy

Diversity:

  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

IJMS:

  • Carlo Matera, University of Milan, Italy
  • Elisabetta Coppi, University of Florence, Italy
  • Ilaria Tonazzini, Nanoscience Institute—National Research Council (CNR) @ NEST in Pisa, Italy

MPs:

  • Pere Catala, University Eye Clinic Maastricht, Maastricht University Medical Center, the Netherlands

Sports:

  • Angela Blasimann, University of Antwerp, Belgium
  • Angelo Sabag, Western Sydney University, Australia

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Biology and Life Sciences—Winners Announced


In order to acknowledge our reviewers, who demonstrate diligence, professionalism, and timeliness when generously dedicating their time to reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer review process.

We are proud to recognize the winners for the year 2022 in biology and life sciences for their outstanding contributions, among extensive competition, by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Agronomy:

  • Ewa Ropelewska, The National Institute of Horticultural Research, Poland
  • Marek Rašovský, Slovak University of Agriculture in Nitra, Slovakia
  • Prakash Jha, Kansas State University, USA
  • Vasileios Greveniotis, Institute of Industrial and Forage Crops, Greece

Biology:

  • Alberto Collareta, University of Pisa, Italy
  • Francisco Curate, University of Coimbra, Portugal
  • Gianpiero Greco, University of Study of Bari, Italy
  • Luca Poli, University of Study of Bari, Italy
  • Shaohua Chen, South China Agricultural University, China

Brain Sciences:

  • Chong Chen, Yamaguchi University Graduate School of Medicine, Japan

Children:

  • Marco Sapienza, University of Catania, Italy
  • Sabina Barrios-Fernández, University of Extremadura, Spain

Diversity:

  • Corrado Battisti, Torre Flavia LTER (Long Term Ecological Research) Station, Italy
  • Daniel Stec, Institute of Systematics and Evolution of Animals of the Polish Academy of Sciences, Poland
  • Emilia Grzędzicka, Institute of Systematics and Evolution of Animals of the Polish Academy of Sciences, Poland
  • Igor Zelnik, University of Ljubljana, Slovenia

Endocrines:

  • Eva S. Liu, 1Harvard Medical School, USA 2Brigham and Women’s Hospital, USA

Fermentation:

  • Aleksandra Szydlowska, Warsaw University of Life Sciences (WULS), Poland
  • Mohamed Ali Abdel-Rahman, Al-Azhar University, Egypt

Fishes:

  • Andrew G. Jeffs, University of Auckland, New Zealand
  • Mohamed Samy-Kamal, Universitat d'Alacant, Spain

Foods:

  • Baskaran Stephen Inbaraj, Fu Jen Catholic University, Taiwan
  • Marzena Włodarczyk-Stasiak, University of Life Sciences in Lublin, Poland
  • Minaxi Sharma, Haute Ecole Provinciale de Hainaut-Condorcet, Belgium
  • Viviani Ruffo de Oliveira, Federal University of Rio Grande do Sul (UFRGS), Brazil

Genes:

  • Federico Manuel Giorgi, University of Bologna, Italy
  • Jan Bocianowski, Poznań University of Life Sciences, Poland
  • Magdalena Mroczek, Center for Cardiovascular Genetics and Gene Diagnostics, Switzerland

IJMS:

  • Keigi Fujiwara, University of Texas MD Anderson Cancer Center, USA
  • Tomasz W. Kaminski, University of Pittsburgh, USA
  • Takujiro Homma, Yamagata University, Japan
  • William Bryan Terzaghi, Wilkes University, United States
  • Zong-jie Cui, Beijing Normal University, China

Insects:

  • Abraão Almeida Santos, University of Florida, USA
  • Agata Kaczmarek, Polish Academy of Sciences, Poland
  • Miguel A. García-Martínez, Universidad Veracruzana, Mexico

Life:

  • Andrei S. Rodin, Diabetes and Metabolism Research Institute, USA
  • Kazuhiko Kotani, Jichi Medical University, Japan

Metabolites:

  • Jianing Mi, King Abdullah University of Science and Technology, Saudi Arabia
  • Nguyen Phuoc Long, Inje University College of Medicine, Republic of Korea
  • Xian Luo, University of Alberta, Canada

Pathogens:

  • Guillaume Fiches, Ohio State University, USA
  • Jianxuan Wu, Gilead Sciences, USA
  • Tomasz M. Karpiński, Poznań University of Medical Sciences, Poland

Plants:

  • Alicia Ayerdi Gotor, Institut Polytechnique UniLaSalle, France
  • Andrea Mastinu, University of Brescia, Italy
  • Edyta Paczos-Grzeda, University of Life Sciences in Lublin, Poland
  • Narayan Bhusal, Seoul National University, Republic of Korea
  • Mohsen Hesami, University of Guelph, Canada

Toxins:

  • Christian Müller, University of Greifswald, Germany
  • Margarita Fernández-Tejedor, IRTA, Spain

Vaccines:

  • Christian Napoli, “Sapienza” University of Rome, Italy
  • Federico Marchesi, University of Parma, Italy
  • Roger E. Thomas, University of Calgary, Canada

Veterinary Sciences:

  • Fun-In Wang, National Taiwan University, Taiwan
  • Valeria Grieco, University of Milan, Italy

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Biology and Life Sciences—Winners Announced


MDPI’s Best PhD Thesis Awards are presented to recognize the young scholars who are judged to have completed the most outstanding PhD thesis in their field of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to warmly congratulate the winners of the 2022 Best PhD Thesis Awards and wish them success in their future research endeavors. MDPI will continue to enhance communication among scientists.

Brain Sciences:

  • “CYP2D in the Brain Alters Response to Drugs and Neurotoxins”
    by Marlaina R. Stocco, University of California, USA
  • “Neural Encoding of Prior Experience in Sensorimotor Behavior”
    by Nicolas Meirhaeghe, Institut de Neurosciences de la Timone, France
  • “Perinatal Stem Cell: Epigenetic, Biological and Differentiative Characteristics”
    by Giulia Gaggi, University "G.D'Annunzio" of Chieti-Pescara, Italy

Genes:

  • “Uncovering the Genetic Variation Involved in Asthma Exacerbations through Multiple Genomic Approaches”
    by Esther Herrera Luis, Universidad de La Laguna, Spain

Veterinary Sciences:

  • “Development of Novel Tools for Monitoring Antimicrobial Resistance in Complex Microbial Communities and Their Application to Improving Our Stewardship of Antimicrobials in Livestock”
    by Ashenafi Feyisa Beyi, Iowa State University, United States

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s Best Paper Awards in Biology and Life Sciences—Winners Announced in 2022


The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as scientific merit, overall impact, and the quality of presentation.

We are honored to present the winners for the year 2022 in biology and life sciences, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Agronomy:

Biology:

Brain Sciences:

Diversity:

Genes:    

IJMS:     

Insects:  

Life:

Metabolites:          

MPs:

Pathogens:

Plants:

Toxins:

Vaccines:               

Veterinary Sciences:

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

27 July 2023
MDPI Insights: The CEO’s Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Peer Review Reports

Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.

MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.

Start and Growth of Open Peer Review at MDPI

The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.

As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.

Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.

Benefits of Open Peer Review

The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.

As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.

Impactful Research

MDPI Papers Cited in the News – IJERPH edition

Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.

During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.

Highly Cited Journal Publications

IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:

  • International Journal of Environmental Research and Public Health: 3509 mentions
  • Nutrients: 2698 mentions
  • International Journal of Molecular Sciences: 1701 mentions
  • Journal of Clinical Medicine: 1131 mentions
  • Viruses: 1111 mentions

These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.

Example of Recent Mentions

During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:

The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper:Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments

Harvard Business Review: “How to Take Better Breaks at Work, According to Research
IJERPH paper:Canine-Assisted Therapy Improves Well-Being in Nurses

National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way
IJERPH paper:Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease

Inside MDPI

MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process

At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.

Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.

To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.

The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.

In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.

Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.

Read more:

Coming Together for Science

The Future of IJERPH

On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.

While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.

Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.

Journal Achievements

In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:

  • Founded by Prof. Dr. Paul B. Tchounwou in 2004
  • Indexed in PubMed in 2008
  • Received its first Impact Factor in 2012
  • Published its 5000th paper in 2017
  • Over 60,000 papers published as at June 30, 2023
  • 131,628,173 paper views in 2018–2022
  • Over 28,000 mentions in prominent news outlets
  • 17,000 papers cited 10 times or more as at June 30, 2023
  • No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
  • Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.

These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.

Closing Thoughts

MDPI’s Impact in Spain

During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.

Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.

The Numbers

Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).

Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.

Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.

Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.

Testimonials

I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:

Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)

Stefan Tochev
Chief Executive Officer
MDPI AG

11 July 2023
MDPI’s Newly Launched Journals in June 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal topics (selected)
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue growth and development;
diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee ([email protected]) if you would like to create more new journals.

3 July 2023
MDPI Insights: The CEO’s Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

The Future is Open, and MDPI is Leading the Way

I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.

1 Million Published Articles

2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.

Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.

Liberating Science

As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.

In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:

"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”

Impactful Research

MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases

MDPI journals are indexed in every single top database in the world.

As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.

Continued Growth of MDPI Journals

The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.

Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.

Read more

Interview with Indexing Manager—Constanze Shelhorn

Inside MDPI

Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science

At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.

Increased Visibility for Preprints

I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.

Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.

Read more

What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?

Coming Together for Science

The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications

In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.

Working Together

Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.

Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.

Managing Events With Sciforum

If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!

Read more

Sciforum: forthcoming events
Spotlight on Antioxidants

Closing Thoughts

Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang

Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team

During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.

I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.

Testimonials

If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:

“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet

Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection

Stefan Tochev
Chief Executive Officer
MDPI AG

28 June 2023
2022 Impact Factors for MDPI Journals

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Journal Impact Factor Rank Quartile Category
Vaccines 7.8 Q1 Immunology
Medicine, Research & Experimental
Antioxidants 7.0 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 6.0 Q2 Cell Biology
Nutrients 5.9 Q1 Nutrition & Dietetics
International Journal of Molecular Sciences 5.6 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Journal of Theoretical and Applied Electronic Commerce Research 5.6 Q2 Business
Biomolecules 5.5 Q1 Biochemistry & Molecular Biology
Biosensors 5.4 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Fractal and Fractional 5.4 Q1 Mathematics, Interdisciplinary Applications
Marine Drugs 5.4 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Pharmaceutics 5.4 Q1 Pharmacology & Pharmacy
Nanomaterials 5.3 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Cancers 5.2 Q2 Oncology
Foods 5.2 Q1 Food Science & Technology
Polymers 5.0 Q1 Polymer Science
Remote Sensing 5.0 Q1 Geosciences, Multidisciplinary
Q2 Remote Sensing
Imaging Science & Photographic Technology
Environmental Sciences
Antibiotics 4.8 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Drones 4.8 Q2 Remote Sensing
Journal of Functional Biomaterials 4.8 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.7 Q1 Pharmacology & Pharmacy
Q2 Biochemistry & Molecular Biology
Medicine, Research & Experimental
Journal of Fungi 4.7 Q2 Mycology
Microbiology
Viruses 4.7 Q2 Virology
Bioengineering 4.6 Q2 Engineering, Biomedical
Gels 4.6 Q1 Polymer Science
Molecules 4.6 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Pharmaceuticals 4.6 Q2 Pharmacology & Pharmacy
Chemistry, Medicinal
Toxics 4.6 Q1 Toxicology
Q2 Environmental Sciences
Biomimetics 4.5 Q1 Engineering, Multidisciplinary
Q2 Materials Science, Biomaterials
Microorganisms 4.5 Q2 Microbiology
Plants 4.5 Q1 Plant Sciences
Biology 4.2 Q2 Biology
Chemosensors 4.2 Q2 Instruments & Instrumentation
Chemistry, Analytical
Electrochemistry
Membranes 4.2 Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Polymer Science
Toxins 4.2 Q1 Toxicology
Q2 Food Science & Technology
Metabolites 4.2 Q2 Biochemistry & Molecular Biology
Batteries 4.0 Q2 Electrochemistry
Materials Science, Multidisciplinary
Q3 Energy & Fuels
Catalysts 3.9 Q2 Chemistry, Physical
Journal of Clinical Medicine 3.9 Q2 Medicine, General & Internal
Land 3.9 Q2 Environmental Studies
Sensors 3.9 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Sustainability 3.9 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Green & Sustainable Science & Technology (SSCI)
Buildings 3.8 Q2 Construction & Building Technology
Engineering, Civil
Agronomy 3.7 Q1 Agronomy
Q2 Plant Sciences
Fermentation 3.7 Q2 Biotechnology & Applied Microbiology
Pathogens 3.7 Q2 Microbiology
Agriculture 3.6 Q1 Agronomy
Diagnostics 3.6 Q2 Medicine, General & Internal
Genes 3.5 Q2 Genetics & Heredity
Journal of Intelligence 3.5 Q2 Psychology, Multidisciplinary
Lubricants 3.5 Q2 Engineering, Mechanical
Processes 3.5 Q2 Engineering, Chemical
Coatings 3.4 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
ISPRS International Journal of Geo-Information 3.4 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Materials 3.4 Q2 Metallurgy & Metallurgical Engineering
Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Micromachines 3.4 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Water 3.4 Q2 Water Resources
Environmental Sciences
Brain Sciences 3.3 Q3 Neurosciences
Energies 3.2 Q3 Energy & Fuels
Fire 3.2 Q1 Forestry
Q2 Ecology
Life 3.2 Q2 Biology
Current Issues in Molecular Biology 3.1 Q3 Biochemistry & Molecular Biology
Horticulturae 3.1 Q1 Horticulture
Animals 3.0 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Insects 3.0 Q1 Entomology
Atmosphere 2.9 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Electronics 2.9 Q2 Engineering, Electrical & Electronic
Physics, Applied
Q3 Computer Science, Information Systems
Forests 2.9 Q1 Forestry
Inorganics 2.9 Q2 Chemistry, Inorganic & Nuclear
Journal of Marine Science and Engineering 2.9 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Metals 2.9 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Tropical Medicine and Infectious Disease 2.9 Q2 Tropical Medicine
Parasitology
Q3 Infectious Diseases
Universe 2.9 Q2 Astronomy & Astrophysics
Physics, Particles & Fields
Healthcare 2.8 Q2 Health Policy & Services (SSCI)
Q3 Health Care Sciences & Services (SCIE)
Applied Sciences 2.7 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Crystals 2.7 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Entropy 2.7 Q2 Physics, Multidisciplinary
Magnetochemistry 2.7 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Symmetry 2.7 Q2 Multidisciplinary Sciences
Actuators 2.6 Q2 Instruments & Instrumentation
Engineering, Mechanical
Aerospace 2.6 Q1 Engineering, Aerospace
Behavioral Sciences 2.6 Q2 Psychology, Multidisciplinary
Current Oncology 2.6 Q3 Oncology
Machines 2.6 Q2 Engineering, Mechanical
Q3 Engineering, Electrical & Electronic
Medicina 2.6 Q3 Medicine, General & Internal
Separations 2.6 Q3 Chemistry, Analytical
Minerals 2.5 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Children 2.4 Q2 Pediatrics
Diversity 2.4 Q2 Biodiversity Conservation
Q3 Ecology
Journal of Cardiovascular Development and Disease 2.4 Q3 Cardiac & Cardiovascular Systems
Mathematics 2.4 Q1 Mathematics
Photonics 2.4 Q3 Optics
Veterinary Sciences 2.4 Q1 Veterinary Sciences
Fishes 2.3 Q2 Marine & Freshwater Biology
Fisheries
Axioms 2.0 Q2 Mathematics, Applied
Systems 1.9 Q2 Social Sciences, Interdisciplinary
Tomography 1.9 Q3 Radiology, Nuclear Medicine & Medical Imaging


Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)

 

13 June 2023
Toxins Receives an Increased CiteScore of 7.5


We are pleased to inform you that Toxins (ISSN: 2072-6651) has received an updated CiteScore of 7.5, an increase of 13.64% compared with the 2021 metric. The 2022 CiteScore™ was released recently, making an assessment of the scientific influence of journals in the 2019 to 2022 period.

Toxins’ CiteScore ranks as follows:

  • Q1 (21 out of 122) in the "Toxicology" category;
  • Q1 (25 out of 133) in the "Health, Toxicology and Mutagenesis" category.

For more journal statistics, please visit https://www.mdpi.com/journal/toxins/stats.

Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.

6 May 2023
Toxins Webinar | Fungal Metabolites: From Toxins to Therapeutics, Held on 12 May 2023


On 12 May 2023, MDPI and the journal Toxins (ISSN: 2072-6651) organized a webinar of the Toxins series, titled “Fungal Metabolites: From Toxins to Therapeutics”. The webinar focused on the study of mycotoxins. Mycotoxins are secondary metabolites produced by various filamentous fungi infecting plants and crops. It is now known that mycotoxins, through their biological activities, play crucial roles in fungi biology and ecology. Mycotoxins also have consequences for animal and human health through the ingestion of contaminated food and feeds, with animals/humans in that case being collateral casualties and not primary targets.

Dr. Marc Maresca and Dr. Isabelle Oswald gave an opening introduction first. Then, Prof. Sarah De Saeger introduced the mycotoxin bioanalysis: from human biomonitoring towards exposomics. Dr. Carine Al Ayoubi developed the evaluation of the mutagenicity and metabolism of the emerging mycotoxin versicolorin A, a precursor of aflatoxin B1. Dr. Hamza Olleik talked about whether fungal cyclo-depsipeptides are toxic or therapeutic. Lastly, Dr. Ana Olívia De Souza presented fungi from Brazilian biodiversity as a source of bioactive secondary metabolites.

Please note that this webinar is associated with a Topic in the Toxins journal: “Editorial Board Members’ Collection Series: Fungal Metabolites: From Toxins to Therapeutics”.

You can watch the recorded webinar at the following link: https://youtu.be/6PkHxGxDOds.

Webinar Chair and Keynote Speakers:

  • Dr. Marc Maresca, Institut des Sciences Moléculaires de Marseille (ISM2)–BiosCiences–UMR, CNRS Aix Marseille Université, France;
  • Dr. Isabelle Oswald, Research Center in Food Toxicology (Toxalim), Toulouse, University of Toulouse, France;
  • Prof. Sarah De Saeger, Department of Bioanalysis, Ghent University, Ghent, Belgium;
  • Dr. Ana Olívia De Souza, Development and Innovation Laboratory, Instituto Butantan, Sao Paulo, Brazil;
  • Dr. Carine Al-Ayoubi, UMR 1331 TOXALIM, INRAE, Toulouse, France;
  • Dr. Hamza Olleik, Institut des Sciences Moléculaires de Marseille, Marseille, France.

27 March 2023
Toxins Webinar | Cyanobacterial Toxins: Toxins Production and Risk Assessment, Held on 12 April 2023


On 12 April 2023, MDPI and the journal Toxins (ISSN: 2072-6651) organized a webinar of the Toxins series, entitled “Cyanobacterial Toxins: Toxins Production and Risk Assessment”. The webinar focused on cyanotoxins’ impacts, namely on irrigation waters, and on the recent cyanotoxin reports uncovered in Portugal. The webinar provided new perspectives, highlighted current impacts, and encouraged new challenges in global research on cyanotoxins.

Dr. Alexandre Campos first developed the cyanotoxins risk assessment on irrigation waters. Dr. Cristiana Moreira showed us the impacts of cyanotoxins on Portugal. After all of the presentations, Prof. Vitor Vasconcelos organized the discussion (Q&A) session. The chair and speakers answered questions raised by scholars one by one. The webinar then came to a successful conclusion.

Please note that this webinar is associated with a Special Issue in the Toxins journal: “Cyanobacterial Toxins: Toxins Production and Risk Assessment”. The deadline is 20 July 2023.

You can watch the recorded webinar at the following link: https://youtu.be/utBHM4rGswo.

Webinar Chair and Keynote Speakers:

  • Prof. Vitor Vasconcelos, Department of Biology, Faculty of Sciences, University of Porto, Portugal;
  • Dr. Alexandre Campos, Blue Biotechnology and Ecotoxicology Group, CIIMAR, Portugal;
  • Dr. Cristiana Moreira, Blue Biotechnology and Ecotoxicology Group, CIIMAR, Portugal.

13 March 2023
MDPI’s Newly Launched Journals in December 2022

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue

grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article

Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue

pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article

Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue

receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article

Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue

drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article

Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue

higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to [email protected].

7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

22 February 2023
Toxins | Google Scholar Metrics Released

We are pleased to announce that Toxins (ISSN: 2072-6651) ranked fifth in the latest release of the Google Scholar Metrics under the subcategory “Toxicology”.

The h5-index of Toxins is 69, and the h5-median is 91. We express our gratitude to all the editors, reviewers, authors and readers of Toxins. Thank you for all your support for the journal.

Please feel free to contact us at [email protected] if you have any questions or suggestions for Toxins. For more information about our rank in Google Scholar Metrics, please visit the website: https://scholar.google.com/citations?view_op=top_venues&hl=en&vq=med_toxicology.

16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

4 February 2023
Toxins | Issue Cover Articles in 2022

The articles below have been selected as cover articles for 2022 by the Editorial Office of Toxins (ISSN: 2072-6651). You can find the specific cover information at the following link:
https://www.mdpi.com/2072-6651/14. We hope that they provide insights and references for scholars in related fields.

1. “Trial Assay for Safe First-Aid Protocol for the Stinging Sea Anemone Anemonia viridis (Cnidaria: Anthozoa) and a Severe Toxic Reaction”
by Ainara Ballesteros, Janire Salazar, Macarena Marambio, José Tena, José Rafael García-March, Diana López, Clara Tellez, Carles Trullas, Eric Jourdan, Corinne Granger et al.
Toxins 2022, 14(1), 27; https://doi.org/10.3390/toxins14010027
Available online: https://www.mdpi.com/2072-6651/14/1/27

2. “Khat, a Cultural Chewing Drug: A Toxicokinetic and Toxicodynamic Summary”
by Bárbara Silva, Jorge Soares, Carolina Rocha-Pereira, Přemysl Mladěnka, Fernando Remião and on behalf of The OEMONOM Researchers
Toxins 2022, 14(2), 71; https://doi.org/10.3390/toxins14020071
Available online: https://www.mdpi.com/2072-6651/14/2/71

3. “Cytotoxicity and Effects on the Synapsis Induced by Pure Cylindrospermopsin in an E17 Embryonic Murine Primary Neuronal Culture in a Concentration- and Time-Dependent Manner”
by María G. Hinojosa, Ana I. Prieto, Clara Muñoz-Castro, María V. Sánchez-Mico, Javier Vitorica, Ana M. Cameán and Ángeles Jos
Toxins 2022, 14(3), 175; https://doi.org/10.3390/toxins14030175
Available online: https://www.mdpi.com/2072-6651/14/3/175

4. “Multiplex Detection of 24 Staphylococcal Enterotoxins in Culture Supernatant Using Liquid Chromatography Coupled to High-Resolution Mass Spectrometry”
by Donatien Lefebvre, Kevin Blanco-Valle, Jacques-Antoine Hennekinne, Stéphanie Simon, François Fenaille, François Becher and Yacine Nia
Toxins 2022, 14(4), 249; https://doi.org/10.3390/toxins14040249
Available online: https://www.mdpi.com/2072-6651/14/4/249

5. “Ochratoxin A and Sterigmatocystin in Long-Ripened Grana Cheese: Occurrence, Wheel Rind Contamination and Effectiveness of Cleaning Techniques on Grated Products”
by Amedeo Pietri, Giulia Leni, Annalisa Mulazzi and Terenzio Bertuzzi
Toxins 2022, 14(5), 306; https://doi.org/10.3390/toxins14050306
Available online: https://www.mdpi.com/2072-6651/14/5/306

6.Liza ramada Juveniles after Exposure to the Toxic Dinoflagellate Vulcanodinium rugosum: Effects on Fish Viability, Tissue Contamination and Microalgae Survival after Gut Passage”
by Aurélien Bouquet, Marie Anaïs Perdrau, Mohamed Laabir, Elodie Foucault, Nicolas Chomérat, Jean Luc Rolland and Eric Abadie
Toxins 2022, 14(6), 401; https://doi.org/10.3390/toxins14060401
Available online: https://www.mdpi.com/2072-6651/14/6/401

7. “Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms”
by Nessrin Alomran, Patricia Blundell, Jaffer Alsolaiss, Edouard Crittenden, Stuart Ainsworth, Charlotte A. Dawson, Rebecca J. Edge, Steven R. Hall, Robert A. Harrison, Mark C. Wilkinson et al.
Toxins 2022, 14(7), 443; https://doi.org/10.3390/toxins14070443
Available online: https://www.mdpi.com/2072-6651/14/7/443

8. “Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine”
by Damiana Scuteri, Paolo Tonin, Pierluigi Nicotera, Marilù Vulnera, Giuseppina Cristina Altieri, Assunta Tarsitano, Giacinto Bagetta and Maria Tiziana Corasaniti
Toxins 2022, 14(8), 529; https://doi.org/10.3390/toxins14080529
Available online: https://www.mdpi.com/2072-6651/14/8/529

9. “In Silico Evaluation of Sesquiterpenes and Benzoxazinoids Phytotoxins against Mpro, RNA Replicase and Spike Protein of SARS-CoV-2 by Molecular Dynamics. Inspired by Nature”
by Francisco J. R. Mejías, Alexandra G. Durán, Nuria Chinchilla, Rosa M. Varela, José A. Álvarez, José M. G. Molinillo, Francisco García-Cozar and Francisco A. Macías
Toxins 2022, 14(9), 599; https://doi.org/10.3390/toxins14090599
Available online: https://www.mdpi.com/2072-6651/14/9/599

10. “Evaluation of a Novel Synthetic Peptide Derived from Cytolytic Mycotoxin Candidalysin”
by Pedro Henrique de Oliveira Cardoso, Ana Paula de Araújo Boleti, Patrícia Souza e Silva, Lincoln Takashi Hota Mukoyama, Alexya Sandim Guindo, Luiz Filipe Ramalho Nunes de Moraes, Caio Fernando Ramalho de Oliveira, Maria Ligia Rodrigues Macedo, Cristiano Marcelo Espínola Carvalho, Alinne Pereira de Castro et al.
Toxins 2022, 14(10), 696; https://doi.org/10.3390/toxins14100696
Available online: https://www.mdpi.com/2072-6651/14/10/696

11. “Early Detrusor Application of Botulinum Toxin A Results in Reduced Bladder Hypertrophy and Fibrosis after Spinal Cord Injury in a Rodent Model”
by Juliana Y. Bushnell, Lindsay N. Cates, Jeffrey E. Hyde, Christoph P. Hofstetter, Claire C. Yang and Zin Z. Khaing
Toxins 2022, 14(11), 777; https://doi.org/10.3390/toxins14110777
Available online: https://www.mdpi.com/2072-6651/14/11/777

12. “Bioactivity Profiling of In Silico Predicted Linear Toxins from the Ants Myrmica rubra and Myrmica ruginodis
by Sabine Hurka, Tim Lüddecke, Anne Paas, Ludwig Dersch, Lennart Schulte, Johanna Eichberg, Kornelia Hardes, Karina Brinkrolf and Andreas Vilcinskas
Toxins 2022, 14(12), 846; https://doi.org/10.3390/toxins14120846
Available online: https://www.mdpi.com/2072-6651/14/12/846

1 February 2023
Toxins Webinar | Biological Activities and Potential Applications of Phytotoxins, 9 February 2023


Date: 9 February 2023
Time: 10:00 am CET | 4:00 am EST | 5:00 pm CST Asia
Webinar ID: 871 9573 7956
Webinar Secretariat: [email protected]
Keywords: fungal pathogens; secondary metabolites; phytotoxins; biological activities; biopesticides
Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/3316738791133/WN_O7wPRUh_SBmGoGjRcrjDkA

Chair:

Dr. Marco Masi

Department of Chemical Sciences, University of Naples Federico II, Italy

 
 
 
 

Invited Speakers:

Dr. Alessio Cimmino

Department of Chemical Sciences, University of Naples Federico II, Italy

 
 
 
 

Dr. Pierluigi Reveglia

Sustainable Agriculture Institute: CSIC, Spain

 
 
 
 

Dr. Jesus Zorrilla

Allelopathy Group, Department of Organic Chemistry, Institute of Biomolecules (INBIO), University of Cadiz, Spain

 
 
 
 

Dr. Roberta Di Lecce

Department of Agricultural Sciences, University of Naples Federico II, Italy

 
 
 
 

Interested in contributing to the topic?
The Special Issue below is open for submission. Please do not hesitate to send in your article.

Special Issue: “Biological Activities and Potential Applications of Phytotoxins
Guest Editor: Dr. Marco Masi
Deadline for manuscript submissions: 28 April 2023

We are looking forward to your participation in our event!

22 December 2022
Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

1 Million Infographic

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

14 December 2022
Editorial Board Members from Toxins Featured in the 2022 Highly Cited Researchers List Published by Clarivate


Recently, ClarivateTM revealed its 2022 list of Highly Cited Researchers™—individuals at universities, research institutes and commercial organizations.

The scientists who were selected for this year’s list of Highly Cited Researchers have published highly cited papers in the 11-year period from January 2011 to December 2021, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. Based on Web of Science Citation data, 6938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.

According to statistics, two members of the Editorial Board of Toxins (ISSN: 2072-6651) have been selected into the list of Highly Cited Researchers of Clarivate in 2022. They are being recognized for their high-quality scientific research achievements and outstanding contributions to professional fields. The Toxins journal office sincerely congratulates all elected Editorial Board Members and hopes that they continue to have an academically productive relationship with the journal.

Name

Affiliation

Prof. Dr. Joseph Jankovic

Baylor College of Medicine, USA

Dr. Liang Chen

Yunnan University, China

14 December 2022
Interview with Mr. Keith Lyons—Winner of Toxins 2021 Best Paper Award

Winning Article: “Diet Breadth Mediates the Prey Specificity of Venom Potency in Snakes”
Authors: Keith Lyons, Michel M. Dugon and Kevin Healy

 

 

 


Photo: Keith attending the British Ecological Society’s 2019 conference at Waterfront Hall, Belfast, where he presented his research on snake venom evolution, which was later published in Toxins.

While studying at the University of Galway (formerly the National University of Ireland, Galway) as an Environmental Science student, Mr. Keith Lyons’s interest in venomous animals quickly became apparent to Dr. Michel Dugon during his second year Zoology lab demonstrations. Seeing his keen interest, Dr. Dugon offered Mr. Lyons a research scholarship for the duration of the summer of 2017, working as an intern with the Noble False Widow spider, Steatoda nobilis, and its venom. Mr. Keith Lyons enjoyed his time working with Dr. Dugon and his team so much that he continued the internship on a voluntary basis for three years, publishing a Steatoda records paper, working with venomous invertebrates and reptiles from Ireland and abroad, e.g., Morocco, and aiding Dr. Dugon in running Eco-Explorers, a STEAM voluntary outreach program that educates the public about native and exotic animals and their ecology. He also worked on his final year undergraduate project with Dr. Dugon, investigating the venoms of two native centipede species (Lithobius forficatus and Lithobius variegatus), the first detailed study of both species’ venom potencies.

As of November 2022, Mr. Keith Lyons is a University of Galway Macroecology Ph.D. student working with his primary supervisor Dr. Kevin Healy and co-supervisor Dr. Dugon. As part of his Ph.D. research, Mr. Lyons continues to work with venom by investigating factors that influence the potency and evolution of different species’ venoms through phylogenetic comparative methods, median lethal dose 50% (LD50) and median effective dose 50% (ED50) experiments. As of November 2022, he has published two studies in Toxins (ISSN: 2072-6651), one discussing how diet breadth drives the evolution of potency in snake venom and the other on how venom optimization and high potency makes Steatoda nobilis a successful invasive spider.

We want to congratulate Mr. Keith Lyons, Mr. Michel M. Dugon and Mr. Kevin Healy for winning the Toxins 2021 Best Paper Award.

Interview with one of the authors–Mr. Keith Lyons:

1. Could you please briefly introduce the main research content of the winning paper?
While venoms have been found to have prey-specific potencies, the role of diet breadth (also known as the number of different taxa found in a species natural diet) on venom potencies has yet to be tested at large macroecological scales. We performed a phylogenetic comparative analysis of 100 snake species and their venom LD50s, collected from the scientific literature, to determine if the evolution of prey-specific venom potencies is a result of the breadth of a species’ diet.

2. Could you describe the difficulties and breakthrough innovations encountered in this research?
The main challenge of the study was compiling the biological data pertaining to snake diet and venom potency. It took a very long time to complete and countless literature searches often yielded little to no data. Despite the large size of the dataset we produced in the end, biological data relating to snakes are very limited. This is a trend we observed in spiders and other venomous groups, showing the importance of producing and compiling this kind of data.

3. How was your experience submitting to Toxins?
Submitting my research to Toxins was a smooth process. I appreciated this as it was my first time submitting research as the lead author. Everyone I corresponded with during the submission process was accommodating and helpful. The deadlines were reasonable throughout, and processing was quick.

4. How do you think Open Access impacts authors?
In the short term, no author is elated about having to pay publication fees, even with waivers (although waivers are greatly appreciated). However, once that obstacle is overcome, I feel it is worth it in the long term for authors, as greater accessibility means increased readership, which ultimately leads to more citations and interest in your research. I believe a significant part of why my snake venom research is performing so well because it was published in an Open Access journal. The benefits associated with increased accessibility are likely the reason behind Open Access publishing becoming more popular among the scientific community.

5. Any suggestions that you have for Toxins, or anything else that you want to talk about?
I would like to thank everyone involved with the journal Toxins for not only selecting my research as the “Issue Cover” for Volume 12 Issue 2 of their journal but also for the 2021 Best Paper (Research Article) Award. It means a lot to my Ph.D. supervisors and me, and we are very grateful for the interest shown in our research.

 

8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

7 December 2022
Meet Us at the 88th Annual Meeting of the Japanese Society of Mycotoxicology, 6 January 2023, Tsukuba, Ibaraki, Japan


Conference: The 88th Annual Meeting of the Japanese Society of Mycotoxicology
Date: 6 January 2023
Venue: Agriculture, Forestry and Fisheries Research Council, Tsukuba, Ibaraki, Japan

MDPI will be attending the 88th Annual Meeting of the Japanese Society of Mycotoxicology as the exhibitor. This meeting will take place on 6 January 2023 in Tsukuba, Ibaraki, Japan.

The 88th annual meeting is organized by the Japanese Society of Mycotoxicology (http://www.jsmyco.org). In addition to general lectures and poster presentations, there will be special lectures, symposiums, and luncheon seminars.

Special lecture: “Use of useful brewing bacteria such as aspergillus”
Symposium: “Challenge the elucidation of biological interactions”

The following MDPI journals will be represented:

If you are planning to attend this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference and booth, please visit the following website: https://www.jsmyco.org/conference/top.html.

17 November 2022
Interview with Prof. Dr. Jean-Denis Bailly—Winner of Toxins 2021 Best Paper Award


Name:
Prof. Dr. Jean-Denis Bailly
Email: [email protected]
The Winning Paper: “Aflatoxin Biosynthesis and Genetic Regulation: A Review”

 

 

 

 

 

Prof. Dr. Jean-Denis Bailly is a veterinarian. He defended his Ph.D. in 1995 and was hired as an associate professor in food safety at the National Veterinary School of Toulouse in 1996 and became a full-time professor in 2014. He has worked on mycotoxicology for more than 20 years with a focus on fungal biodiversity and its evolution and the biotic and abiotic factors controlling mycotoxin production. For several years, he has worked on the development of a strategy to inhibit AFB1 synthesis by using plant extracts. The aim is to inhibit toxin production without interfering with fungal growth in order not to create an ecological vacuum that could benefit other pathogenic organisms, nor lead to resistance appearance since there is no selective pressure on the fungi.

We want to congratulate Prof. Dr. Jean-Denis Bailly for winning the Toxins 2021 Best Paper Award.

The following is an interview with Prof. Dr. Jean-Denis Bailly:

1. Could you please briefly introduce the main content of the winning paper?
The main aim of this review is to present an exhaustive overview of all parameters that may interfere positively or negatively with aflatoxin B1 biosynthesis. AFB1 production is the result of complex biosynthetic pathways involving many genes that are themselves controlled by many environmental parameters.
This review mostly relies on the Ph.D. work of Dr. Isaura Caceres. She worked under my supervision on the identification of natural extracts able to inhibit aflatoxin B1 production in Aspergillus flavus. She was recently hired as an associate professor at the University of Bordeaux.

2. Could you describe the difficulties and breakthrough innovations in this research field?
AFB1 is probably the most important mycotoxin as a public health issue. It is carcinogenic in humans and this is also a natural contaminant leading to the highest number of DALYs (disability-adjusted life years) worldwide.
Understanding the molecular mechanisms that influence the production of this highly toxic food contaminant may help in identifying ways to prevent its biosynthesis and therefore improve food safety by targeting the environmental responses that lead to a decrease or suppression in toxin production.
However, secondary metabolism in fungi is very complex and varied, and many genes have been shown to interfere with AFB1 synthesis. It is challenging to identify the direct connections between these genes and their function and the AFB1 cluster gene.

3. How was your experience submitting to Toxins?
I had already submitted several papers to Toxins, which has become a highly recognized scientific journal in the field of natural toxins and especially mycotoxins. The submission process is quite easy and peer-review process is extremely rapid, which is very much appreciated.

4. How do you think Open Access impacts authors?
Open Access makes papers easily accessible, which favors their citation in other works. This is also a good way to make research available to all researchers, regardless of their country and funding resources.

14 November 2022
Editorial Board Members from Toxins Featured in Stanford’s List of the World’s Top 2% Scientists


Stanford University has recently published an update of the list of the top 2% most widely cited scientists—the World’s Top 2% Scientists.

The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.

We are pleased to share that 54 Editorial Board Members from Toxins (ISSN: 2072-6651) were featured in Stanford University World’s Top 2% Scientists list in 2022.

Name

Prof. Dr. Alberto Ritieni

Prof. Dr. Ketan Patel

Prof. Dr. Aldo Laganà

Prof. Dr. Klaus Aktories

Prof. Dr. Allan Cembella

Prof. Dr. Laura Anfossi

Prof. Dr. Azzam A. Maghazachi

Prof. Dr. Ligang Zhou

Prof. Dr. Andreja Rajkovic

Prof. Dr. Sophie Liabeuf

Prof. Dr. Annie Pfohl-Leszkowicz

Dr. Ludger Johannes

Prof. Dr. Antonio F. Logrieco

Prof. Dr. Luis M. Botana

Dr. Antonio Moretti

Dr. Marc Maresca

Prof. Dr. Björn Meijers

Dr. Marco Masi

Dr. Bojana Žegura

Prof. Dr. Miklós Mézes

Dr. Bruno Goud

Prof. Dr. Philippe Guerre

Prof. Dr. Carmela Fimognari

Prof. Dr. Paola Battilani

Prof. Dr. Cesare Montecucco

Prof. Dr. Peiwu Li

Prof. Dr. R. Manjunatha Kini

Dr. Peter A. Keyel

Dr. Dominic Raj

Dr. Michel R. Popoff

Prof. Dr. Dirk Dressler

Prof. Dr. Richard A. Manderville

Prof. Dr. Antonio Evidente

Dr. Andreas Rummel

Prof. Dr. Federica Cheli

Prof. Dr. Sarah De Saeger

Prof. Dr. Florian Lang

Prof. Dr. Stephan Pflugmacher

Prof. Dr. Walter A. Hall

Prof. Dr. Xiulan Sun

Dr. Hiroshi Watanabe

Prof. Dr. András Székács

Dr. Irina Vetter

Prof. Dr. Timothy L. Cover

Dr. Isabelle P. Oswald

Dr. Ting Zhou

Prof. Dr. Jean E. Crabtree

Dr. Wolfgang Wüster

Prof. Dr. John D. Groopman

Prof. Dr. Yidong Wu

Prof. Dr. Joseph Jankovic

Prof. Dr. Yonghua Xiong

Prof. Dr. Juan Ferré

Prof. Dr. Wentao Xu

The latest Stanford rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world.

We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Toxins.

28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

28 June 2022
2021 Impact Factors - Released

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

Journal Impact Factor Rank Category
Antioxidants 7.675 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 7.666 Q2 Cell Biology
Nutrients 6.706 Q1 Nutrition & Dietetics
Cancers 6.575 Q1 Oncology
Pharmaceutics 6.525 Q1 Pharmacology & Pharmacy
International Journal of Molecular Sciences 6.208 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Marine Drugs 6.085 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Biomolecules 6.064 Q2 Biochemistry & Molecular Biology
Batteries * 5.938 Q2 Electrochemistry
Energy & Fuels
Materials Science, Multidisciplinary
Viruses 5.818 Q2 Virology
Biosensors 5.743 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Journal of Fungi 5.724 Q1 Mycology
Q2 Microbiology
Nanomaterials 5.719 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Metabolites 5.581 Q2 Biochemistry & Molecular Biology
Foods 5.561 Q1 Food Science & Technology
Drones * 5.532 Q2 Remote Sensing
Remote Sensing 5.349 Q1 Geosciences, Multidisciplinary
Imaging Science & Photographic Technology
Q2 Remote Sensing
Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 5.318 Q2 Business
Antibiotics 5.222 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Pharmaceuticals 5.215 Q1 Pharmacology & Pharmacy
Q2 Chemistry, Medicinal
Biology 5.168 Q1 Biology
Fermentation 5.123 Q2 Biotechnology & Applied Microbiology
Toxins 5.075 Q1 Toxicology
Q2 Food Science & Technology
Bioengineering * 5.046 Q2 Engineering, Biomedical
Polymers 4.967 Q1 Polymer Science
Journal of Clinical Medicine 4.964 Q2 Medicine, General & Internal
Vaccines 4.961 Q2 Immunology
Medicine, Research & Experimental
Molecules 4.927 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Microorganisms 4.926 Q2 Microbiology
Journal of Functional Biomaterials * 4.901 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.757 Q2 Medicine, Research & Experimental
Pharmacology & Pharmacy
Biochemistry & Molecular Biology
Plants 4.658 Q1 Plant Sciences
International Journal of Environmental Research and Public Health 4.614 Q1 Public, Environmental & Occupational Health (SSCI)
Q2 Public, Environmental & Occupational Health (SCIE)
Environmental Sciences (SCIE)
Membranes 4.562 Q1 Polymer Science
Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Pathogens 4.531 Q2 Microbiology
Catalysts 4.501 Q2 Chemistry, Physical
Toxics 4.472 Q2 Toxicology
Environmental Sciences
Gels 4.432 Q1 Polymer Science
Journal of Cardiovascular Development and Disease 4.415 Q2 Cardiac & Cardiovascular Systems
Chemosensors 4.229 Q1 Instruments & Instrumentation
Q2 Chemistry, Analytical
Q3 Electrochemistry
Genes 4.141 Q2 Genetics & Heredity
Diagnostics 3.992 Q2 Medicine, General & Internal
Agronomy 3.949 Q1 Agronomy
Plant Sciences
Land 3.905 Q2 Environmental Studies
Sustainability 3.889 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Q4 Green & Sustainable Science & Technology (SSCI)
Sensors 3.847 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Materials 3.748 Q1 Metallurgy & Metallurgical Engineering
Q2 Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Biomimetics * 3.743 Q2 Engineering, Multidisciplinary
Q3 Materials Science, Biomaterials
Tropical Medicine and Infectious Disease * 3.711 Q1 Tropical Medicine
Q2 Parasitology
Q3 Infectious Diseases
Lubricants * 3.584 Q2 Engineering, Mechanical
Fractal and Fractional 3.577 Q1 Mathematics, Interdisciplinary Applications
Water 3.530 Q2 Water Resources
Q3 Environmental Sciences
Micromachines 3.523 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Journal of Personalized Medicine 3.508 Q2 Medicine, General & Internal
Health Care Sciences & Services
Agriculture 3.408 Q1 Agronomy
Processes 3.352 Q2 Engineering, Chemical
Separations 3.344 Q2 Chemistry, Analytical
Magnetochemistry 3.336 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Brain Sciences 3.333 Q3 Neurosciences
Buildings 3.324 Q2 Construction & Building Technology
Engineering, Civil
Forests 3.282 Q1 Forestry
Energies 3.252 Q3 Energy & Fuels
Life 3.251 Q2 Biology
Coatings 3.236 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
Animals 3.231 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Journal of Intelligence * 3.176 Q2 Psychology, Multidisciplinary
Fishes 3.170 Q1 Marine & Freshwater Biology
Q2 Fisheries
Healthcare 3.160 Q2 Health Policy & Services (SSCI)
Health Care Sciences & Services (SCIE)
Inorganics * 3.149 Q2 Chemistry, Inorganic & Nuclear
Insects 3.139 Q1 Entomology
Atmosphere 3.110 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Current Oncology 3.109 Q3 Oncology
ISPRS International Journal of Geo-Information 3.099 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Diversity 3.029 Q2 Biodiversity Conservation
Ecology
Tomography 3.000 Q3 Radiology, Nuclear Medicine & Medical Imaging
Current Issues in Molecular Biology 2.976 Q3 Biochemistry & Molecular Biology
Medicina 2.948 Q3 Medicine, General & Internal
Symmetry 2.940 Q2 Multidisciplinary Sciences
Horticulturae 2.923 Q1 Horticulture
Machines 2.899 Q2 Engineering, Mechanical
Engineering, Electrical & Electronic
Systems * 2.895 Q2 Social Sciences, Interdisciplinary
Applied Sciences 2.838 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Children 2.835 Q2 Pediatrics
Minerals 2.818 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Universe 2.813 Q2 Astronomy & Astrophysics
Q3 Physics, Particles & Fields
Journal of Marine Science and Engineering 2.744 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Entropy 2.738 Q2 Physics, Multidisciplinary
Fire * 2.726 Q2 Forestry
Q3 Ecology
Metals 2.695 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Electronics 2.690 Q3 Engineering, Electrical & Electronic
Computer Science, Information Systems
Physics, Applied
Crystals 2.670 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Aerospace 2.660 Q1 Engineering, Aerospace
Mathematics 2.592 Q1 Mathematics
Photonics 2.536 Q3 Optics
Actuators 2.523 Q2 Instruments & Instrumentation
Q3 Engineering, Mechanical
Veterinary Sciences 2.518 Q2 Veterinary Sciences
Behavioral Sciences * 2.286 Q3 Psychology, Multidisciplinary
Axioms * 1.824 Q2 Mathematics, Applied

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

 

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2022)

 

17 June 2022
Toxins | Special Issue Mentor Program


We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.

This program intends to provide an opportunity for early career scientists to enhance their editing, networking, and organizational skills and to work closely with our journal to gain more editorial experience. Early career scientists who have novel ideas for new Special Issues of Toxins (ISSN: 2072-6651) will act as Guest Editors under the mentorship of an experienced scientist; this mentor could be a member of the Toxins Editorial Board or may be from other well-established research institutes or laboratories, etc.

The mentee’s responsibilities include:

  • Providing a CV, including a list of publications;
  • Proposing a Special Issue title and a short introduction;
  • Writing a brief promotion plan for the Special Issue;
  • Writing an editorial for the online Special Issue;
  • Reviewing and making decisions for submissions under the mentorship of our Editorial Board Members.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Co-editing the Special Issue with younger scholars and performing quality control of publications in the Special Issue;
  • Providing suggestions to younger scholars if they have doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the office regularly to discuss problems and improvement suggestions for the Special Issue.

Certificates and awards:

When the Special Issue is closed, the Editorial Office will provide official certificates for all the mentors. Younger scholars will be prioritized as candidates for Toxins Young Investigator Awards in future editions.

If you are interested in this opportunity, please send your Special Issue proposal to the Toxins Editorial Office ([email protected]), or complete and submit the form at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/toxins. We will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail after receiving your application.

In addition to the new Special Issue Mentor Program, Toxins continues to welcome all Special Issue proposals based on hot research topics as usual.

Toxins Editorial Office

9 June 2022
2021 CiteScores - Released


The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Journal

CiteScore

Quartile

Category

Non-coding RNA

10.1

Q1

Genetics

Journal of Functional Biomaterials

10.0

Q1

Biomedical Engineering

Marine Drugs

8.1

Q1

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Batteries

7.9

Q1

Electrical and Electronic Engineering

Nutrients

7.9

Q1

Nutrition and Dietetics

Remote Sensing

7.4

Q1

General Earth and Planetary Sciences

Drones

7.2

Q1

Computer Science Applications

International Journal of Molecular Sciences

6.9

Q1

Inorganic Chemistry

Journal of Sensor and Actuator Networks

6.9

Q1

Computer Networks and Communications

Cells

6.7

Q1

General Biochemistry, Genetics and Molecular Biology

Nanomaterials

6.6

Q1

General Chemical Engineering

Toxins

6.6

Q1

Health, Toxicology and Mutagenesis

Viruses

6.6

Q1

Infectious Diseases

Antioxidants

6.5

Q1

Food Science

Fibers

6.5

Q1

Civil and Structural Engineering

Resources

6.4

Q1

Nature and Landscape Conservation

Sensors

6.4

Q1

Instrumentation

Big Data and Cognitive Computing

6.1

Q1

Management Information Systems

Molecules

5.9

Q1

Chemistry (miscellaneous)

Polymers

5.7

Q1

Polymers and Plastics

Biosensors

5.6

Q1

Engineering (miscellaneous)

Catalysts

5.5

Q1

General Environmental Science

Smart Cities

5.5

Q1

Urban Studies

Future Internet

5.4

Q2

Computer Networks and Communications

Beverages

5.3

Q1

Food Science

Fermentation

5.3

Q1

Plant Science

Environments

5.2

Q1

Ecology, Evolution, Behavior and Systematics

Inventions

5.2

Q1

General Engineering

Journal of Open Innovation: Technology, Market, and Complexity

5.1

Q1

Development

Colloids and Interfaces

5.0

Q1

Chemistry (miscellaneous)

Energies

5.0

Q1

Control and Optimization

ISPRS International Journal of Geo-Information

5.0

Q1

Geography, Planning and Development

Sustainability

5.0

Q1

Geography, Planning and Development

Fire

4.9

Q1

Forestry

Robotics

4.9

Q1

Control and Optimization

Soil Systems

4.9

Q1

Soil Science

Geosciences

4.8

Q1

General Earth and Planetary Sciences

Journal of Manufacturing and Materials Processing

4.8

Q1

Mechanical Engineering

Tropical Medicine and Infectious Disease

4.8

Q1

Public Health, Environmental and Occupational Health

Water

4.8

Q1

Geography, Planning and Development

International Journal of Environmental Research and Public Health

4.5

Q1

Public Health, Environmental and Occupational Health

Sports

4.5

Q1

Physical Therapy, Sports Therapy and Rehabilitation

Entropy

4.4

Q1

Mathematical Physics

Journal of Clinical Medicine

4.4

Q1

General Medicine

Symmetry

4.3

Q1

General Mathematics

Cosmetics

4.2

Q1

Surgery

Foods

4.1

Q1

Health Professions (miscellaneous)

Journal of Fungi

4.1

Q1

Plant Science

ChemEngineering

4.0

Q1

General Engineering

Forests

4.0

Q1

Forestry

Journal of Intelligence

4.0

Q1

Education

Antibiotics

3.9

Q1

General Pharmacology, Toxicology and Pharmaceutics

Cryptography

3.9

Q1

Applied Mathematics

Behavioral Sciences

3.8

Q1

Development

Buildings

3.8

Q1

Architecture

Metals

3.8

Q1

Metals and Alloys

Publications

3.5

Q1

Communication

Social Sciences

3.4

Q1

General Social Sciences

Mathematics

2.9

Q1

General Mathematics

Fractal and Fractional

2.8

Q1

Analysis

Animals

2.7

Q1

General Veterinary

Axioms

2.6

Q1

Algebra and Number Theory

Heritage

1.8

Q1

Conservation

Religions

1.0

Q1

Religious Studies

Philosophies

0.9

Q1

Philosophy

Source: 2021 CiteScores™ (Elsevier)

2 June 2022
MDPI’s 2021 Outstanding Reviewer Awards in “Biology & Life Sciences”—Winners Announced

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Biology & Life Sciences” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all the winners on their achievement.

MDPI will continue to provide support and recognition to the academic community.

Biology:

  • Enrico Vito Perrino, CIHEAM, Mediterranean Agronomic Institute of Bari, Italy
  • Dhirendra Kumar, National Institute of Environmental Health Sciences, Research Triangle Park, USA
  • Carlos A. Viegas, Univesity of Trás-os-Montes e Alto Douro, Portugal
  • Yuri Shavrukov, Flinders University, Australia
  • Bipin Gaihre, Mayo Clinic, USA

Brain Sciences:

  • Craig D. Workman, University of Iowa, USA
  • Vivian Ciaramitaro, University of Massachusetts Boston, USA
  • Yang Zhang, University of Minnesota, USA

Cells:

  • Bonam Srinivasa Reddy, Université de Paris, France
  • Homma Takujiro, Yamagata University, Japan
  • Hwang, In Koo, Seoul National University, South Korea
  • Kobeissy Firas, University of Florida, USA
  • Rebelo, Sandra, University of Aveiro, Portugal

Diversity:

  • Günter Gollmann, University of Vienna, Austria
  • Stephan Koblmüller, University of Graz, Austria
  • Emiliano Mori, Istituto di Ricerca sugli Ecosistemi Terrestri, Italy

Horticulturae:

  • Joshua D. Klein, Agricultural Research Organization—The Volcani Center, Israel
  • Ana Cristina S Figueiredo, Faculdade de Ciências da Universidade de Lisboa, Portugal

Insects:

  • Carmelo Peter Bonsignore, Università Mediterranea di Reggio Calabria, Italy
  • Klaus H. Hoffmann, University of Bayreuth, Germany
  • Ivan Milosavljević, University of California, USA

Metabolites:

  • Remigiusz Bachor, University of Wrocław, Poland
  • Nguyen Phuoc Long, Inje University College of Medicine, South Korea
  • Chi Chen, University of Minnesota, USA

Nutrients:

  • Jadwiga Hamułka, Warsaw University of Life Sciences, Poland
  • Grace Campbell, University of Sydney, Australia
  • Nicholas Norwitz, Harvard Medical School, USA
  • Stefan Kabisch, Charité University Hospital Berlin, Germany
  • Luis Rodrigo, University of Oviedo, Spain

Veterinary Sciences:

  • Carlos Viegas, Univesity of Trás-os-Montes e Alto Douro, Portugal
  • Arvind Sharma, The University of Queensland, Australia

2 June 2022
MDPI’s 2021 Young Investigator Awards in “Biology & Life Sciences”—Winners Announced

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the 2021 winners in the “Biology & Life Sciences” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions.

MDPI will continue to provide support and recognition to the academic community.

Agriculture:

  • Carlos Guzmán, University of Cordoba, Spain

Animals:

  • Katharina Hohlbaum, Freie Universität Berlin, Germany

Cells:

  • Uri Ben-David, Tel Aviv University, Israel

Diversity:

  • Enrico Lunghi, Institute of Zoology Chinese Academy of Sciences in Beijing, China

Foods:

  • Guodong Zhang, University of Massachusetts Amherst, USA

Horticulturae:

  • Luke Bell, Temperate Horticulture, University of Reading, UK

International Journal of Molecular Sciences:

  • Alessandro D’Urso, University of Catania, Italy.
  • Apostolos Zaravinos, University of Cyprus, Cyprus
  • Cesar de la Fuente-Nunez, University of Pennsylvania, USA
  • Maria Teresa Caccamo, Messina University, Italy
  • Tiziana Bonifacino, University of Genoa, Italy

Journal of Fungi:

  • Federico Baltar, University of Vienna, Austria
  • Rebecca Drummond, University of Birmingham, UK
  • Miriam Oses-Ruiz, Public University of Navarre, Spain

Life:

  • João Pedro da Silva Machado Lobo, University of Porto, Portugal
  • Vincenzo Russo, University of Campania Luigi Vanvitelli, Italy

Metabolites:

  • Gabriele Rocchetti, Catholic University of Sacred Heart, Italy

Nutrients:

  • Fiona Lavelle, Queen's University Belfast, UK
  • Matthew Snelson, Monash University, Australia

Pathogens:

  • Si Ming Man, Australian National University, Australia
  • Jasper Fuk-Woo Chan, University of Hong Kong, China

Plants:

  • Stefania Sut, University of Padova, Italy
  • Mohamed Ahmed El-Esawi, Tanta University, Tanta, Egypt

Vaccines:

  • Nicholas M. Provine, University of Oxford, UK

Viruses:

  • Nicholas S. Heaton, Duke University, USA

2 June 2022
MDPI’s 2021 Travel Awards in “Biology & Life Sciences”—Winners Announced

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Biology & Life Sciences” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the winners of 2021 Travel Awards and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Agriculture:

  • Zahra Bitarafan, Norwegian Institute of Bioeconomy Research (NIBIO), Norway
  • Nikolaos Tsoulias, Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB), Germany

Fermentation:

  • Michela Verni, University of Bari, Italy
  • Philipp Demling, RWTH Aachen University, Germany

Horticulturae:

  • Jagveer Singh, Punjab Agricultural University, India
  • Ibrar Hussain, State University of Londrina, Brazil

Microorganisms:

  • Francis Muchaamba, University of Zurich, Switzerland

Methods and Protocols:

  • Tanja Eisemann, SBP Medical Discovery Institute, USA

Nutrients:

  • Mrinalini Dey, National Institute for Health Research, UK
  • Ben Kirk, University of Melbourne, Australia
  • Kirrilly Pursey, University of Newcastle, Australia
  • Dieuwertje Kok, Wageningen University, the Netherlands
  • Hanna Huber, University of Bonn, Germany
  • Marlene Lages, University of Porto, Portugal
  • Zohra S. Lassi, University of Adelaide, Australia
  • Rik Olde Engberink, Amsterdam University Medicial Center, the Netherlands
  • Sarah Warkentin, University of Porto (ISPUP), Portugal
  • Álvaro Hernáez, Norwegian Institute of Public Health, Norway
  • Leila Abdelhamid, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, USA
  • Maria Michela Cesare, University of Siena, Italy
  • Kaisa Hiippala, University of Helsinki, Finland

Pathogens:

  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal
  • Hejun Liu, Scripps Research Institute, USA
  • Tomokazu Tamura, Princeton University, USA

Toxins:

  • Cecilie Knudsen, Technical University of Denmark, Denmark
  • Laura Biessy, Cawthron Institute, New Zealand
  • Marcelo Mendes Rabelo, University of Florida, USA

Vaccines:

  • Hee Chun Chung, Seoul National University, South Korea
  • Alejandro Marin Lopez, Yale University, USA

2 June 2022
MDPI’s 2021 Best Paper Awards in “Biology & Life Sciences”—Winners Announced

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the subject areas of “Biology & Life Sciences”, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Animals:

by Wenchao Liu, Yilin Yuan, Chenyu Sun, Balamuralikrishnan Balasubramanian, Zhihui Zhao and Lilong An

Animals 2019, 9(8), 506, doi 10.3390/ani9080506

by Peter Coals, Dawn Burnham, Andrew Loveridge, David W. Macdonald, Michael ’t Sas-Rolfes, Vivienne L. Williams and John A. Vucetich

Animals 2019, 9(2), 52; doi 10.3390/ani9020052

by Giovanni Sogari, Mario Amato, Ilaria Biasato, Silvana Chiesa and Laura Gasco

Animals 2019, 9(4), 119; doi 10.3390/ani9040119

Antibodies:

by Mark L. Chiu; Dennis R. Goulet; Alexey Teplyakov and Gary L. Gilliland

Antibodies 2019, 8(4), 55; doi 10.3390/antib8040055

Antioxidants:

by Luca Frattaruolo, Gabriele Carullo, Matteo Brindisi, Sarah Mazzotta, Luca Bellissimo, Vittoria Rago, Rosita Curcio, Vincenza Dolce, Francesca Aiello and Anna Rita Cappello

Antioxidants 2019, 8(6), 186; doi 10.3390/antiox8060186

by Chunhe Gu, Kate Howell, Frank R. Dunshea and Hafiz A. R. Suleria

Antioxidants 2019, 8(9), 405; doi 10.3390/antiox8090405

by Spyridon A. Petropoulos, Ângela Fernandes, Maria Inês Dias, Ioannis B. Vasilakoglou, Konstantinos Petrotos, Lillian Barros and Isabel C. F. R. Ferreira

Antioxidants 2019, 8(8), 293; doi 10.3390/antiox8080293

by Rubén Domínguez, Mirian Pateiro, Mohammed Gagaoua, Francisco J. Barba, Wangang Zhang and José M. Lorenzo

Antioxidants 2019, 8(10), 429; doi 10.3390/antiox8100429

Biology:

by Michael H. Hastings, Elizabeth S. Maywood and Marco Brancaccio

Biology 2019, 8(1), 13; doi 10.3390/biology8010013

by Gail D. Schwieterman, Daniel P. Crear, Brooke N. Anderson, Danielle R. Lavoie, James A. Sulikowski, Peter G. Bushnell and Richard W. Brill

Biology 2019, 8(3), 56; doi 10.3390/biology8030056

Biomolecules:

by Shuichi Nakamura and Tohru Minamino

Biomolecules 2019, 9(7), 279; doi 10.3390/biom9070279

by Dmitrii Usoltsev, Vera Sitnikovaandrey Kajava and Mayya Uspenskaya

Biomolecules 2019, 9(8), 359; doi 10.3390/biom9080359

by Gerhard Liebisch, Josef Ecker, Sebastian Roth, Sabine Schweizer, Veronika Öttl, Hans-Frieder Schött, Hongsup Yoon, Dirk Haller, Ernst Holler, Ralph Burkhardt and Silke Matysik

Biomolecules 2019, 9(4), 121; doi 10.3390/biom9040121

by Anna Janaszewska, Joanna Lazniewska, Przemysław Trzepiński, Monika Marcinkowska and Barbara Klajnert-Maculewicz

Biomolecules 2019, 9(8), 330; doi 10.3390/biom9080330

Cells:

by Heng Sheng Sow, Jiang Ren, Marcel Camps, Ferry Ossendorp and Peter ten Dijke

Cells 2019, 8(4), 320; doi 10.3390/cells8040320

by Dinender K. Singla, Taylor A. Johnson and Zahra Tavakoli Dargani

Cells 2019, 8(10), 1224; doi 10.3390/cells8101224

by Laura M. Doyle and Michael Zhuo Wang

Cells 2019, 8(7), 727; doi 10.3390/cells8070727

by Yu Han, Xuezhou Li, Yanbo Zhang, Yuping Han, Fei Chang and Jianxun Ding

Cells 2019, 8(8), 886; doi 10.3390/cells8080886

Genes:

by Sarah B. Kingan, Haynes Heaton, Juliana Cudini, Christine C. Lambert, Primo Baybayan, Brendan D. Galvin, Richard Durbin, Jonas Korlach and Mara K. N. Lawniczak

Genes 2019, 10(1), 62; doi 10.3390/genes10010062

by Katherine E Bohnsack, Claudia Höbartner and Markus T Bohnsack

Genes 2019, 10(2), 102; doi 10.3390/genes10020102

by Laura M. Boykin, Peter Sseruwagi, Titus Alicai, Elijah Ateka, Ibrahim Umar Mohammed, Jo-Ann L. Stanton, Charles Kayuki, Deogratius Mark, Tarcisius Fute, Joel Erasto, Hilda Bachwenkizi, Brenda Muga, Naomi Mumo, Jenniffer Mwangi, Phillip Abidrabo, Geoffrey Okao-Okuja, Geresemu Omuut, Jacinta Akol, Hellen B. Apio, Francis Osingada, Monica A. Kehoe, David Eccles, Anders Savill, Stephen Lamb, Tonny Kinene, Christopher B. Rawle, Abishek Muralidhar, Kirsty Mayall, Fred Tairo and Joseph Ndunguru

Genes 2019, 10(9), 632; doi 10.3390/genes10090632

by Elamin Hafiz Baillo, Roy Njoroge Kimotho, Zhengbin Zhang and Ping Xu

Genes 2019, 10(10), 771; doi 10.3390/genes10100771

Horticulturae:

by Lida Fuentes, Carlos R. Figueroa and Monika Valdenegro

Horticulturae 2019, 5(2), 45; doi 10.3390/horticulturae5020045

by Marta Guarise, Gigliola Borgonovo, Angela Bassoli and Antonio Ferrante

Horticulturae 2019, 5(1), 13; doi 10.3390/horticulturae5010013

Insects:

by Rik Clymans, Vincent Van Kerckvoorde, Eva Bangels, Wannes Akkermans, Ammar Alhmedi, Patrick De Clercq, Tim Beliën and Dany bylemans

Insects 2019, 10(7), 200; doi 10.3390/insects10070200

by Marc Kenis, Hannalene du Plessis, Johnnie Van den Berg, Malick Niango Ba, Georg Goergen, Koffi Eric Kwadjo, Ibrahim Baoua, Tadele Tefera, Alan Buddie, Giovanni Cafà, Lisa Offord, Ivan Rwomushana and Andrew Polaszek

Insects 2019, 10(4), 92; doi 10.3390/insects10040092

by Rafael R. da Costa, Haofu Hu, Hongjie Li and Michael Poulsen

Insects 2019, 10(4), 87; doi 10.3390/insects10040087

International Journal of Molecular Sciences:

by Rüdiger Hardeland

Int. J. Mol. Sci. 2019, 20(5), 1223; doi 10.3390/ijms20051223

by Elise Lévy, Nadine El Banna, Dorothée Baïlle, Amélie Heneman-Masurel, Sandrine Truchet, Human Rezaei, Meng-Er Huang, Vincent Béringue, Davy Martin and Laurence Vernis

Int. J. Mol. Sci. 2019, 20(16), 3896; doi 10.3390/ijms20163896

by Beatriz Herrero-Fernandez, Raquel Gomez-Bris, Beatriz Somovilla-Crespo and Jose Maria Gonzalez-Granado

Int. J. Mol. Sci. 2019, 20(21), 5293; doi 10.3390/ijms20215293

by Claudia Beaurivage, Elena Naumovska, Yee Xiang Chang, Edo D. Elstak, Arnaud Nicolas, Heidi Wouters, Guido van Moolenbroek, Henriëtte L. Lanz, Sebastiaan J. Trietsch, Jos Joore, Paul Vulto, Richard A.J. Janssen, Kai S. Erdmann, Jan Stallen and Dorota Kurek

Int. J. Mol. Sci. 2019, 20(22), 5661; doi 10.3390/ijms20225661

by Maiko Okano, Masanori Oshi, Ali Linsk Butash, Eriko Katsuta, Kazunoshin Tachibana, Katsuharu Saito, Hirokazu Okayama, Xuan Peng, Li Yan, Koji Kono, Toru Ohtake and Kazuaki Takabe

Int. J. Mol. Sci. 2019, 20(17), 4197; doi 10.3390/ijms20174197

by Shaista Afroz, Rieko Arakaki, Takuma Iwasa, Masamitsu Oshima, Maki Hosoki, Miho Inoue, Otto Baba, Yoshihiro Okayama and Yoshizo Matsuka

Int. J. Mol. Sci. 2019, 20(3), 711; doi 10.3390/ijms20030711

Life:

by Márió Gajdács, Zoltán Bátori, Marianna Ábrók, Andrea Lázár and Katalin Burián

Life 2020, 10(2), 16; doi 10.3390/life10020016

by Carla Ferreira, Catarina Almeida, Sandra Tenreiro and Alexandre Quintas

Life 2020, 10(6), 86; doi 10.3390/life10060086

Nutrients:

by Ronald D. Hills, Benjamin A. Pontefract, Hillary R. Mishcon, Cody A. Black, Steven C. Sutton and Cory R. Theberge

Nutrients 2019, 11(7), 1613; doi 10.3390/nu11071613

by Harri Hemilä and Elizabeth Chalker

Nutrients 2019, 11(4), 708; doi 10.3390/nu11040708

by Humaira Jamshed, Robbie A. Beyl, Deborah L. Della Manna, Eddy S. Yang, Eric Ravussin and Courtney M. Peterson

Nutrients 2019, 11(6), 1234; doi 10.3390/nu11061234

Pathogens:

by Israr Kha, Naeem Ullah, Lajia Zha, Yanrui Bai, Ashiq Khan, Tang Zhao, Tuanjie Che and Chunjiang Zhang

Pathogens 2019, 8(3), 126; doi 10.3390/pathogens8030126

by Spyridoula-Angeliki Nikou,Nessim Kichik, Rhys Brown, Nicole O. Ponde, Jemima Ho, Julian R. Naglik and Jonathan P. Richardson

Pathogens 2019, 8(2), 53; doi 10.3390/pathogens8020053

by Steven Batinovic, Flavia Wassef, Sarah A. Knowler, Daniel T.F. Rice, Cassandra R. Stanton, Jayson Rose, Joseph Tucci, Tadashi Nittami, Antony Vinh, Grant R. Drummond, Christopher G. Sobey, Hiu Tat Chan, Robert J. Seviour, Steve Petrovski and Ashley E. Franks

Pathogens 2019, 8(3), 100; doi 10.3390/pathogens8030100

Plants:

by Muhammad Hammad Saleem, Johan Potgieter and Khalid Mahmood Arif 

Plants 20198(11), 468; doi 10.3390/plants8110468

by Ida Linić, Dunja Šamec, Jiří Grúz, Valerija Vujčić Bok, Miroslav Strnad and Branka Salopek-Sondi

Plants 20198(6), 155; doi 10.3390/plants8060155

by Marie Agatha Mohn, Besarta Thaqi and Katrin Fischer-Schrader

Plants 20198(3), 67; doi 10.3390/plants8030067

by Chiara Biselliandrea Volante, Francesca Desiderio, Alessandro Tondelli, Alberto Gianinetti, Franca Finocchiaro, Federica Taddei, Laura Gazza, Daniela Sgrulletta, Luigi Cattivelli and Giampiero Valè

Plants 20198(8), 292; doi 10.3390/plants8080292

23 March 2022
Toxins | Top 10 Downloaded Articles in 2021

1. Muscle Tone Physiology and Abnormalities
Jacky Ganguly et al.
Toxins 2021, 13(4), 282; https://doi.org/10.3390/toxins13040282
Available online: https://www.mdpi.com/2072-6651/13/4/282

2. Botulinum Toxin: An Update on Pharmacology and Newer Products in Development
Supriyo Choudhury et al.
Toxins 2021, 13(1), 58; https://doi.org/10.3390/toxins13010058
Available online: https://www.mdpi.com/2072-6651/13/1/58

3. Physical and Chemical Methods for Reduction in Aflatoxin Content of Feed and Food
Péter Sipos et al.
Toxins 2021, 13(3), 204; https://doi.org/10.3390/toxins13030204
Available online: https://www.mdpi.com/2072-6651/13/3/204

4. The Food Poisoning Toxins of Bacillus cereus
Richard Dietrich et al.
Toxins 2021, 13(2), 98; https://doi.org/10.3390/toxins13020098
Available online: https://www.mdpi.com/2072-6651/13/2/98

5. Aflatoxin Detoxification Using Microorganisms and Enzymes
Yun Guan et al.
Toxins 2021, 13(1), 46; https://doi.org/10.3390/toxins13010046
Available online: https://www.mdpi.com/2072-6651/13/1/46

6. Botulinum Toxin in Movement Disorders: An Update
Joseph Jankovic et al.
Toxins 2021, 13(1), 42; https://doi.org/10.3390/toxins13010042
Available online: https://www.mdpi.com/2072-6651/13/1/42

7. Wasp Venom Biochemical Components and Their Potential in Biological Applications and Nanotechnological Interventions
Aida A. Abd El-Wahed et al.
Toxins 2021, 13(3), 206; https://doi.org/10.3390/toxins13030206
Available online: https://www.mdpi.com/2072-6651/13/3/206

8. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
Zeinab Breijyeh et al.
Toxins 2021, 13(2), 117; https://doi.org/10.3390/toxins13020117
Available online: https://www.mdpi.com/2072-6651/13/2/117

9. Association of Polygenic Risk Score and Bacterial Toxins at Screening Colonoscopy with Colorectal Cancer Progression: A Multicenter Case-Control Study
Alfonso Piciocchi et al.
Toxins 2021, 13(8), 569; https://doi.org/10.3390/toxins13080569
Available online: https://www.mdpi.com/2072-6651/13/8/569

10. Effective Locations for Injecting Botulinum Toxin into the Mentalis Muscle; Cadaveric and Ultrasonographic Study
Da-Yae Choi et al.
Toxins 2021, 13(2), 96; https://doi.org/10.3390/toxins13020096
Available online: https://www.mdpi.com/2072-6651/13/2/96

30 January 2022
2021 Outstanding Toxicologist Award for Women—Winner Announced

The editorial team of Toxins (ISSN: 2072-6651) is pleased to announce the winner of the 2021 Outstanding Toxicologist Award for Women: Christina Schroeder, at the National Cancer Institute, NIH, USA.

Dr. Schroeder’s research focuses on biodiscovery and peptide engineering in venom-derived toxins to investigate ion channels involved in pain and cancer. She completed her Ph.D. in Pharmacology at the University of Queensland, Australia, on the structure–activity relationships of omega-conotoxins targeting calcium channels. She completed her postdoctoral training at the Scripps Research Institute, USA, the University of Queensland, and the University of New South Wales, Australia. In 2014 she was granted research funding from the National Health and Medical Research Council, Australia, and in 2017 she was awarded a Future Fellowship from the Australian Research Council, allowing her to pursue independent research at the Institute for Molecular Bioscience, at the University of Queensland. She has published more than 80 articles on the discovery, structure, and function of animal toxins targeting ion channels and submitted 28 NMR-obtained toxin structures to the PDB. Her most noteworthy work contributed to the understanding of the importance of toxin–membrane binding for sodium channel inhibition and the development of bivalent toxins with dual pharmacology, specifically targeting sodium channels involved in pain. In 2020, she joined the Chemical Biology Laboratory at the National Cancer Institute, NIH, USA, as a Stadtman investigator, and she holds an adjunct Associate Professor position at the University of Queensland, Australia.

We would like to congratulate the winner in recognition of her excellence in research related to toxicology. We look forward to her future academic contributions.

22 December 2021
Toxins | 27th Meeting on Toxinology of the French Society of Toxinology (SFET)—Best Oral Communication Award and Best Poster Award Winners

The editorial team of Toxins (ISSN: 2072-6651) would like to congratulate the winner of the Best Poster Award, Ms. Anne-Cécile Van Baelen, and the winner of the Best Oral Communication Award, Dr. Barbara Ribeiro, at the 27th Meeting on Toxinology of the French Society of Toxinology (SFET).

Toxins Best Poster Award Winner

Toxins Best Oral Communication Award Winner

Left: Ms. Anne-Cécile Van Baelen, doctoral fellow from SIMoS, CEA de Saclay, Gif-sur-Yvette, Fance;

Right: Dr. Barbara Ribeiro postdoctoral fellow from the Institute du Thorax, Nantes, France.

The following are the titles of their work:

“Characterization of Innovative Animal Toxins for the Functional Study of Angiotensin Receptors

Authors: Anne-Cécile Van Baelen, Nicolas Gilles, Denis Servent and Philippe Robin

Affiliation: Université Paris-Saclay, CEA Départment Médicaments et Technologies pour la Santé (DMTS), SIMoS, F-91191 Gif-sur-Yvette, France

Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells

Authors: Stephan De Waard, Jérôme Montnach, Barbara Ribeiro, Sébastien Nicolas, Virginie Forest, Flavien Charpentier, Matteo Elia Mangoni, Nathalie Gaborit, Michel Ronjat, Gildas Loussouarn, Patricia Lemarchand and Michel De Waard

Affiliation: L’unité de recherche de I’institut du thorax Inserm UMR 1087 / CNRS UMR 6291 Nantes, France

22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction

It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

Abate, Antonio
Abatzoglou, John T.
Abbaszadeh, Mostafa
Acharya, U. Rajendra
Acharya, Viral V.
Agarwal, Ravi P.
Ahn, Myung-Ju
Airoldi, Laura
Ali, Imran
Allakhverdiev, Suleyman I.
Aluko, Rotimi E.
Anasori, Babak
Andersson, Dan I.
Andes, David
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Arqub, Omar Abu
Aschner, Michael
Assaraf, Yehuda G.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Atangana, Abdon
Bahram, Mohammad
Bakris, George L.
Balandin, Alexander A.
Baleanu, Dumitru
Balsamo, Gianpaolo
Bando, Yoshio
Banks, William A.
Bansal-Travers, Maansi
Barba, Francisco J.
Barros, Lillian
Basit, Abdul W.
Baskonus, Haci Mehmet
Bassetti, Matteo
Battino, Maurizio
Bell, Jordana T.
Bellomo, Nicola
Benediktsson, Jon Atli
Benelli, Giovanni
Benjakul, Soottawat
Bhatnagar, Amit
Biddle, Stuart J. H.
Biondi, Antonio
Biondi-Zoccai, Giuseppe
Bjarnsholt, Thomas
Blaabjerg, Frede
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boffetta, Paolo
Bogers, Marcel
Bonomo, Robert A.
Bowman, David M.J.S.
Boyer, Cyrille
Brestic, Marian
Brevik, Eric C.
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cai, Jianchao
Calhoun, Vince D.
Calin, George
Cao, Jinde
Cao, Guozhong
Carvalho, Andre F.
Castellanos-Gomez, Andres
Cerqueira, Miguel Ângelo Parente Ribeiro
Chang, Jo-Shu
Chang, Chih-Hao
Chastin, Sebastien
Chau, Kwok-wing
Chemat, Farid
Chen, Xiaobo
Chen, YangQuan
Chen, Jianmin
Chen, Chaoji
Chen, Min
Chen, Qi
Chen, Jun
Chen, Xi
Chen, Peng
Chen, Yulin
Chen, Bo
Chen, Chen
Chen, Zhi-Gang
Chen, Wei-Hsin
Chen, Gang
Chen, Yongsheng
Chen, Xiang
Chen, Yimin
Chen, Runsheng
Chen, Lidong
Chen, Shaowei
Chen, Qian
Chen, Yu
Chen, Shuangming
Chiclana, Francisco
Cho, Sun Young
Choi, Wonyong
Chowdhary, Anuradha
Choyke, Peter L.
Cichocki, Andrzej
Corella, Dolores
Corma, Avelino
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Crommie, Michael F.
Cui, Yi
Cui, Haiying
Cui, Qinghua
Cummings, Kenneth Michael
Dai, Shifeng
Dai, Sheng
Daiber, Andreas
Davis, Steven J.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Decker, Eric Andrew
Dekel, Avishai
Demaria, Marco
Deng, Yong
Deng, Xiangzheng
DePinho, Ronald A.
Desneux, Nicolas
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Dionysiou, Dionysios D.
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Fan
Dou, Shi Xue
Dou, Letian
Du, Qian
Du, Bo
Dube, Shanta Rishi
Dufresne, Alain
Dummer, Reinhard
Dupont, Didier
Edwards, David
Elaissari, Abdelhamid
Elhoseny, Mohamed
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estévez, Mario
Fabbro, Doriano
Facchetti, Antonio
Fan, Zhanxi
Fang, Chuanglin
Fasano, Alessio
Fečkan, Michal
Felser, Claudia
Feng, Liangzhu
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Ferreira, Isabel C. F. R.
Filippi, Massimo
Fisher, Helen
Fortino, Giancarlo
Fosso Wamba, Samuel
Franceschi, Claudio
Fujita, Hamido
Fujita, Masayuki
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gan, Lihua
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Minrui
Gao, Huijun
Gao, Wei
Gao, Huile
Garbe, Claus
Garcia, Hermenegildo
Gasbarrini, Antonio
Gasco, Laura
Gautret, Philippe
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghadimi, Noradin
Ghaffari, Roozbeh
Ghamisi, Pedram
Giampieri, Francesca
Glick, Bernard R.
Gnant, Michael
Goel, Ajay
Gogotsi, Yury
Goldewijk, Kees Klein
Gong, Jinlong
Gong, Yongji
Govindan, Kannan
Granato, Daniel
Grancini, Giulia
Green, Douglas R.
Grosso, Giuseppe
Gu, Ke
Guan, Cao
Guastella, Adam J.
Guerrero, Josep M.
Gui, Guan
Guizani, Mohsen
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Habibi-Yangjeh, Aziz
Hagemann, Stefan
Hagger, Martin
Hamblin, Michael R.
Hammoudeh, Shawkat
Han, Heesup
Hanes, Justin
Harrison, Roy M.
Hartung, Hans-Peter
Hasanuzzaman, Mirza
He, Jr-Hau
He, Hongwen
He, Jiaqing
He, Debiao
Henseler, Jörg
Herrera, Francisco
Herrera-Viedma, Enrique
Hetz, Claudio
Ho Kim, Jung
Holmes, Elaine
Hossain, Ekram
Hsueh, Po-Ren
Hu, Xiaosong
Hu, Wenbin
Huang, Jianping
Huang, Hongwei
Huang, Yu
Huang, Jianying
Huang, Peng
Huang, Baibiao
Huang, Shaoming
Hubacek, Klaus

Iqbal, Hafiz M. N.
Ismail, Ahmad Fauzi
Izzo, Angelo A.
Jacobson, Kenneth A.
Jain, Atul
Jankovic, Joseph
Jelezko, Fedor
Ji, Xiaobo
Ji, Guangbin
Jiang, Hai-Long
Jiang, Lei
Jiang, Junjun
Jiang, Qing
Jiang, Shibo
Jin, Shi
Jones, Peter A.
Kalantar-zadeh, Kourosh
Kaner, Richard B.
Kannan, Kurunthachalam
Kappos, Ludwig
Karagiannidis, George K.
Karimi, Hamid Reza
Karimi-Maleh, Hassan
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Keesstra, Saskia
Kepp, Oliver
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kim, Ki-Hyun
Kim, Haegyeom
Kim, Jeonghun
Kim, Jong Seung
Kirkwood, John M.
Kisi, Ozgur
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Konopleva, Marina Y.
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kou, Gang
Krausmann, Fridolin
Krebs, Frederik C.
Kroemer, Guido
Kuca, Kamil
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Devendra
Kumar, Alan Prem
Kumar, Sudhir
Kumar Sangaiah, Arun
Kurths, Juergen
Kuznetsov, Nikolay V.
Kuzyakov, Yakov
Kwan, Mei-Po
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lammers, Twan
Lamuela-Raventos, Rosa M.
Lancellotti, Patrizio
Landi, Francesco
Laurent, Sophie
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Sang Soo
Lee, Jin-Wook
Lee, Pooi See
Lehmann, Johannes
Lei, Yaguo
Lei, Ting
Leng, Lijian
Leung, Dennis Y. C.
Leung, Victor C. M.
Levine, Ross
Li, Wei
Li, Jie
Li, Jinghong
Li, Jun
Li, Heng
Li, Gang
Li, Yat
Li, Peng
Li, Hailong
Li, Changpin
Li, Yan
Li, Yurui
Li, Xiaodi
Li, Hong
Li, Shutao
Li, Hongyi
Li, Zhijun
Li, Peiyue
Lin, Yuehe
Lin, Hongjun
Lin, Lin
Lip, Gregory Y. H.
Liu, Jian
Liu, Meng
Liu, Hong
Liu, Tao
Liu, Lei
Liu, Jianxing
Liu, Wei
Liu, Gang
Liu, Yang
Liu, Peide
Lockhart, Shawn R.
Long, Hualou
Löscher, Wolfgang
Lu, Jun
Lu, Jianquan
Lu, Nanshu
Lucey, Brian
Lund, Henrik
Luo, Jun
Luo, Yi
Luo, Jingshan
Luo, Yangchao
Lupton, Deborah
Luque, Rafael
Lv, Wei
Lvov, Yuri M.
Lyons, Timothy W.
Ma, Tianyi
Ma, Jun
Ma, Jiayi
Ma, Wen-Xiu
Ma, Yanming
Maggioni, Aldo Pietro
Mahmood, Nasir
Mahmoudi, Morteza
Mai, Liqiang
Mallavarapu, Megharaj
Mandala, Mario
Mardani, Abbas
Marengo, Jose
Maria Rossolini, Gian
Martinoia, Enrico
Mathiesen, Brian Vad
Mathivanan, Suresh
Mattick, John S.
Matyjaszewski, Krzysztof
McCabe, Matthew E.
McCauley, Darren
McClements, David Julian
Melcher, Karsten
Melenhorst, Jan Joseph
Melero, Ignacio
Mezzetti, Bruno
Mirjalili, Seyedali
Mishchenko, Artem
Mittler, Ron
Moreau, Philippe
Motohashi, Hozumi
Mousavi Khaneghah, Amin
Mu, Shichun
Mueller, Lukas A.
Mueller-Roeber, Bernd
Muenzel, Thomas
Muhammad, Khan
Munger, J. William
Nauen, Ralf
Naushad, Mu.
Negri, Eva
Nemeroff, Charles B.
Newman, David J.
Niaura, Raymond S.
Nie, Feiping
Nieto, Juan J.
Novara, Agata
Nunkoo, Robin
Ogino, Shuji
Olabi, Abdul-Ghani
Ong, Hwai Chyuan
O'Regan, Donal
Orsini, Nicola
Ouyang, Minggao
Ozcan, Aydogan
Pacher, Pal
Pan, Xiaoqing
Pan, Likun
Pan, Quan-Ke
Pang, Huan
Pavela, Roman
Pedrycz, Witold
Pei, Yanzhong
Peng, Shushi
Peng, Qing
Peng, Mugen
Perc, Matjaz
Perez-Alvarez, Jose Angel
Perlin, David S.
Piquero, Alex R.
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Postolache, Mihai
Potenza, Marc N.
Poulter, Benjamin
Preat, Veronique
Prinsep, Michele R.
Pu, Hong-Bin
Putnik, Predrag
Qiu, Jieshan
Qu, Xiaogang
Quiles, José L.
Rabczuk, Timon
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Recio, Isidra
Reiter, Russel J.
Remuzzi, Giuseppe
Ren, Jinsong
Ren, Jun
Riahi, Keywan
Richardson, Paul G.
Rignot, Eric
Rimm, David
Rinn, John L.
Robert, Caroline
Rodriguez, Rosa M.
Rojo, Teofilo
Ros, Emilio
Rosen, Marc A.
Roubaud, David
Russo, Alessandro
Russo, Gian Luigi

Saad, Fred
Saad, Walid
Sadorsky, Perry
Sander, Chris
Santamouris, Mattheos
Santoro, Gabriele
Saraiva, Jorge A.
Sarchiapone, Marco
Scalbert, Augustin
Schloter, Michael
Schneider, Gisbert
Schubert, Ulrich S.
Schulz, Rainer
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scorrano, Luca
Scott, David
Scott, Stuart A.
Scott, Daniel
Serra-Majem, Lluis
Sethi, Gautam
Shabala, Sergey
Shaheen, Sabry M.
Shao, Zongping
Sharma, Gaurav
Shen, Guozhen
Shen, Hao
Sheremet, Mikhail A.
Shi, Peng
Shi, Yumeng
Shoenfeld, Yehuda
Siano, Pierluigi
Sillanpaa, Mika
Simões, Manuel
Simpson, Richard J.
Singh, Bhupinder Pal
Singh, Vijay P.
Smagghe, Guy
Song, Yu
Song, Houbing
Sood, Anil K.
Srivastava, Hari M.
Stadler, Marc
Stadler, Peter F.
Stanley, H. Eugene
Stoumpos, Constantinos C.
Strano, Michael S.
Stunnenberg, Hendrik G.
Su, [email protected]
Su, Chun-Yi
Subramanian, S. V.
Sun, Zhipei
Sun, Fengchun
Sun, Hongqi
Sunderland, Elsie M.
Suzuki, Nobuhiro
Svenning, Jens-Christian
Szabo, Csaba
Szallasi, Arpad
Szolnoki, Attila
Tacke, Frank
Tan, Weihong
Tan, Chaoliang
Tang, Hua
Tang, Chuyang
Tang, Chuan-He
Tanzi, Rudolph E.
Teichmann, Sarah
Telenti, Amalio
Thakur, Vijay Kumar
Thiele, Holger
Tian, Jie
Tohge, Takayuki
Tran, Lam-Son Phan
Truhlar, Donald G.
Tsao, Rong
Tsuda, Kenichi
Tukker, Arnold
Tung, Chen-Ho
Turskis, Zenonas
Urquhart, Andrew
Valko, Marian
Van Breusegem, Frank
Van de Wiele, Tom
van der Werf, Guido
van Wesemael, Bas
Vangronsveld, Jaco
Varma, Rajender S.
Varsani, Arvind
Varshney, Rajeev K.
Vasilakis, Nikos
Vasilakos, Athanasios V.
Vasquez, Juan C.
Vatanen, Tommi
Ventura, Marco
Vermote, Eric
Veronese, Nicola
Verpoorte, Robert
Vethaak, A. Dick
Vieta, Eduard
Vincent, Jean-Louis
Wagner, Wolfgang
Walton, Vaughn M.
Wan, Jiafu
Wan, Shaohua
Wang, Qi
Wang, Joseph
Wang, Meng
Wang, Tao
Wang, Yuan
Wang, Xin
Wang, Chao
Wang, Yong
Wang, Jun
Wang, Erkang
Wang, Sibo
Wang, Jian
Wang, Ning
Wang, John
Wang, Qin
Wang, Shaojian
Wang, Guoxiu
Wang, Huanting
Wang, Chunsheng
Wang, Gongming
Wang, Zhong Lin
Wang, Lianzhou
Wang, Shaobin
Wang, Yang
Wang, Zifa
Wei, Zhixiang
Wei, Leyi
Weissleder, Ralph
Wen, Guanghui
Wiens, John J.
Wigneron, Jean-Pierre
Willerslev, Eske
Wishart, David S.
Witlox, Frank
Wu, Jun
Wu, Tom
Wu, Hao Bin
Wu, Hui
Wu, Haijun
Wu, Zhongbiao
Wu, Zhong-Shuai
Wu, Zheng-Guang
Xia, Meimei
Xia, Xinhui
Xiang, Quanjun
Xiao, Jianbo
Xiao, Jie
Xie, Jian-Hua
Xin, Sen
Xing, Baoshan
Xiong, Rui
Xu, Bin
Xu, Li Da
Xu, Yi-Jun
Xu, Hui
Xu, Zeshui
Yamauchi, Yusuke
Yan, Huaicheng
Yan, Kai
Yang, Chenguang
Yang, Xiao-Jun
Yang, Bing
Yang, Yun-Gui
Yang, Jie
Yang, Jian
Yang, Xinsong
Yang, Shihe
Yang, Yi
Yang, Yang
Yao, Jen-Chih
Yao, Yonggang
Yazyev, Oleg
Yin, Yulong
Yin, Zongyou
Yin, Shen
Yin, Ya-xia
Yin, Shou-Wei
Ying, Guang-Guo
Young, Allan H.
Yu, Shu-Hong
Yu, Jun
Yu, Guihua
Yu, Wenwu
Yu, Guocan
Yu, Minghao
Zarco-Tejada, Pablo J.
Zavadskas, Edmundas Kazimieras
Zeadally, Sherali
Zhai, Tianyou
Zhang, Wei
Zhang, Binlin
Zhang, Shujun
Zhang, Guoping
Zhang, Zengqiang
Zhang, Yu Shrike
Zhang, Qichun
Zhang, Xian-Ming
Zhang, Guowen
Zhang, Min
Zhang, Yue-Jun
Zhang, Shaoqing
Zhang, Fan
Zhang, Weili
Zhang, Xiaodong
Zhang, Zhien
Zhang, Tierui
Zhang, Hongjie
Zhang, Dengsong
Zhang, Liangpei
Zhang, Dan
Zhang, Yu-Dong
Zhang, Fusuo
Zhao, Yi
Zhao, Guochun
Zhao, Li-Dong
Zheng, Hao
Zheng, Gengfeng
Zhong, Cheng
Zhou, Weiqi
Zhou, Qi
Zhou, Jizhong
Zhu, Hongwei
Zhu, Chengzhou
Zhu, Junfa
Zhu, Zhe
Zhu, Quanxin
Zhuang, Xiaodong
Zhuang, Xiaoying
Zou, Quan

The full list of 2021 Highly Cited Researchers  can be accessed at the following webpage in the Web of ScienceTM https://recognition.webofscience.com/awards/highly-cited/2021/.

--- Highly Cited Researchers (HCR) is a Clarivate product.

16 November 2021
Topical Advisory Panel Established to Support Editorial Board

Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.

The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.

Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.

To qualify as a Topical Advisory Panel Member, applicants must:

  • Have expertise and experience in the field related to the journal;
  • Have received a Ph.D. in the last 10 years, approximately;
  • Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
  • Currently hold an independent research position in academia or a government institute.

If you are interested in this role, please contact the editorial office by email.

We look forward to hearing from you soon.

25 October 2021
Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October

Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.

The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.

For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.

International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.

Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.

Read our anniversary blog post: "Sharing 'Collective Human Knowledge': The Benefits of Open Access Publication"

Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.

The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.

Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.

We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.

  • 25 October 2021
    Energies journal and Institute of Mechanics, Chinese Academy of Sciences
  • 28 October 2021
    Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University
  • 29 October 2021
    Processes journal and Beijing Institute of Technology
  • 29 October 2021
    Coatings journal and Wuhan University of Technology

MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.

23 September 2021
2020 MDPI Top Reviewer Award—Winners Announced


Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

  • Adriana Burlea-Schiopoiu;
  • Alban Kuriqi;
  • Álvaro González-Vila;
  • Alessandro Alaimo;
  • Alexey Beskopylny;
  • Alexander Yu Churyumov;
  • Alberto Fernández-Isabel;
  • Andrea Mastinu;
  • Antonios N. Papadopoulos;
  • Anton Rassõlkin;
  • Antonio Humberto Hamad Minervino;
  • Arkadiusz Matwijczuk;
  • Artur Słomka;
  • Baojie He;
  • Bartłomiej Potaniec;
  • Bojan Đurin;
  • Camilo Arturo Rodriguez Diaz;
  • Carmelo Maria Musarella;
  • Chiachung Chen;
  • Chiman Kwan;
  • Cristian Busu;
  • Danil Pimenov;
  • Dan-Cristian Dabija;
  • Delfín Ortega-Sánchez;
  • Demetrio Antonio Zema;
  • Denis Butusov;
  • Elena Lucchi;
  • Gaurab Dutta;
  • Livia Anastasiu;
  • M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

22 September 2021
MDPI Joins SDG Publishers Compact

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
[email protected]

16 September 2021
Welcoming New Editorial Board Members of Toxins

We are very honored that 43 new editorial members have joined Toxins since April. We would like to welcome these recognized researchers:

Dr. Thomas Durek, The University of Queensland, Brisbane, Australia;
Prof. Dr. Shihua Wang, Fujian Agriculture and Forestry University, China;
Prof. Dr. Wentao Xu, China Agricultural University, China;
Dr. Sonia Marin-Sillue, University of Lleida, Spain;
Prof. Dr. Miklós Mézes, Szent Istvan University, Godollo, Hungary;
Prof. Dr. Maurizio Brigotti, Università di Bologna, Italy;
Dr. Steve Morton, NOAA National Centers for Coastal Ocean Science, USA;
Prof. Dr. Juan Ferré, Universitat de València, Spain;
Prof. Dr. Allan Cembella, Universität Bremen, Bibliothekstraße, Germany;
Prof. Dr. Jean-Denis Bailly, Université de Toulouse, France;
Prof. Dr. Cristina Juan García, University of Valencia, Spain;
Prof. Dr. Sabine Schorr-Galindo, Université de La Réunion, France;
Prof. Dr. Harald Genth, Hannover Medical School, Germany;
Prof. Dr. Marylène Poirié, Sophia Agrobiotech Institute, INRAE, France;
Prof. Dr Thomas M. Harris, Vanderbilt University, USA;
Dr. Mark Poli, US Army Medical Research Institute of Infectious Diseases, USA;
Dr. Triantafyllos Kaloudis, Athens Water Supply & Sewerage Company, Greece;
Prof. Dr. Antonio Evidente, University of Naples “Federico II”, Italy;
Dr. Marco Masi, University of Naples, Italy;
Prof. Dr. John Leslie, Kansas State University, USA;
Prof. Dr. Borden Lacy, Vanderbilt University School of Medicine, USA;
Dr. Rosario Iglesias, University of Valladolid, Spain;
Prof. Dr. Mandar Jog, University of Western, Canada;
Prof. Dr. Alfonso Fasano, University of Toronto, Canada;
Prof. Dr. Jun Chen, Institute of Hydrobiology, Chinese Academy of Science, China;
Dr. Ken Teter, University of Central Florida, USA;
Dr. Jacob Galan, Texas A&M University-Kingsville, USA;
Prof. Dr. Eric Oswald, Toulouse University Hospital, France;
Dr. Imourana Alassane-Kpembi, Université de Montréal, Canada;
Dr. Nolwenn Hymery, Université de Brest, France;
Prof. Dr. Ana Juan-Garcí, University of Valencia, Spain;
Prof. Dr. András Székács, National Agricultural Research and Innovation Centre, Hungary;
Dr. Mark McClain, Vanderbilt University Medical Center, USA;
Prof. Dr. Jang-Seu Ki, Sangmyung University, Korea;
Dr. Marie-Yasmine Dechraoui Bottein, University of Copenhagen, Denmark;
Dr. Shupeng Yang, Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, China.

10 September 2021
Recruiting Volunteer Reviewers for Toxins

Toxins has recently been receiving an increasing number of interesting paper submissions. We would like to invite you to review manuscripts for Toxins (https://www.mdpi.com/journal/toxins).

Volunteer reviewers of Toxins will enjoy the following benefits:

  • All reviewers will receive a personalized review confirmation certificate in appreciation of their efforts;
  • All reviewers will be considered for the outstanding reviewer award granted annually by the Toxins Editorial Board and Editorial Team, to gratefully acknowledge the work they have done;
  • Those reviewers who provide timely, thorough, and rigorous peer review reports will receive a discount voucher that can be applied to their future publications in any MDPI journal;
  • All reviewers will be included in the journal’s annual reviewer acknowledgements;
  • Proactive and cooperative volunteer reviewers may be offered the opportunity to join the Editorial Board of the journal (subject to the approval of the Editor-in-Chief);
  • All reviewers can build their profile on Publons and have their reviewing activity automatically added for participating journals.

If you are interested in joining us as a volunteer reviewer, please click on the link below to apply:
https://susy.mdpi.com/volunteer_reviewer_info/update.

After your registration has been approved, you will be able to see a list of manuscripts that are recruiting reviewers. 

If you have any other questions, please contact the Toxins Editorial Office ([email protected]). We look forward to hearing from you.

3 August 2021
Announcement on Japanese Consumption Tax (JCT)

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

30 June 2021
2020 Impact Factors - Released

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

  • 10 journals received their first impact factor
  • 96% of journals increased their impact factor from 2019
  • 32 journals (38%) ranked among the top 25% of journals, in at least one category
Journal Impact Factor Rank Category
Cancers 6.639 Q1 • Oncology
Cells 6.600 Q2 • Cell Biology
Pharmaceutics 6.321 Q1 • Pharmacology & Pharmacy
Antioxidants 6.313 Q1 • Food Science & Technology 
• Biochemistry & Molecular Biology
• Chemistry, Medicinal
Biomedicines 6.081 Q1 • Medicine, Research & Experimental
• Pharmacology & Pharmacy 
• Biochemistry & Molecular Biology
International Journal of Molecular Sciences 5.924 Q1 • Biochemistry & Molecular Biology
Q2 • Chemistry, Multidisciplinary
Pharmaceuticals 5.863 Q1 • Pharmacology & Pharmacy
• Chemistry, Medicinal
Journal of Fungi 5.816 Q1 • Mycology
• Microbiology
Nutrients 5.719 Q1 • Nutrition & Dietetics
Biosensors 5.519 Q1 • Chemistry, Analytical
• Instruments & Instrumentation
Q2 • Nanoscience & Nanotechnology
Marine Drugs 5.118 Q1 • Chemistry, Medicinal
• Pharmacology & Pharmacy
Biology 5.079 Q1 • Biology
Nanomaterials 5.076 Q1 • Physics, Applied
Q2 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary 
• Nanoscience & Nanotechnology
Viruses 5.048 Q2 • Virology
Journal of Personalized Medicine 4.945 Q1 • Medicine, General & Internal
• Health Care Sciences & Services
Metabolites 4.932 Q2 • Biochemistry & Molecular Biology
Biomolecules 4.879 Q2 • Biochemistry & Molecular Biology
Remote Sensing 4.848 Q1 • Geosciences, Multidisciplinary
Q2 • Remote Sensing
• Imaging Science & Photographic Technology 
• Environmental Sciences
Gels * 4.702 Q1 • Polymer Science
Antibiotics 4.639 Q2 • Infectious Diseases
• Pharmacology & Pharmacy
Toxins 4.546 Q1 • Toxicology
• Food Science & Technology
Vaccines 4.422 Q2 • Immunology
• Medicine, Research & Experimental
Molecules 4.412 Q2 • Chemistry, Multidisciplinary
• Biochemistry & Molecular Biology
Foods 4.350 Q2 • Food Science & Technology
Polymers 4.329 Q1 • Polymer Science
Journal of Clinical Medicine 4.242 Q1 • Medicine, General & Internal
Toxics 4.146 Q2 • Toxicology
• Environmental Sciences
Catalysts 4.146 Q2 • Chemistry, Physical
Microorganisms 4.128 Q2 • Microbiology
Membranes 4.106 Q1 • Polymer Science
Q2 • Engineering, Chemical
• Materials Science, Multidisciplinary 
• Chemistry, Physical
Genes 4.096 Q2 • Genetics & Heredity
Fermentation * 3.975 Q2 • Biotechnology & Applied Microbiology
Journal of Cardiovascular Development and Disease * 3.948 Q2 • Cardiac & Cardiovascular Systems
Plants 3.935 Q1 • Plant Sciences
Life 3.817 Q2 • Biology
Diagnostics 3.706 Q2 • Medicine, General & Internal
Current Oncology 3.677 Q3 • Oncology
Materials 3.623 Q1 • Metallurgy & Metallurgical Engineering
Q2 • Materials Science, Multidisciplinary
• Chemistry, Physical 
• Physics, Applied 
• Physics, Condensed Matter
Sensors 3.576 Q1 • Instruments & Instrumentation
Q2 • Chemistry, Analytical
• Engineering, Electrical & Electronic
Pathogens 3.492 Q2 • Microbiology
Agronomy 3.417 Q1 • Agronomy
• Plant Sciences
Chemosensors 3.398 Q2 • Instruments & Instrumentation
• Chemistry, Analytical
Q3 • Electrochemistry
Land 3.398 Q2 • Environmental Studies
Brain Sciences 3.394 Q3 • Neurosciences
International Journal of Environmental Research and Public Health 3.390 Q1 • Public, Environmental & Occupational Health (SSCI)
Q2 • Public, Environmental & Occupational Health (SCIE)
• Environmental Sciences (SCIE)
Tomography 3.358 Q2 • Radiology, Nuclear Medicine & Medical Imaging
Fractal and Fractional * 3.313 Q1 • Mathematics, Interdisciplinary Applications
Sustainability 3.251 Q2 • Environmental Sciences (SCIE)
• Environmental Studies (SSCI)
Q3 • Green & Sustainable Science & Technology (SCIE)
• Green & Sustainable Science & Technology (SSCI)
Water 3.103 Q2 • Water Resources
• Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 3.049 Q3 • Business
Energies 3.004 Q3 • Energy & Fuels
Agriculture 2.925 Q1 • Agronomy
ISPRS International Journal of Geo-Information 2.899 Q2 • Geography, Physical
• Computer Science, Information Systems
Q3 • Remote Sensing
Micromachines 2.891 Q2 • Instruments & Instrumentation
• Physics, Applied
Q3 • Chemistry, Analytical
• Nanoscience & Nanotechnology
Coatings 2.881 Q2 • Materials Science, Coatings & Films
• Physics, Applied
Q3 • Materials Science, Multidisciplinary
Children 2.863 Q2 • Pediatrics
Processes 2.847 Q3 • Engineering, Chemical
Separations 2.777 Q3 • Chemistry, Analytical
Insects 2.769 Q1 • Entomology
Animals 2.752 Q1 • Agriculture, Dairy & Animal Science
• Veterinary Sciences
Symmetry 2.713 Q2 • Multidisciplinary Sciences
Atmosphere 2.686 Q3 • Meteorology & Atmospheric Sciences
• Environmental Sciences
Applied Sciences 2.679 Q2 • Engineering, Multidisciplinary
• Physics, Applied
Q3 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary
Photonics 2.676 Q2 • Optics
Buildings * 2.648 Q2 • Construction & Building Technology
• Engineering, Civil
Healthcare 2.645 Q2 • Health Policy & Services (SSCI)
Q3 • Health Care Sciences & Services (SCIE)
Minerals 2.644 Q2 • Mining & Mineral Processing
• Mineralogy
• Geochemistry & Geophysics
Forests 2.634 Q1 • Forestry
Crystals 2.589 Q2 • Crystallography
Q3 • Materials Science, Multidisciplinary
Entropy 2.524 Q2 • Physics, Multidisciplinary
Diversity 2.465 Q2 • Biodiversity Conservation
Q3 • Ecology
Journal of Marine Science and Engineering 2.458 Q2 • Oceanography
• Engineering, Marine 
• Engineering, Ocean
Medicina 2.430 Q2 • Medicine, General & Internal
Machines * 2.428 Q2 • Engineering, Mechanical
Q3 • Engineering, Electrical & Electronic
Electronics 2.397 Q3 • Engineering, Electrical & Electronic
• Computer Science, Information Systems 
• Physics, Applied
Fishes * 2.385 Q2 • Fisheries
• Marine & Freshwater Biology
Metals 2.351 Q2 • Metallurgy & Metallurgical Engineering
Q3 • Materials Science, Multidisciplinary
Horticulturae * 2.331 Q1 • Horticulture
Veterinary Sciences * 2.304 Q1 • Veterinary Sciences
Universe 2.278 Q3 • Physics, Particles & Fields
• Astronomy & Astrophysics
Mathematics 2.258 Q1 • Mathematics
Magnetochemistry 2.193 Q3 • Chemistry, Inorganic & Nuclear
• Chemistry, Physical 
• Materials Science, Multidisciplinary
Current Issues in Molecular Biology 2.081 Q4 • Biochemistry & Molecular Biology
Actuators 1.994 Q3 • Instruments & Instrumentation
• Engineering, Mechanical
Aerospace * 1.659 Q2 • Engineering, Aerospace

* Journals given their first Impact Factor in 2021

Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)

15 June 2021
Toxins | 2020 Young Investigator Award—Winner Announced

Dear Colleagues,

As Editor-in-Chief of Toxins, I am pleased to announce that the following applicant has been selected as the winner of the Toxins 2020 Young Investigator Award.

Dr. Andreas Hougaard Laustsen
Technical University of Denmark, Denmark

With so many high-quality applicants, the evaluation process and final decision were challenging. We would like to thank all the applicants for submitting their fascinating range of research topics. On behalf of the Assessment Committee, I congratulate the winner on his accomplishment.

Prof. Dr. Jay W. Fox
Editor-in-Chief, Toxins

On behalf of the Toxins 2020 Young Investigator Award Evaluation Committee

21 May 2021
Toxins | “Biotoxin Research” Youth Forum, 9–11 June 2021, Beijing, China

Biotoxins seriously threaten human and animal health, and are directly related to food safety. It has been a research hotspot in the fields of agriculture, food and public health. In order to strengthen China’s biotoxin research, especially academic exchanges among young researchers, the "Biotoxin Research" Youth Forum will be held from June 9–11 in Beijing, China.

1. Conference topics

The meeting will be organized around the following three topics:

1.1. Detection, Monitoring and Early Warning of Biotoxins (Convenors: Qi Zhang and Wentao Xu)

1.2. Toxicological Evaluation and Risk Assessment of Biotoxins (Convenors: Xiulan Sun and Meng Wang)

1.3. Safety Control of Biotoxins (Convenors: Fuguo Xing and Peilong Wang)

2. Conference Organization

Organizer:

National Science and Technology Innovation Alliance for Mycotoxin Prevention and Control

Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences

Oil Crops Research Institute, Chinese Academy of Agricultural Sciences

Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences

Participation Unit:

Toxins (MDPI)

Beijing Meizheng Biotechnology Group

Shanghai Yirou Information Technology Co., Ltd. (Continuous update...)

Main sponsor:

Mars Global Food Safety Center, Beijing Qinbang Biotechnology, Beijing Zhongjian Baotai, Qingdao Pribolab, Agilent Technologies, Shanghai Xiongtu Biotechnology, Hebei Elisa (Continuous update...)

3. Academic Advisory Committee

Director: Peiwu Li (Academician)

Deputy Director: Fengzhong Wang (Director)

Committee: Yongning Wu, Shuo Wang, Zhixian Gao, Shiping Tian, Ying Chen, Zhonghua Ma, Yang Liu, Changpo Sun, Jianrong Shi and Aibo Wu

4. Youth Academic Committee (in alphabetical order)

Boqiang Li, Erqi Guan, Fei Shen, Fuguo Xing, Hongyin Zhang, Jianhong Xu, Jin Mao, Jun Tian, Liangbin Hu, Meng Wang, Qi Zhang, Qiugang Ma, Xiaolin Zhang, Xiulan Sun, Wentao Xu, Wei Guo, Wei Wang, Yan Wang, Yueju Zhao and Zhongjie Zhang 

5. Organizing Committee

Aibo Wu, Qi Zhang, Fuguo Xing, Meng Wang, Peilong Wang, Wentao Xu, Wei Guo, Mengning Ren, Yanjia Wen, Gang Wang, Jing Jin, Xu Li, Bolei Yang, Junning Ma and Bowen Tai

6. Schedule

  • 9 June 2021

All day: Conference registration, exhibitions set up

  • 10 June 2021

Morning:

Opening ceremony

Leader's speech:

  1. Fengzhong Wang (director)
  2. Leader of the Ministry of Agriculture and Rural Affairs

Expert report:

  1. Peiwu Li (Academician, Invited)—(45 min)
  2. Shiping Tian (Professor) Institute of Botany, Chinese Academy of Sciences—(25 min)
  3. Zhonghua Ma (Professor), College of Agriculture and Biotechnology, Zhejiang University—(25 min)
  4. Ren Lai (Professor), Kunming Institute of Zoology, Chinese Academy of Sciences—(25 min)
  5. Jinglin Wang (Professor) Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences—(25 min)

Afternoon:

Expert report:

  1. Aibo Wu (Professor) Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences—(25 min)
  2. Yang Liu (Professor), School of Food Science and Engineering, Foshan University of Science and Technology—(25 min)
  3. Changpo Sun (Professor) Standard Quality Center, National Grain and Material Reserve Bureau—(25 min)
  4. Jianrong Shi (Professor) Jiangsu Academy of Agricultural Sciences
  5. Hongyin Zhang (Professor) School of Food and Bioengineering, Jiangsu University

To be continued...

  • 11 June 2021

Session Report

Morning:

Topic 1: Rapid Detection of Biotoxins

Topic 2: Toxicity Evaluation of Biotoxins

Topic 3: Comprehensive Prevention and Control of Biotoxins

Afternoon:

Topic 4: Biotoxins Monitoring and Early Warning

Topic 5: Risk Assessment of Biotoxins

Topic 6: Safe Detoxification of Biotoxins

7. Contacts

Academic Contact:

Fuguo Xing 010-62811868, 15801607126

Gang Wang 010-62819472, 15501150911

Jing Jin 010-62819472, 15210682859

Bowen Tai 010-62819472, 13269858921

Chenxi Zhang 010-62819472, 15701575736

Email: [email protected]

Exhibitor Contact:

Xu Li 010-62819472,13811976783

Bolei Yang 010-62819472, 18519373787

Mailing address: Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences, No. 2, Yuanmingyuan West Road, Haidian District, Beijing 100193, China

Email: [email protected]

Preparatory Group for the Youth Forum on Biotoxin Research

6 May 2021
Toxins | 2021 Travel Award—Winners Announced

Dear Colleagues,

As Editor-in-Chief of Toxins, I am pleased to announce that the following three applicants have been selected as the winners of the Toxins 2021 Travel Award.

  • Cecilie Knudsen
    A Ph.D. student at the Technical University of Denmark, Denmark
  • Laura Biessy
    A Ph.D. student at the Cawthron Institute, New Zealand
  • Marcelo Mendes Rabelo
    A postdoctoral researcher at the University of Florida, USA

With so many high-quality applicants, the evaluation process and final decision were challenging. We would like to thank all the applicants for submitting their fascinating range of research topics. On behalf of the assessment committee, I congratulate the winners on their accomplishments.

Prof. Dr. Jay W. Fox
Editor-in-Chief, Toxins

On behalf of the Toxins 2021 Travel Awards Evaluation Committee

29 April 2021
Congratulations to Best Speaker Award Winners at the 7th Venoms to Drugs Conference, Daydream Island, Whitsunday, 2021 (Sponsored by Toxins)

The editorial team of Toxins would like to congratulate the winners of the Best Speaker Award, Benjamin J. Tombling and Nisharnthi M. Duggan, at the 7th Venoms to Drugs Conference.

See the image of the awardees below (from left to right): Glenn King (Program Committee), Nisharnthi M. Duggan from Richard Payne’s lab at the University of Sydney (Best Speaker Award Winner), Paul Alewood (Convenor), Benjamin J. Tombling from David Craik’s lab at the University of Queensland (Best Speaker Award Winner), and Richard Lewis (Program Committee).

Here are the titles and abstracts of their work:

To Affinity and Beyond: Engineering Sub-optimal Peptide Drug leads Using Bioactive Cyclisation

Benjamin J. Tombling

Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, Qld 4072, Australia

Peptides are regarded as promising next-generation therapeutics. However, to facilitate the translation of bioactive peptides into the clinic, optimisation strategies are almost always required. Peptide cyclisation strategies have been used to improve the drug-like properties of linear peptides. Until now, the primary focus has been on the use of ‘inert’ peptide linkers with respect to a biological target. Here, we show that affinity can be significantly improved by enriching the linker with functional amino acids, a concept termed bioactive cyclisation. We engineered a peptide inhibitor of PCSK9, a target for the clinical management of hypercholesterolemia, to demonstrate this concept. The identification of an optimised cyclisation linker from library screening produced a cyclic peptide with 100-fold improved affinity over the sub-optimal parent peptide. Furthermore, the cyclic peptide efficiently restores cholesterol metabolism in functional human liver cell assays, demonstrating a clear relationship between affinity and efficacy. The combination of thermodynamic binding analysis, SAR, NMR and MD studies confirmed the cyclisation linker forms favourable interactions with PCSK9, which are responsible for enhanced activity. A comprehensive analysis of bioactive peptides suggests many have underdeveloped affinities and we propose that implementing bioactive cyclisation linkers is a valuable addition to the armamentarium of peptide optimisation tools. This work was recently published in Journal of Medicinal Chemistry (DOI: 10.1021/acs.jmedchem.0c01766)

Brief Introduction of Benjamin J. Tombling: Benjamin completed his undergraduate studies in chemistry at The University Edinburgh before moving to Brisbane, Australia, where he recently finished his PhD under the supervision of Dr Conan Wang and Professor David Craik at The University of Queensland. His research has focused on establishing a platform of technologies to enhance the drug-like properties of underdeveloped peptide drugs leads, predominately for the development of inhibitors of PCSK9—a validated therapeutic target for the clinical management of hypercholesterolemia. However, a major incentive behind his work is that the strategies developed have the potential to be broadly applied throughout peptide drug design, including the engineering of toxin-derived peptides. Outside of the lab, he has a keen interest for watching and playing a variety of sports, and he enjoys spending time at the beach and cooking up a BBQ, taking advantage of the sunny days that Australia has to offer.

Total Chemical Synthesis of Venom and Salivary Proteins via Ligation Technologies

Nisharnthi M. Duggan, Sameer S. Kulkarni, Timothy S. Chisholm, Emma E. Watson and
Richard J. Payne

School of Chemistry, The University of Sydney, NSW 2006, NSW, Australia

The therapeutic potential of venom polypeptides and proteins is well recognised, with several venoms and venom-derived molecules approved for clinical use [1]. This has led to a significant demand for technologies to rapidly and efficiently access these biomolecules, especially when production through recombinant expression is low yielding, or for those bearing functionally important post-translational modifications (PTMs) [2]. We have developed a range of ligation technologies that enable the rapid chemical synthesis of peptides and proteins, with or without PTMs [3]. This talk will highlight the use of solid phase peptide synthesis and native chemical ligation in the synthesis of neuroprotective, cysteine-knot, funnel-web spider venom-derived peptide Hi1a, as well as the optimisation of oxidative folding [4]. A more recently developed methodology is the diselenide-selenoester ligation reaction [5,6]. This technology enables the fusion of peptide fragments with unprecedented kinetics and can be coupled with in situ deselenisation chemistry to afford native polypeptides and proteins [6,7]. The power of the DSL methodology will be highlighted via two examples: 1) the one-pot synthesis of anti-thrombotic salivary protein thrombostasin and 2) the total synthesis of a library of modified anti-thrombotic sulfoproteins, each of which could be assembled, purified and quantified for a bioassay within a few hours [8].

  1. King, G. F. Expert Opin Biol Ther. 2011, 11, 1469-1484.
  2. Kulkarni, S. et al. Nature Rev. Chem. 2018, 2, 0122.
  3. Thompson, R. E. et al.  J. Am. Chem. Soc. 2014, 136, 8161-8164.
  4. King, G. F. et al. Proc. Natl. Acad. Sci. U.S.A. 2016, 114, 3750-3755.
  5. Mitchell, N. J. et al. J. Am. Chem. Soc. 2015, 137, 14011-14014.
  6. Kulkarni, S. et al. Nature Protocols, 2019, 14, 2229-2257.
  7. Mitchell, N. J. et al. Chem. 2017, 2(5), 703-715.
  8. Watson, E. E. et al. Proc. Natl. Acad. Sci. U. S. A. 2019, 16, 13873-13878.

Brief Introduction of Nisharnthi M. Duggan: Nisha is a PhD candidate at The University of Sydney, working for Professor Richard Payne in the area of organic chemistry and chemical biology. She graduated from Monash University in 2016 with a Bachelor of Science (Advanced, Hons I), including an honors research project focusing on synthetic methodology with Professor David Lupton. In 2017, Nisha took a break from her studies to undertake research at the ANU with Professor Michael Sherburn, and then briefly worked as an experimental scientist at CSIRO in Melbourne before moving to Sydney to commence her PhD in 2018. Throughout her PhD, Nisha has worked on the synthesis of venom and salivary peptides that may be used to treat stroke and thrombotic disease.

28 April 2021
Book BuilderCompile a Customized E-Book from Your Favorite MDPI Open Access Content

MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.

Selections

In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.

This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.

 

We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.

Special Issue Reprints

The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool  to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.

For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.

In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.

 



Why choose MDPI Books?

In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.

If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.

Contact: Laura Wagner, MDPI Books Manager (email)

15 April 2021
MDPI Celebrates Company Milestone With 25th Anniversary Page
"We exist to help scientists achieve their own objectives"


In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.

MDPI has been a pioneer of Open Access publishing ever since the concept was first created.

In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.

Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.

Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.

MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.

31 March 2021
Welcoming New Members to the Editorial Board of Toxins

We welcome the following 34 recognized researchers, who recently joined the Editorial Board of Toxins:

Prof. Dr. Matthew P. Rowe, University of Oklahoma, USA
Dr. Siro Luvisetto, Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR) of Italy, Italy
Dr. Juan C. Blanco, Marine Research Centre (CIMA), Spain
Prof. Dr. Christine Edwards, Robert Gordon University, UK
Dr. Lorena Tuchscherr, Institute of Medical Microbiology, Germany
Dr. Antonia Susca, Institute of Science of Food Production (ISPA), National Research Council (CNR), Italy
Dr. Houda Berrada Ramdani, Universitat de València (UV), Spain
Dr. Alicia Rodríguez, University of Extremadura, Spain
Prof. Federica Cheli, Coordinating Research Centres (CRC) – Innovation for well-being and Environment (I-WE) - Università degli Studi di Milano, Italy
Dr. Zbigniew Adamski, Adam Mickiewicz University, Poland
Prof. Dr. Sophie Liabeuf, UPJV University, France
Dr. Francesco Giansanti, University of L’Aquila, Italy
Dr. Massimo Bortolotti, Alma Mater Studiorum—University of Bologna, Italy
Dr. Emiko Sato, Tohoku University, Japan
Prof. Dr. Andrea Bolognesi, University of Bologna, Italy
Dr. Fabrizio Anniballi, Department of Food Safety, Nutrition and Veterinary Public Health, Italy
Dr. Bruno Goud, Department of Cell Biology and Cancer (UMR CNRS 144), Institut Curie, France
Dr. Laurent Marsollier, French Institute of Health and Medical Research, France
Prof. Dr. Antonella Giannantoni, University of Siena, Azienda Ospedaliero-Universitaria Santa Maria alle Scotte, Italy
Prof. Dr. Andrea Santamato, Riuniti Hospital, University of Foggia, Italy
Dr. Christina Schroeder, National Cancer Institute, National Institutes of Health, USA
Dr. Jeroen Kool, Division of BioAnalytical Chemistry, Amsterdam Institute of Molecular and Life Sciences, The Netherlands
Dr. Sandra Sousa, Institute for Molecular and Cell Biology, Portugal
Dr. Florence Richard-Forget, INRAE, UR 1264 MycSA Mycologie et Sécurité des Aliments. Centre de recherche Nouvelle-Aquitaine-Bordeaux, France
Prof. Ren Lai, Kunming Institute of Zoology, Chinese Academy of Sciences, China
Prof. Dr. Ligang Zhou, China Agricultural University, China
Prof. Dr. Yidong Wu, Nanjing Agricultural University, China
Dr. Peter A. Keyel, Texas Tech University, USA
Prof. Dr. Moo-Seung Lee, Korea University of Science and Technology, Korea
Dr. Stéphanie Simon, Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la santé, France
Prof. Dr. José Miguel Ferreras, Department of Biochemistry, Molecular Biology and Physiology, Faculty of Sciences, University of Valladolid, Spain
Prof. Dr. Lucía Citores, Department of Biochemistry, Molecular Biology and Physiology, Faculty of Sciences, University of Valladolid, Spain
Prof. Dr. Sofia N. Chulze, Research Institute on Mycology and Mycotoxicology (IMICO), National Scientific and Technological Research Council from Argentina (CONICET), Universidad Nacional de Río Cuarto (UNRC), Argentina
Prof. Dr. Daniel Gillet, Section of Molecular Engineering for Health (SIMoS), JOLIOT, CEA, Université Paris-Saclay, France

Further details about the Editorial Board can be found at: https://www.mdpi.com/journal/toxins/editors.

17 March 2021
Toxins | Congratulations to GT-Toxins Award Winner at the 6th German Pharm-Tox Summit, Digital, 2021

The Editorial Team of Toxins would like to congratulate the winner of the GT-Toxins Award, Katharina Sessler, at the 6th German Pharm-Tox Summit.

Here is the title and abstract of her work:

The Enzyme Subunit SubA of Shiga Toxin-Producing E. coli Strains Demonstrates Comparable Intracellular Transport and Cytotoxic Activity as the Holotoxin SubAB

K. Sessler 1, P. Papatheodorou 1, F. Wondany 2, M. Krause 3, S. Noettger 1, D. Bernhard 3, J. Michaelis 2, H. Schmidt 3, H. Barth 1

1 University Ulm Medical Center, Institute of Pharmacology and Toxicology, Ulm, Germany

2 University Ulm, Institute of Biophysics, Ulm, Germany

3 University of Hohenheim, Institute of Food Science and Biotechnology, Hohenheim, Germany

Shiga toxin-producing Escherichia coli (STEC) strains are bacterial pathogens, which are mainly found in the gastrointestinal tract of farm and wildlife animals. The bacteria can be transmitted to humans via food and causes diarrheal and extraintestinal diseases. In addition to the Shiga toxin, some STEC strains also produce a second toxin, namely the subtilase cytotoxin (SubAB) [1]. SubAB belongs to the family of AB5 toxins, consisting of an enzymatically active A subunit (SubA) and separate B subunits (SubB), which mediate cell binding and uptake of SubAB. Inside the host cell, SubAB is transported via a retrograde pathway into the endoplasmic reticulum (ER), where it cleaves the glucose-regulated protein GRP78. SubAB-induced GRP78 cleavage activates a cellular stress response eventually resulting in cell death [1]. We previously demonstrated that SubA, without SubB, binds and intoxicates HeLa cells [2], whereas the cellular and molecular mechanisms behind this remained unclear. In the present study, we found that even in the absence of SubB, SubA is internalized into cells, reaches the endoplasmic reticulum (ER) and cleaves the chaperone GRP78. Furthermore, SubA-induced GRP78 cleavage in cells is prevented by the pre-treatment of cells with brefeldin A (BFA), which inhibits the transport of protein toxins into the ER. Obviously, SubA contains a yet undescribed ER localization signal, predicted by the software scanProsite™ as a SEEL motif at the C-terminus. Hence, a SubA mutant, lacking the SEEL motif (SubAΔC344), was generated, which exhibited no cytotoxicity alone, but only together with SubB, when tested on HeLa and HCT116 cells. Fluorescence microscopy revealed that SubAΔC344 is generally taken up into cells, but further investigations regarding substrate cleavage have shown that SubAΔC344-induced GRP78 cleavage was delayed when compared to wildtype SubA. We therefore assume that the SEEL motif plays a crucial role in guiding SubA into the ER [3]. Furthermore, we confirmed our findings in the human intestinal mini-gut organoid system. Our results not only contribute to a better understanding of the mode of action of the subtilase cytotoxin, but also raise the question whether a B component-independent cytotoxic effect of the A component is also true for other bacterial AB5 toxins.

  1. Paton AW et al. (2010), Toxins (Basel) 2(2):215–228.
  2. Funk J et al. (2015), Infect Immun 83(6):2338–2349.
  3. Sessler K et al. (2021); Arch. Toxicol. (in press)

10 March 2021
Journal Selector: Helping to Find the Right MDPI Journal for Your Article


At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.

As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.

We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.

The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.

We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.

The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.

Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)

5 March 2021
Toxins | 2020 Outstanding Reviewer Award—Winners Announced

We are pleased to announce the winners of the Toxins 2020 Outstanding Reviewer Award. The Toxins Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers to checking the manuscripts submitted to Toxins. It is due to their efforts that the high quality of the journal and quick turnaround is maintained.

The following awardees have been selected by the Editor-in-Chief of Toxins, Prof. Dr. Jay W. Fox. Each of them will receive a customized gift and a certificate to recognize their outstanding work:

Dr. Kirill S. Antonets

Affiliation: Laboratory for Proteomics of Supra-Organismal Systems, All-Russia Research Institute for Agricultural Microbiology (ARRIAM), Saint Petersburg, Russia.

Faculty of Biology, St. Petersburg State University (SPbSU), Saint Petersburg, Russia.

Research Interests: bioinformatics; structural biology; bacterial genomics; transcriptomics; molecular biology of host–pathogen interactions

"I would like to thank the Toxins Editorial Board for this Award and for their efforts in providing fast, convenient and transparent processing of manuscripts and reviews."

Dr. Alberto Rico-Yuste

Affiliation: Department of Analytical Chemistry, Complutense University of Madrid, Madrid, Spain.

Research Interests: molecular imprinted polymers; optical chemosensors; food analysis; mycotoxins; spectroscopy; fluorescence

First of all, I would like to thank the committee for considering me worthy of this award. I consider that reviewing articles is an important part of scientific work.At the same time that it helps to improve the quality of the journals and of the articles that appear in them, it allows to increase the critical capacity of the reviewer. In addition, it is a way to learn and broaden one's knowledge. The publication of an article is the result of a lot of work and I believe that it is everyone's job that their contribution to the scientific society has more weight. That is why I must also thank my mentors for instilling in me the importance of carrying out this type of review with great professionalism and thoroughness.

For more information about Toxins awards, please see the following link: https://www.mdpi.com/journal/toxins/awards.

24 December 2020
Welcoming New Members to the Editorial Board of Toxins

It is our pleasure to welcome the following 3 recognized researchers, who recently joined the Editorial Board of Toxins:

Prof. Dr. Aibo Wu
CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences
Interests: mycotoxins; microbial molecular biology; fungal biology; molecular microbiology

Prof. Dr. Michael Richardson
Institute of Biology Leiden, Leiden University
Interests: evo-devo; reptiles; evolution; chick embryo

Prof. Dr. Yukako Fujinaga
Department of Bacteriology, Kanazawa University
Interests: Clostridium botulinum; botulinum toxin; clostridial neurotoxins

We look forward to their contributions to the journal.

15 December 2020
MDPI adopts C4DISC principles to improve diversity and inclusion in scholarly communications

MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.

The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.

MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.

Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.

The Coalition is committed to:

  • eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
  • creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
  • promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
  • raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
  • supporting our members in achieving diversity and inclusion within their organizations.

14 December 2020
Article Layout and Templates Revised for Future Volumes

At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.

The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.

The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:

1) Information is displayed in the left information bar.


2) In the main text, there is a blank column on the left.


3) Small tables/figures are aligned on the left, large tables/figures are centered.

11 December 2020
2020 "Highly Cited Researchers" on MDPI Journal's Editorial Boards

We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.

Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.


Adams, Dave
Agarwal, Ravi P.
Ahn, Choon Ki
Ahn, Myung-Ju
Albrecht, Randy A.
Andersson, Dan I.
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Artaxo, Paulo
Balsamo, Gianpaolo
Barba, Francisco J.
Benediktsson, Jon Atli
Benelli, Giovanni
Bhatnagar, Amit
Bialystok, Ellen
Blaabjerg, Frede
Blay, Jean-Yves
Bogers, Marcel
Bolton, Declan J.
Boyer, Cyrille
Brocca, Luca
Bruix, Jordi
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cabrerizo-Lorite, Francisco Javier
Cai, Jianchao
Calhoun, Vince D.
Cantu, Robert C.
Cerqueira, Miguel
Chang, Jo-Shu
Chau, Kwok-wing
Chemat, Farid
Chen, Jianmin
Chen, Jun
Chen, Min
Chen, Shaowei
Chen, Wei
Chen, Wei-Hsin
Chen, Xiaofeng
Chen, Yangkang
Chen, Zhi-Gang
Chiclana, Francisco
Corella, Dolores
Cortes, Javier
Cortes, Jorge
Cummings, Kenneth Michael
Dai, Shifeng
Decker, Eric A.
DePinho, Ronald A.
Dimopoulos, Meletios-Athanasios
Dincer, Ibrahim
Du, Yihong
Dupont, Didier
Edwards, David
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estruch, Ramón
Fang, Chuanglin
Fasano, Alessio
Fernandez-Lafuente, Roberto
Ferreira, Isabel
Fortino, Giancarlo
Galluzzi, Lorenzo
Galvano, Fabio
Gandomi, Amir H.
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Wei
Garbe, Claus
García, Hermenegildo
Geschwind, Daniel H.
Giampieri, Francesca
Giralt, Sergio A.
Glanz, Karen
Goldewijk, Kees Klein
Gössling, Stefan
Govindan, Kannan
Granato, Daniel
Grosso, Giuseppe
Grosso, Giuseppe
Guerrero, Josep M.
Haase, Dagmar
Hagger, Martin S.
Hamblin, Michael R.
Han, Heesup
Jankovic, Joseph
Janotti, Anderson

Jiang, Hai-Long
Kalaji, Hazem M.
Kalantar-Zadeh, Kourosh
Kaner, Richard B.
Karimi, Hamid Reza
Kataoka, Kazunori
Keesstra, Saskia
Kepp, Oliver
Kerminen, Veli-Matti
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kim, Ki-Hyun
Klemeš, Jiří Jaromír
Klenk, Hans-Peter
Konopleva, Marina Y.
Krammer, Florian
Krebs, Frederik C.
Kroemer, Guido
Kudo, Masatoshi
Kurths, Juergen
Kurzrock, Razelle
Kuznetsov, Nikolay V.
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lancellotti, Patrizio
Lee, Sangmoon
Leung, Victor C. M.
Li, Jinghong
Li, Yurui
Lindahl, José M. Merigó
Lip, Gregory Y. H.
Loh, Xian Jun
Long, Hualou
Lund, Henrik
Luo, Jingshan
Luque, Rafael
Lyons, Timothy W.
Ma, Jun
Ma, Wen-Xiu
Ma, Yanming
Maeda, Keisuke
Makarova, Kira
Mantovani, Alberto
Martín-Belloso, Olga
Martinoia, Enrico
Marzband, Mousa
Masclaux-Daubresse, Celine
Masson, Patrick
Mateos, María Victoria
Mathiesen, Brian Vad
Matyjaszewski, Krzysztof
McArthur, Grant A.
McCauley, Darren
Medlock, Jolyon M.
Melero, Ignacio
Mezzetti, Bruno
Miroshnichenko, Andrey E.
Moran, Daniel
Mueller, Lukas A.
Mueller-Roeber, Bernd
Naushad, Mu
Nemeroff, Charles B.
Nieto, Juan J.
O'Donnell, Colm
Ogino, Shuji
Olabi, Abdul-Ghani
O'Regan, Donal
Orsini, Nicola
Oswald, Isabelle P.
Ozcan, Aydogan
Pahl-Wostl, Claudia
Pang, Huan
Payne, James E.
Peng, Shushi
Perc, Matjaz
Perez-Alvarez, Jose Angel
Piquero, Alex R.
Ploss, Alexander
Postolache, Mihai
Pradhan, Biswajeet
Prinsep, Michele R.
Qian, Dong
Qu, Xiaogang
Reiter, Russel J.
Riahi, Keywan
Richter, Andreas
Rignot, Eric
Robert, Caroline
Ros, Emilio
Rosell, Rafael

Rosen, Marc A.
Rossolini, Gian Maria
Saad, Fred
Saad, Walid
Sadorsky, Perry
Sakthivel, Rathinasamy
Schwab, Matthias
Scolyer, Richard A.
Serra-Majem, Lluis
Sethi, Gautam
Seto, Karen C.
Settele, Josef
Seymour, John F.
Shi, Peng
Siano, Pierluigi
Sillanpää, Mika
Simal-Gandara, Jesus
Smagghe, Guy
Srivastava, Hari M.
Stadler, Peter F.
Sun, Fengchun
Sunderland, Elsie M.
Suzuki, Nobuhiro
Svenning, Jens-Christian
Tan, Weihong
Teixeira, José António
Thakur, Vijay Kumar
Tong, Shilu
Tornabene, Francesco
Tsao, Rong
Tukker, Arnold
Turskis, Zenonas
Uversky, Vladimir N.
van Wesemael, Bas
Van Zwieten, Lukas
Vangronsveld, Jaco
Varma, Rajender S.
Varshney, Rajeev K.
Vasquez, Juan C.
Velicogna, Isabella
Vieta, Eduard
Wade, Timothy J.
Wagner, Wolfgang
Wamba, Samuel Fosso
Wang, Chunsheng
Wang, Guoxiu
Wang, Joseph
Wang, Qi
Wang, Tao
Wang, Yuan
Wiens, John J.
Wu, Hao Bin
Wu, Hui
Wu, Tom
Wu, Zhongbiao
Xia, Xinhui
Xiao, Wenjiao
Xin, Sen
Xiong, Rui
Xu, Bin
Xu, Zeshui
Yan, Huaicheng
Yang, Bing
Yang, Hongxing
Yang, Jie
Yang, Xiao-Jun
Yin, Shen
Ying, Guang-Guo
Young, Allan H.
Yu, Guihua
Zarco-Tejada, Pablo J.
Zavadskas, EdmundasKazimieras
Zeadally, Sherali
Zhang, Fan
Zhang, Liangpei
Zhang, Qichun
Zhang, Xian-Ming
Zhang, Yue-Jun
Zhao, Guochun
Zhao, Li-Dong
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan

The full list of 2020 Highly Cited Researchers  can be accessed on https://recognition.webofsciencegroup.com/awards/highly-cited/2020/

--- Highly Cited Researchers (HCR) is a Clarivate product.

19 November 2020
Toxins Series Webinars: Join us for our two webinars on November 26th and 27th


In this webinar, we will present some examples of fungal phytotoxins that could be used as potential bioherbicides and of phytotoxins produced by pathogenic fungi of agrarian plants. Furthermore, the importance of the absolute configuration assignment and the main methodology used for its determination will be presented as well as some examples of their total synthesis.

Chair: Marco Masi

Date: 26th November 2020

Time: 1:00pm CET | 6:00am CST

Webinar ID: 984 7644 1392

Register for Free Here: https://sciforum.net/conference/Toxins-1

text

This webinar will project the SDGs of Agenda 2030 by presenting some examples of natural antioxidants present in food that can alleviate the effects of mycotoxins in vitro, the study of the increased presence of mycotoxins in wheat associated with climate change, and the results obtained in biomonitoring mycotoxins in children’s urine.

Date: 27 November 2020

Time: 9:00am CET | 2:00am CST | 4:00pm UTC+8

Chair: Ana Juan- García

Webinar ID: 886 5296 8196

Register for Free Here: https://sciforum.net/conference/Toxins-2

For any questions about the webinar, please send an email to [email protected]

28 September 2020
Welcoming New Members to the Editorial Board of Toxins

We welcome the following 7 recognized researchers, who recently joined the Editorial Board of Toxins:

Dr. Shinichiro Kurosawa, Boston University School of Medicine, USA

Prof. Dr. Somshuvra Mukhopadhyay, The University of Texas at Austin, USA

Prof. Dr. Philippe Guerre, Université de Toulouse, France

Prof. Dr. Ketan Patel, University of Reading, United Kingdom

Prof. Dr. Ketan Patel, University of Reading, United Kingdom

Dr. Thérèse Malliavin, Institut Pasteur and CNRS UMR 3528, Unité de Bioinformatique Structurale, France

Dr. Félix Núñez, Universidad de Extremadura, Unité de Bioinformatique Structurale, Spain

We look forward to their contributions to the journal.

Toxins Editorial Office

9 July 2020
Open Access Agreement Between Jisc Collections and MDPI

We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.

All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.

Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.

Jisc logo

About Jisc

Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection.  Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.

For more information, contact [email protected].

About MDPI

MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).

For any questions about this agreement, please contact the MDPI IOAP team at [email protected].

29 June 2020
Updated Impact Factors Released in the Journal Citation Reports (Clarivate)

The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.

  • Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
  • 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
  • Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).

First Impact Factors

Journal Impact Factor Rank Category Details
Actuators 1.957 31/64 (Q2) • Instruments & Instrumentation Link
Agriculture 2.072 25/91 (Q2) • Agronomy Link
Biology 3.796 19/93 (Q1) • Biology Link
Biomedicines  4.717 30/138 (Q1)
36/270 (Q1)
• Medicine, Research & Experimental
• Pharmacology & Pharmacy
Link
Biosensors 3.240 24/86 (Q2) • Chemistry, Analytical Link
Chemosensors 3.108 16/64 (Q1)
27/86 (Q2)
13/27 (Q2)
• Instruments & Instrumentation
• Chemistry, Analytical
• Electrochemistry
Link
Children 2.078 50/128 (Q2) • Pediatrics Link
Healthcare 1.916 62/102 (Q3)
45/87 (Q3)
• Health Care Sciences & Services (SCIE)
• Health Policy & Services (SSCI)
Link
Journal of Fungi 4.621 5/29 (Q1)
31/135 (Q1)
• Mycology
• Microbiology
Link
Journal of Personalized Medicine 4.433 24/165 (Q1)
10/102 (Q1)
• Medicine, General & Internal
• Health Care Sciences & Services
Link
Land 2.429 58/123 (Q2) • Environmental Studies (SSCI) Link
Life 2.991 26/93 (Q2)
109/267 (Q2)
• Biology
• Microbiology
Link
Magnetochemistry 1.947 22/45 (Q2)
109/159 (Q3)
201/314 (Q3)
• Chemistry, Inorganic & Nuclear
• Chemistry, Physical
• Materials Science, Multidisciplinary
Link
Membranes 3.094 53/143 (Q2)
129/314 (Q2)
23/89 (Q2)
• Engineering, Chemical
• Materials Science, Multidisciplinary
• Polymer Science
Link
Pharmaceuticals 4.286 49/270 (Q1) • Pharmacology & Pharmacy Link
Photonics 2.140 48/97 (Q2) • Optics Link
Separations 1.900 53/86 (Q3) • Chemistry, Analytical Link
Toxics 3.271 32/92 (Q2)
92/265 (Q2)
• Toxicology
• Environmental Sciences
Link

Updated Impact Factors

Journal Impact Factor Rank Category Details
Agronomy 2.603 18/91 (Q1)
65/234 (Q2)
• Agronomy
• Plant Sciences
Link
Animals 2.323 10/63 (Q1)
14/142 (Q1)
• Agriculture, Dairy & Animal Science
• Veterinary Sciences
Link
Antibiotics 3.893 23/93 (Q1)
64/270 (Q1)
• Infectious Diseases
• Pharmacology & Pharmacy
Link
Antioxidants 5.014 10/139 (Q1)
56/297 (Q1)
7/61 (Q1)
• Food Science & Technology
• Biochemistry & Molecular Biology
• Chemistry, Medicinal
Link
Applied Sciences 2.474 161/314 (Q3)
32/91 (Q2)
88/177 (Q2)
62/154 (Q2)
• Materials Science, Multidisciplinary
• Engineering, Multidisciplinary
• Chemistry, Multidisciplinary
• Physics, Applied
Link
Atmosphere 2.397 48/93 (Q3) • Meteorology & Atmospheric Sciences Link
Biomolecules 4.082 98/297 (Q2) • Biochemistry & Molecular Biology Link
Brain Sciences 3.332 113/271 (Q2) • Neurosciences Link
Cancers 6.126 37/244 (Q1) • Oncology Link
Catalysts 3.520 65/159 (Q2) • Chemistry, Physical Link
Cells 4.366 70/195 (Q2) • Cell Biology Link
Coatings 2.436 10/21 (Q2) • Materials Science, Coatings & Films Link
Crystals 2.404 10/26 (Q2)
165/314 (Q3)
• Crystallography
• Materials Science, Multidisciplinary
Link
Diagnostics 3.110 39/165 (Q1) • Medicine, General & Internal Link
Diversity 1.402 119/168 (Q3) • Ecology Link
Electronics 2.412 125/266 (Q2) • Engineering, Electrical & Electronic Link
Energies 2.702 63/112 (Q3) • Energy & Fuels Link
Entropy 2.494 33/85 (Q2) • Physics, Multidisciplinary Link
Foods 4.092 27/139 (Q1) • Food Science & Technology Link
Forests 2.221 17/68 (Q1) • Forestry Link
Genes 3.759 53/177 (Q2) • Genetics & Heredity Link
Insects 2.220 18/101 (Q1) • Entomology Link
International Journal of Environmental Research and Public Health (IJERPH) 2.849 58/193 (Q2)

32/170 (Q1)

105/265 (Q2)
• Public, Environmental & Occupational Health (SCIE)
• Public, Environmental & Occupational Health (SSCI)
• Environmental Sciences (SCIE)
Link
International Journal of Molecular Sciences (IJMS) 4.556 74/297 (Q1)
48/177 (Q2)
• Biochemistry & Molecular Biology
• Chemistry, Multidisciplinary
Link
ISPRS International Journal of Geo-Information (IJGI) 2.239 31/50 (Q3)
18/30 (Q3)
• Geography, Physical
• Remote Sensing
Link
Journal of Clinical Medicine 3.303 36/165 (Q1) • Medicine, General & Internal Link
Journal of Marine Science and Engineering 2.033 31/66 (Q2) • Oceanography Link
Marine Drugs 4.073 16/61 (Q2) • Chemistry, Medicinal Link
Materials 3.057 132/314 (Q2) • Materials Science, Multidisciplinary Link
Mathematics 1.747 28/324 (Q1) • Mathematics Link
Medicina 1.205 107/165 (Q3) • Medicine, General & Internal Link
Metabolites 4.097 95/297 (Q2) • Biochemistry & Molecular Biology Link
Metals 2.117 18/79 (Q1)
185/314 (Q3)
• Metallurgy & Metallurgical Engineering
• Materials Science, Multidisciplinary
Link
Micromachines 2.523 56/92 (Q3)
23/64 (Q2)
• Nanoscience & Nanotechnology
• Instruments & Instrumentation
Link
Microorganisms 4.152 37/135 (Q2) • Microbiology Link
Minerals 2.380 6/21 (Q2)
11/30 (Q2)
• Mining & Mineral Processing
• Mineralogy
Link
Molecules 3.267 70/177 (Q2)
141/297 (Q2)
• Chemistry, Multidisciplinary
• Biochemistry & Molecular Biology
Link
Nanomaterials 4.324 89/314 (Q2)
42/103 (Q2)
• Materials Science, Multidisciplinary
• Nanoscience & Nanotechnology
Link
Nutrients 4.546 17/89 (Q1) • Nutrition & Dietetics Link
Pathogens 3.018 65/135 (Q2) • Microbiology Link
Pharmaceutics 4.421 44/270 (Q1) • Pharmacology & Pharmacy Link
Plants 2.762 58/234 (Q1) • Plant Sciences Link
Polymers 3.426 16/89 (Q1) • Polymer Science Link
Processes 2.753 59/143 (Q2) • Engineering, Chemical Link
Remote Sensing 4.509 9/30 (Q2) • Remote Sensing Link
Sensors 3.275 22/86 (Q2)
77/266 (Q2)
15/64 (Q1)
• Chemistry, Analytical
• Engineering, Electrical & Electronic
• Instruments & Instrumentation
Link
Sustainability 2.576 120/265 (Q2)
26/41 (Q3)

53/123 (Q2)
6/8 (Q3)
• Environmental Sciences (SCIE)
• Green & Sustainable Science & Technology (SCIE)
• Environmental Studies (SSCI)
• Green & Sustainable Science & Technology (SSCI)
Link
Symmetry 2.645 29/71 (Q2) • Multidisciplinary Sciences Link
Toxins 3.531 21/92 (Q1)
34/139 (Q1)
• Toxicology
• Food Science & Technology
Link
Universe 1.752 18/29 (Q3)
42/68 (Q3)
• Physics, Particles & Fields
• Astronomy & Astrophysics
Link
Vaccines 4.086 57/158 (Q2)
50/138 (Q2)
• Immunology
• Medicine, Research & Experimental
Link
Viruses 3.816 12/37 (Q2) • Virology Link
Water 2.544 31/94 (Q2) • Water Resources Link

Source: Clarivate 2020, InCites Journal Citation Reports®.

1 June 2020
Congratulations to Best Poster Award Winner at the 5th German Pharm-Tox Summit, Leipzig, Germany, 2020 (Sponsored by Toxins)

The editorial team of Toxins would like to congratulate the winner of the Best Poster Award, Daniel Henkel, at the 5th German Pharm-Tox Summit.

Here are the title and abstract of his work:

Evaluation of Chondroitin Sulfate Proteoglycan-4 and Frizzled-1,2,7 for Cytopathic and Cytotoxic Effects of TcdB from Historic and Hypervirulent Clostridioides difficile Strains

Daniel Henkel 1, Helma Tatge 1, Dennis Schoettelndreier 1, Liang Tao 2,3, Min Dong 2 and
Ralf Gerhard 1

1   Institute of Toxicology, Hannover Medical School, Hannover, Germany
2   Department of Urology, Boston Children's Hospital, Boston, MA, USA
3   Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Westlake University, Hangzhou, China;

Clostridioides difficile is a gram-positive and spore-forming bacterium that is the main cause of nosocomial, antibiotic-induced diarrhea. The clinical symptoms are caused by two exotoxins that are released by C. difficile (TcdA and TcdB). Both toxins are 300 kDa sized glucosyltransferases that inactivate small intracellular Rho-GTPases by mono-glucosylation. This leads to the destruction of the organisation of the actin cytoskeleton and to the rounding of the cells. This drastic morphological change is a valid and safe method to detect the activity of the toxins.

In order to enter the cells, the toxins first bind to their receptors on the cell surfaces, whereupon they are taken up into the cells by receptor-mediated endocytosis. So far, three receptors have been identified for the main virulence factor TcdB: chondroitin sulfate proteoglycan-4 (CSPG4/NG2), poliovirus receptor like 3 (PVRL3/nectin-3) and the Wnt receptor proteins Frizzled1,2,7 (FZD1,2,7). While the binding regions for CSPG4 and FZD1,2,7 have been identified, the functional binding to PVRL3 and a resulting toxin uptake has not yet been validated. Our investigations, however, show that the contribution of PVRL3 to toxin uptake is negligible.

The CSPG4 and FZD receptor binding domains of TcdB have only been investigated independently from each other, although they are located in close spatial proximity. In our work we have therefore investigated a possible dependence of both receptor binding domains and determined the respective proportion of the receptors on the effect of TcdB. For this purpose, we prepared recombinant TcdB from both the historical strain VPI10463 of Clade I (TcdBVPI) and the hypervirulent strain R20291 of Clade II (TcdBR20). In addition, we have used variants that can no longer bind either to CSPG4 (TcdBΔCROPs), or to FZD1,2,7 (TcdBVPIF1597S) or to either of the two receptors (TcdBVPIΔCROPs F1597S). In addition, we have used HeLa wild-type and HeLa CSPG4-/- cells complementarily in cell rounding assays and cytotoxicity tests. We could show that CSPG4 is the major receptor for both TcdBVPI and TcdBVPI in terms of cytopathic activity, accounting for estimated 70 % and 90 % effect, respectively. Furthermore, CSPG4 mediates almost exclusively the cytotoxic effect in HeLa cells.

In the historical TcdBVPI a phenylalanine (F1597) is essential for binding to FZD1,2,7, which is replaced by a serine in TcdBR20. Consequently, TcdB from the hypervirulent strain does not bind to FZD1,2,7. Against this background, we have prepared the mutant TcdBVPIF1597S, which showed a reduced cytopathic potency identical to that of TcdBR20.

By using toxins that specifically address one of two receptors, and by using HeLa cells, which lack CSPG4 as a receptor, in a complementary approach we evaluated additive function of CSPG4 and FZD1,2,7 for historical TcdBVPI. Both receptor binding sites can independently mediate toxin uptake. Thus, in case of TcdB the two-receptor model means an extension of the target cell spectrum – rather than increased cell specificity. The increased cell specificity is only achieved by the loss of functional FZD binding, as is the case with TcdBR20 from the hypervirulent strain. Our results now allow to attribute the stronger inflammatory effect of the hypervirulent C. difficile strains to the focused effect of TcdBR20 on CSPG4-positive cells, such as immune cells or cells of the enteric nervous system.

13 May 2020
COVID-19 Academic Resources Center


Since 1996, MDPI has been committed to supporting the research community by providing the latest research freely available and making relevant and useful research available as quickly as possible. The world is current experiencing a pandemic of COVID-19, and researchers are working extremely hard to understand it and find a cure.

The values MDPI holds strongly are particularly important at the moment, and we will continue to publish relevant, peer-reviewed research as quickly as possible in open access format. This means that it will immediately be available for researchers, health professionals, and the general public to read, distribute, and reuse. We believe that scientific advancements will be crucial to overcoming this pandemic, and will do everything we can to support researchers working looking for solutions.

COVID-19 Academic Resources Center contains a variety of information related to COVID-19 available from MDPI, including journal articles, special issues, and preprints, among others.

For more information, please visit: https://www.mdpi.com/covid-19

6 May 2020
2019 Toxins Young Investigator Award: Winner Announced

2019 Toxins Young Investigator Award

Professor Casewell’s research focuses on evolutionary and biomedical aspects of animal toxins. Following the completion of his PhD studies at Bangor University, UK, where he focused on characterising the composition of saw-scaled viper venoms, Nick worked in research and development at an antivenom manufacturing company. Thereafter, he won a research fellowship to investigate the evolution of fish venoms, before moving to Liverpool School of Tropical Medicine (LSTM), UK, in 2014 to take up a faculty position. In 2019, Nick was appointed as Professor of Neglected Tropical Diseases by LSTM, and he also currently holds the position of Wellcome Trust Research Fellow. He has published over 70 papers on animal toxins, and his most notable work relates to understanding the processes that generate toxin variation and how this information can be applied to better inform new treatment strategies for the world’s snakebite victims.

It was a difficult decision given the number of high-quality applications for the award, and we would like to thank all the applicants from various fields of study for their participation, and all the Award Committee members for their efforts in evaluating the many applications. We congratulate the winner, Prof. Nicholas R Casewell, on his accomplishments. We wish him further success in his career.

For more information about Toxins awards, please visit https://www.mdpi.com/journal/toxins/awards.

6 May 2020
2020 Toxins Travel Award: Winner Announced

We are pleased to announce the winner of the 2020 Travel Award sponsored by MDPI and Toxins. The award was granted to an outstanding young researcher:

2020 Toxins Travel Award

Dr. Steve Peigneur is a Postdoctoral Researcher in the lab of Toxicology & Pharmacology at the Catholic University of Leuven (KU Leuven) in Belgium. He has published over 125 articles in peer-reviewed journals. In 2019, he obtained his PhD in Biochemistry at the Federal University of Minas Gerias in Belo Horizonte, Brazil. His research in the field of drug discovery and development mainly focusses on the characterisation of novel ligands for ion channels and receptors, starting from natural sources such as venomous animals and poisonous plants. The aim is to investigate toxins for their therapeutic or insecticidal potential.

This has certainly been a difficult decision, given the volume of high-quality applications for the awards. We would like to thank all of the applicants for submitting what was collectively such a range of diverse and fascinating research topics and congratulate the winner on his accomplishments.

For more information about Toxins awards, please check: https://www.mdpi.com/journal/toxins/awards

15 April 2020
2019 Toxins Outstanding Reviewer Award: Winner Announced

We are pleased to announce the winner of the 2019 Outstanding Reviewer Award sponsored by MDPI and Toxins. This award was granted to two outstanding reviewers for the quality, timeliness, and volume of their reviews.

2019 Toxins Outstanding Reviewer Award
Dr. Matthias Koch holds a Ph.D. in Analytical Chemistry and is Head of the BAM division that focuses on the trace analysis of organic pollutants in food and environmental matrices. His work over the last 20 years has aimed at developing and improving analytical procedures, standardization of methods, and developing reference materials. One of his main research areas in recent years has been the simulation and identification of transformation products, especially for food-related mycotoxins. He authored or co-authored more than 80 peer-reviewed papers.

2019 Toxins Outstanding Reviewer Award

Dr. Sumit Ghosh was awarded his Ph.D. in Cellular and Molecular Biology from North Dakota State University in the summer of 2012. He then continued his postdoctoral work in the field of Immunology at North Dakota State University, where he investigated the role of B lymphocytes and extracellular matrix components (ECM) components in allergic fungal asthma. He is a Registered Biosafety Professional, Certified Safety Professional l and currently serves on the Publication and Distance Learning Committee of American Biological Safety Association International (ABSA). Additionally, he serves on the editorial board of numerous national and international journals. He is an Environmental Health and Safety Leader with extensive research experience in Biological Safety, OSHA, EPA, DOT regulations, and in-depth knowledge of high-containment labs. He is currently Associate Director of Research Safety/Research Biosafety Officer at the Abigail Wexner Research Institute at Nationwide Children’s Hospital.

We would like to congratulate the winners and thank them for their dedication and efforts in providing critical feedback to authors and contributing to upholding the standard and integrity of peer review.

For more information about Toxins awards, please check: https://www.mdpi.com/journal/toxins/awards

9 April 2020
Free Open Platforms to Support Academics During the COVID-19 Pandemic

As a leading Open Access publisher, MDPI is committed to fostering open scientific exchange in all forms across all disciplines. Due to the outbreak of COVID-19, many researchers have to stay at home and many academic conferences have been cancelled or postponed. In light of these changes, MDPI has adopted numerous initiatives that may help accelerate scientific exchange and provide support to the academics during this period.

Scholarly Community—Encyclopedia

Encyclopedia is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.

Comprehensive and Free Literature DatabaseScilit

Scilit is a comprehensive, free database for scientists that uses a new method to collate data and index scientific material. Our crawlers extract the latest data from CrossRef and PubMed on a daily basis. This means that newly published articles are immediately added to Scilit.

Display Academic AchievementsSciProfiles

SciProfiles is an innovative social network for researchers and scholars that is developed by MDPI. In line with our broad mission, the purpose of SciProfiles is to accelerate discovery and innovation by facilitating immediate access to research results and providing opportunities for academic networking.

Organize and Participate in Conferences OnlineSciforum

Sciforum is an event planning platform that supports open science by offering the opportunity to host and participate in academic conferences. It provides an environment for scholarly exchange, discussion of topics of current interest, building of networks, and establishing collaborations.

Post Early Versions of Research OutputsPreprints

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. We post original research articles and comprehensive reviews, and papers can be updated by authors at any time. Content on Preprints is not peer-reviewed, and feedback can be received from readers.

***

MDPI remains committed to open science and open data and has signed a statement, along with more than thirty scholarly publishers, showing our intention to facilitate sharing of new research findings as early on as possible. The initiative sees publishers collectively removing barriers to new research, in the face of a global healthcare crisis.

4 April 2020
Congratulations to the Winner of the Toxins Travel Student Award at Venom Week VII, Gainesville, Florid, USA, 2020 (Sponsored by Toxins)

The editorial team of Toxins would like to congratulate the winner of the Toxins Travel Student Award, Roberto Ponce Lopez, at Venom Week VII.

text

 

Here are the title and abstract of his work:

Sphingomylinase D-Crotamine Recombinant Fusion Protein as Immunogen for the Production of Antibodies Against Crotamine

Ponce-López, R.1,*, Olvera-Rodríguez, A.1, Borja-Jiménez, M.2, Neri-Castro, E.1, Olvera-Rodríguez, L.1, Alagón, A.1

1   Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México; [email protected] (P.-L.R.)

2   Facultad de Ciencias Biológicas, Universidad Juárez del Estado de Durango, Gómez Palacio, Durango, México

Background: Crotoxin (molecular weight (MW): ~24 kDa) and crotamine (MW: ~5 kDa) are two of the most studied neurotoxic components found in several rattlesnake venoms (Crotalus spp.). The former compound is well neutralized by antivenoms, whereas the latter is well known for its spastic paralysis symptom provoked in mice with no evidence of neutralization. Recently, it was reported that crotamine is the major toxin found in some neonate and juvenile Mexican rattlesnake venoms such as Crotalus molossus nigrescens (~50%). Currently, the available Mexican pit viper antivenoms neither recognize nor neutralize crotamine from C. m. nigrescens, possibly explained by its low immunogenicity due to its low molecular weight. Sphingomyelinase D (SMD) is a highly immunogenic enzyme (MW: ~30 kDa) found in Loxosceles spp. spider venom. To increase immunogenicity of a low molecular weight toxin, we hypothesized that our novel recombinant fusion protein, composed of crotamine from C. m. nigrescens and sphingomyelinase D from L. reclusa used as carrier, will contribute significantly to the generation of neutralizing antibodies against crotamine, preventing its spastic paralysis and lethality.

Methods: Crotamine cDNA was synthetized from the venom gland mRNA of a C. m. nigrescens individual from Mexico, and one plasmid containing L. reclusa SMD was available in the laboratory. By standard genetic engineering procedures, we cloned in tandem sphingomyelinase D and one crotamine isoform into the expression vector pQE30. This fusion protein was expressed in Origami Escherichia coli. Using the recombinant protein, we performed immunization protocols in rabbits and, during the scheme, we measured ELISA antibody titers to purified crotamine from C. m. nigrescens venom. 

Results: The fusion protein was obtained at 3 mg/L of bacterial culture with the expected 37.5 kDa molecular mass as analyzed by SDS-PAGE and Western blot analysis. The fusion protein was lethal in mice (LD50 = 2.8 μg/g weight of mice) showing no effects of spastic paralysis. Based on ELISA and Western blot, serum samples of immunized rabbits reacted to crotamine.

Discussion/Conclusion: The SMD–crotamine fusion protein used as immunogen generates antibodies that recognize crotamine. We are using pre-incubation experiments to analyze the neutralization ability of antibodies to prevent spastic paralysis and lethality from crotamine in mice.

Keywords: crotamine; sphingomyelinase-d; molecular-carrier; recombinant-protein

Acknowledgment: Fordecyt 303045.

25 March 2020
MDPI Comment on the COVID-19 Virus

The world is currently suffering from a global pandemic of the corona virus COVID-19. MDPI expresses its sympathies for all of those affected by the virus and stands in solidarity with medical staff and researchers treating patients and searching for scientific solutions.

MDPI has previously published papers covering corona viruses in addition to new papers on the current outbreak, see all papers here. In particular, Viruses has published a number of Special Issues and papers on the topic (see here, here, and here) as well as a forthcoming Special Issue.

Alongside journal articles, MDPI has been a strong supporter of preprints, which are increasingly being used to rapidly disseminate the latest research, and we run the preprint server Preprints.org. Our database of research articles, Scilit, is free to use and covers all publishers including preprint servers. New papers are often in search results within hours of publication and users can set up alerts for new papers.

Our main priority during this period has been the health and safety of staff, and we continue to allow staff to work at home and closely monitor the situation in all locations in which we work. Despite the restrictions, we continue to provide a full publication service and, by close collaboration with our editorial boards and making use our in-house teams, ensure that there are no unnecessary delays in publishing vital research. Fast and open publication has always been at the core of MDPI values and is now more important than ever.

We hope that a solution to the current situation will emerge soon. In the meantime, we will do our best to continue communicating vital research in all fields.

18 March 2020
MDPI Co-Signed Position Statement on Transformative Agreements

The advantages of the open access model of scientific publishing are being increasingly recognized in the scientific community. It allows new scientific evidence to be accessed from the moment of publication for free by anyone around the globe, boosting the impact of new research. In response, many funders, libraries and universities have been adopting new principles to accelerate the transition to open access.

Recently, “transformative agreements” have been negotiated between traditional publishers and various institutions. While increasing the number of open access papers, these agreements lack binding commitments to a full transition to open access, their conditions vary across different regions, and access is still limited for many users.

MDPI is a co-signatory of the recent position statement raising concerns about potential downsides of transformative agreements and how they may delay a full transition to open access. The statement highlights that these models “risk perpetuating current limitations on access, transparency and market competitiveness, while simultaneously facilitating excessive charges on the public purse”.

As a pioneering open access journal publisher, MDPI is the first to promote the importance of science being made available to everyone. Our peer-reviewed journals, covering diverse academic disciplines, are fully accessible to the public free of charge under a Creative Commons Attribution License (CC BY). This is why, along with other open access publishers, MDPI is a proud signatory of the position paper and is committed to contributing to the replacement of weak transitional agreements with “agreements with publishers that are already fully committed to open science and who offer full, immediate and transparent Open Access”.

Read the position paper here

16 March 2020
Encyclopedia Outstanding Contributor Awards 2020 - Open for Application

We are pleased to announce that Encyclopedia will be awarding five Outstanding Contributor Awards for researchers in 2020. The nominations and applications will be assessed by an Evaluation Committee consisting of senior scholars from the Encyclopedia Editorial Board.

Prize for Winners

  1. An official certificate;
  2. A cash award of 500 CHF or an MDPI discount voucher of 800 CHF.


Application Deadline

31 December, 2020 (Please send your application email with a list of all entries you contributed to our office before the deadline: [email protected])

Candidate Requirements

  1. Have a Ph.D. degree;
  2. Have more than three qualified entries published in Encyclopedia in 2020.

Evaluation Standards

  1. Number of entries published in Encyclopedia in 2020;
  2. Quality of entries online (including length, figure quality, and novelty);
  3. Impact of entries (including the number of likes, discussion contents, views, and downloads).

If you are a researcher and have not yet contribute entries to Encyclopedia, please do not miss this chance to highlight your research results.

25 December 2019
Congratulations to the Winners of the Best Poster Award and the Best Oral Communication Award at the 26th Meeting of the French Society of Toxinology (SFET), Paris, France, 2019 (Sponsored by Toxins)

The editorial team of Toxins would like to congratulate the winner of the Best Poster Award, Ludivine LOPEZ, and the Best Oral Communication Award, Geoffrey MASUYER, at the 26th Meeting of the French Society of Toxinology (SFET).


Here are the titles and abstracts of their work:

Title: High-Throughput Screening of Venom for Identification of Active Compound in Ion Channels

Author: Ludivine LOPEZ 1,2,*, Sébastien NICOLAS 1, Lucie JAQUILLARD 2, Jérôme MONTNACH 1, Rémy BEROUD 2, Michel DE WAARD 1

Affiliation:

1    Institut du thorax, INSERM UMR 1087/CNRS UMR 6291, LabEx “Ion Channels, Science & Therapeutics”, 44007 Nantes, France.

2    Smartox Biotechnology, 6 rue des Platanes, 38120 Saint Egrève, France.

Abstract:

Dysfunctions of voltage-gated sodium channels (Nav) have been associated with many pathological conditions such as cardiac diseases, neuropathic pain, and epilepsy. In order to study the role of these channels in diseases or to restore function, specific molecules targeting ion channels are needed. Highly specific molecules for a given isoform of sodium channel are hard to discover with the usual chemical libraries. Animal venoms, and especially spider venoms, contains about tens of peptides acting on ion channels and therefore represent interesting libraries for drug discovery. By screening spider venoms on Nav, we aimed to identify new toxins targeting specifically one channel isoform with the use of an automated patch-clamp (APC) technique (SyncroPatch364, Nanion). For this purpose, all venoms were preliminary fractionated in libraries of 64 fractions and tested on several stable Nav cell lines. APC allows two venoms to be tested at the same time and accelerate the drug discovery process. Fractions of interest are those that reduce sodium peak current (by at least 30%), slow down inactivation, or increase late sodium current. False-positive fractions were excluded based on detection of material in HPLC or mass spectrometry. Until now, two different Nav lines have been tested: Nav1.5 and Nav1.6. Primary screening allows identification of 28 fractions active in at least one isoform. Among them, 24 are specific for one channel (10 for Nav1.5, 14 for Nav1.6). The majority of positive fractions induce a slowdown in inactivation (5 for Nav1.5, 12 for Nav1.6). The selected fractions were re-fractionated with a complementary purification technique until the isolated peptides were obtained. These molecules were tested again for bioactivity and underwent full de novo sequencing, chemical synthesis, and full pharmacological characterization. This study suggests that among the large number of toxins in venoms, a great variety target sodium channels with specificity for each sodium channel isoform, and illustrates how ACP is essential for screening.

Title: A Clostridial-Like Neurotoxin That Selectively Targets Anopheles Mosquitoes

Author: Geoffrey MASUYER 1,2,*, Estefania CONTRERAS 3, Nadia QURESHI 3, Swati CHAWLA 3, Harpal S. DHILLON 3, Ham Lim LEE 4, Jianwu CHEN 3, Pål STENMARK 2,5, Sarjeet S GILL 3

Affiliation:

1    Department of Pharmacy and Pharmacology, University of Bath, United Kindom.

2    Department of Biochemistry and Biophysics, Stockholm University, Sweden.

3    Department of Molecular, Cell and Systems Biology, University of California Riverside, USA.

4    Unit of Medical Entomology, Institute for Medical Research, Kuala Lumpur, Malaysia.

5    Department of Experimental Medical Science, Lund University, Sweden.

Abstract:

Clostridial neurotoxins are potent toxins that target the nervous system of vertebrates causing paralytic diseases such as tetanus and botulism. Here, we present a new member of this family of toxins, PMP1, a clostridial-like neurotoxin that selectively targets Anopheles mosquitoes, thus expending the range of host species targeted by this family. PMP11 was isolated from Paraclostridium bifermentans strains collected in geographically varied anopheline endemic areas. PMP1 was showed to use a common mechanism of toxicity that disrupts SNARE-mediated exocytosis by cleavage of syntaxin. Our results suggest PMP1 employs a different receptor recognition strategy, illustrated by the high-resolution structure of the PMP1 binding domain. The discovery of PMP1 has a significant impact on our understanding of the clostridial neurotoxin evolution. Importantly, it provides an exciting opportunity for the development of innovative biotechnological tools that can reduce malaria through anopheline control.

25 December 2019
Congratulations to the Winners of the Student Poster Award and Student Talk Award at 20th IST World Congress, Buenos Aires, Argentina, 2019 (Sponsored by Toxins)

The editorial team of Toxins would like to congratulate the winner of the Student Poster Award, Jonas Jürgensen, and Student Talk Award, Cebrina Nolan, at the 20th IST World Congress.

Here are the titles and abstracts of their work:

Title: Harnessing Monoclonal Antibodies for Development of a Specific Treatment against Naja nigricollis Envenoming

Author: Jonas Jürgensen

Affiliation: Technical University of Denmark

Abstract:

The African black-necked spitting cobra (Naja nigricollis) is one of the most notorious snake species found on the African continent. Its venom consists of a highly potent mixture of cytotoxins which cause severe local tissue damage in victims, who are left with permanent sequalae after a bite. The availability of antivenom is currently scarce throughout the African continent. Furthermore, due to their heterologous origin and low content of therapeutically active antibodies, these antivenoms have a propensity to cause severe adverse reactions, including serum sickness and anaphylaxis, which could lead to death of the patient.

Recombinant antibodies represent a therapeutic alternative. We are presently developing an antivenom based on recombinant human monoclonal immunoglobulin G (IgG) antibodies, which are predicted to be safer, cost-competitive, and more efficacious than the existing treatment. Here, we present a subset of this work: Through the utilization of phage display technology, the possibility of discovering and expressing novel human single-chain variable antibody fragments (scFv) against the five most medically relevant venom toxins from N. nigricollis has been demonstrated, with four being cytotoxins and one being phospholipase A2. Out of the 486 monoclonal scFvs analyzed, 164 were considered good binders. Of these, 94 were sequenced, resulting in the identification of 31 unique scFvs. The binding properties of these scFvs will be evaluated, and the most promising leads will be converted into an immunoglobulin G format and assessed in vivo. It is our hope that the work in this project will help enable radical improvement in the treatment of snakebite envenoming.

Title: Investigating the Neuromodulatory Effects of Corazonin in Emerald Jewel Wasp Venom

Author: Cebrina Nolan

Affiliation: University of California, Riverside

Abstract:

The parasitoid jewel wasp, Ampulex compressa, induces hypokinesia (a sleep-like state) and reduced fecundity in its host, the American cockroach Periplaneta americana, through direct envenomation of its central nervous system. A proteomic screening of the venom identified over 250 protein components, with many not having been previously observed in arthropod venoms nor found to play a role in modulating insect locomotion. Of the multitude of toxins identified, the presence and function of corazonin was investigated as it was able to bind to Rhodnius prolixus corazonin receptors. Corazonin is a highly conserved peptidergic neurohormone found within all insect orders except Coleoptera (beetles). Despite its conserved sequence, its function varies greatly between different insect genera. A recent study revealing the involvement of corazonin in the behavior switching of ponerine gamergates to infertile workers was associated with the involvement of Ampulex corazonin in suppressing fecundity. These findings led us to investigate the function of corazonin in the venom via injecting Ampulex corazonin into the brains of virgin females. Following treatment, changes in fecundity were monitored by measuring the relative gene expression of vitellogenin yolk proteins, average ovariole protein content, and average ovariole volume size in stung and corazonin-injected females. Changes in cockroach fecundity were compared to nontreated and saline-injected controls. Both the sting and corazonin injections resulted in significant decreases in vitellogenin gene expression as well as a reduction in average ovariole protein content and ovariole size in virgin female cockroaches. Thus, it is suggested that the role of corazonin in venom may be to suppress ovary development and preserve energy within females. Our findings reveal alternative mechanisms of how venoms can inhibit reproductive abilities as well as provide further insight on the effects of corazonin in the central nervous system of arthropods.

11 October 2019
Introducing SciProfiles, an Academic Social Network

MDPI is pleased to announce the release of SciProfiles, its social network platform for researchers and scholars.

The purpose of SciProfiles is aligned with MDPI’s broad mission to accelerate discovery and innovation by facilitating immediate access to research results and to serve scholars and communities by providing opportunities for academic networking.

SciProfiles also ambitions to serve as a sustainable, transparent and community-driven research evaluation system aligned with the DORA principles (https://sfdora.org/). Through their scientific profiles, academics can highlight their contribution to research communities, and measure their impact on their field, beyond publication numbers and impact factors. SciProfiles is currently a beta version and will enrich to give researchers the possibility to highlight all of their contributions to science and their scientific communities as authors, reviewers, editors, conference organizers, conference panelists, conference keynote speakers, or even as lecturers or student mentors at their University.

The classic components of popular community social networks, including follower/following, classical metrics, endorsements and recommendations (https://www.mdpi.com/about/announcements/1690), comments (https://www.mdpi.com/about/announcements/1397) are or will be very soon highlighted in SciProfiles as open science contributions.

To help increase the impact and visibility of articles and their authors to an appropriate audience, the platform offers a NewsFeed that includes recommendations of relevant content based on interests, publication history, saved searches or colleagues’ recommendations.

SciProfiles’ avatars are now being integrated on several MDPI platforms, meaning that you will directly access researchers’ profiles from any of the MDPI platforms:

MDPI's journal publishing website: www.mdpi.com
MDPI's conference hosting and management website: www.sciforum.net
MDPI's pre-print website : www.preprints.org
MDPI's knowledge sharing website : www.encyclopedia.pub
MDPI's books store: www.mdpi.com/books
MDPI's literature database : www.scilit.net

SciProfiles aims to serve scientific communities at large. It can be embedded into third-party websites and also welcomes integration of data from third-parties.

Dr. Shu-Kun Lin: https://sciprofiles.com/profile/2
Dr. Franck Vazquez: https://sciprofiles.com/profile/FranckVazquez
Dr. Martyn Rittman: https://sciprofiles.com/profile/martynrittman

2 October 2019
Winners of the 2019 MDPI Writing Prize

We are delighted to announce the winners of the 2019 MDPI Writing Prize. Entrants were asked to write on the theme "Judging research: How should research and researchers be evaluated and rewarded?" We received a large number of excellent essays from PhD students and postdocs, and the process of shortlisting and choosing winners was not an easy one. The winners demonstrated excellent writing skills alongside interesting and thought-provoking ideas.

As last year, we will begin the process of collating all entries into a book that will be available in open access format. Alongside promoting good writing skills, we see the prize as a way to promote the voices of early career researchers within broader debates and policy discussions.

Congratulations to all of the participants and especially the winners. The winners are:

1st Prize (500 CHF):
Albin Nilsson (National Centre for Nuclear Research, Warsaw, Poland)
[Read here]

2nd Prize (250 CHF):
Qi Zhang (Shandong University, Jinan, China)
[Read here]
Igor Ogashawara (Indiana University, Indianapolis, US)
[Read here]

3rd Prize (100 CHF):
Margaret Sivapragasam (Universiti Teknologi Petronas, Perak, Malaysia)
[Read here]
Arvind Sharma (The University of Queensland, Gatton, Australia)
[Read here]
Jose Flores-Guerrero (University Medical Center Groningen, Groningen, The Netherlands)
[Read here]

The MDPI Writing Prize is an annual award supported by MDPI Author Services, which provides services including language editing, reformatting, plagiarism checks, and image editing.

20 September 2019
MDPI Now Gives Scholars the Possibility to Endorse and Recommend Articles

MDPI is pleased to announce the release of a new functionality giving the possibility for researchers and scholars to endorse, and formally recommend articles to their colleagues.

MDPI was an early signatory of the San Francisco Declaration on Research Assessment (https://sfdora.org/read/) which calls for improvement in how quality and impact of scholarly research outputs are evaluated, especially in moving beyond journal-based citation metrics (journal Impact Factor, Scopus Citescore, etc.).

MDPI supports the establishment of article-level impact metrics, including citations, views, downloads, and Altmetric scores. These measures serve as an impact indicator for research articles on a case–by-case basis, assessing paper on its own merit. However, these metrics are also subjective and can give a biased picture of the article impact: they do not directly reflect the quality or the intrinsic scientific value of the article.

In our view, community engagement with publications based on community-driven metrics can help to overcome this limitation. We have therefore launched an option for scholars to endorse articles, indicating their own assessment of its content and making a recommendation to their community. This follows our implementation of the open source Hypothesis commenting tool, which has been available for all articles published by MDPI for over a year (https://www.mdpi.com/about/announcements/1397). Both endorsement and commenting are available for all previously published and forthcoming MDPI articles.

In addition to potentially serving as a sustainable solution to article assessment, endorsements will help scientific communities to identify the most relevant articles, independently of the journal in which it was published.

The code for the endorsing functionality, which relies on DOIs and ORCIDs, will be made available on GitHub with an open source license.

Dr. Shu-Kun Lin, President and Founder
Dr. Franck Vazquez, Chief Scientific Officer
Dr. Martyn Rittman, Publishing Director

12 September 2019
ETOX19 Best Paper Awards Sponsored by Toxins

Congratulations to the winners of the Best Poster Award and Best Short Talk Award at the 19th European Workshops on Bacterial Protein Toxins (ETOX19), Davos, Switzerland, 2019, sponsored by Toxins.

The editorial team of Toxins would like to congratulate Charles Ericson—the winner of the Best Poster Award at the 19th European Workshops on Bacterial Protein Toxins (ETOX19).


The title and abstract of Charles Ericson’s work are presented below:

Title: Bacterial Phage Tail-like Structure Harbors Two Effectors with Varying Functions

Author: Charles Ericson

Affiliation: ETH Zürich, Institute of Molecular Biology & Biophysics, 8093 Zürich, Schweiz

Abstract: Many bacteria interact with target organisms using syringe-like structures called contractile injection systems (CIS). CIS structurally resemble headless bacteriophages and share evolutionarily related proteins such as in the tail tube, sheath, and baseplate complex. Recent evidence shows that CIS are specialized in puncturing membranes, and often deliver effectors to target cells. In many cases, CIS mediate trans-kingdom interactions between bacteria and eukaryotes, however, the effectors delivered to these target cells and their mode of action are often uncharacterized. It had been previously shown that an array of extracellular CIS produced by the marine bacteria Pseudoalteromonas luteoviolacea, deemed MACs (metamorphosis associated contractile structures), were able to induce the metamorphosis of the marine tubeworm Hydroides elegans. By cryo-electron tomography imaging and functional assays, we further investigated this interaction between the tubeworms and MACs, and were able to identify an effector protein, termed Mif1, that was found to be sufficient for triggering the metamorphosis. We then established that MACs are able to interact and kill two separate eukaryotic cell lines, fall armyworm Sf9 ovarian cells and J774A.1 murine macrophages. A secondary effector termed Pne1 was found to be responsible for this cell line killing ability. Interestingly, Pne1 was found to not play a role in the metamorphosis of the H. elegans larvae.

We established ex vivo and in vivo models that have identified two separate MAC effectors that interact with different eukaryotic systems. Our insights help to shed light on MACs that appear to have multiple eukaryotic targets. These results also help to define new mechanisms of CIS-mediated bacteria–eukaryote interactions and are a first step toward understanding the roles these structures may be playing in mediating their surrounding environments.


The editorial team of Toxins would like to congratulate Shihono Teruya—the winner of the Best Short Talk Award at the 19th European Workshops on Bacterial Protein Toxins (ETOX19).

The title and abstract of Shihono Teruya’s work are presented below:

Title: Identification of Bordetella Dermonecrotic Toxin Receptor

Author: Shihono Teruya

Affiliation: Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka 565-0871, Japan

Abstract:

Dermonecrotic toxin (DNT), a virulence factor produced by the pathogenic bacteria belonging to the genus Bordetella, is known to exhibit toxin effects by activating Rho small GTPase of target cells. Our research group reported that the toxin was the causative agent for turbinate atrophy in pigs infected with B. bronchiseptica; however, its role in whooping cough—human infection with B. pertussis—is still unknown. In order to address this issue, we attempted to determine DNT-sensitive organs/tissues in host animals through identification of the DNT receptor. As the toxin affects only limited types of animal cells, its receptor is considered to be expressed by a specific tissue with a specific cell function. First, in order to facilitate high-throughput screening for the receptor, we generated a DNT–diphtheria toxin fragment A (DTA) fusion protein that caused cell death on DNT-sensitive cells, but not insensitive cells. Utilizing the combination of DNT–DTA and the CRISPR/Cas9 system, we performed a genome-wide screening for DNT–DTA-resistant cells with loss of function of a gene after introduction of a sgRNA library, and identified Gene X that encodes a transmembrane protein X as a DNT receptor candidate. The cells whose Gene X was specifically knocked out were highly resistant to DNT, and ectopic expression of Gene X restored DNT sensitivity. Furthermore, immunoprecipitation assay and competitive antagonist assays revealed a molecular interaction between X and DNT. These results suggest that X is a receptor for DNT. Since X is highly expressed in neuronal tissues, we consider that DNT may have function as a neurotrophic toxin.

11 September 2019

Create an Entry in Encyclopedia to Get a 100 CHF Voucher in Publishing in MDPI Journals

Encyclopedia is pleased to announce that certain well-prepared entries are eligible for a 100 CHF voucher, which can be used for paper publication in any journals in MDPI. We believe that your contribution would be a great help in keeping up with scientific developments. Do not miss the chance to publish with us. Please clink here to find the detailed guideline.

Encyclopedia is a free online reference created and curated by active scholars. It aims to highlight the latest research results as well as provide a comprehensive record of scientific development. If you have any suggestions or questions, please feel free to contact us via [email protected].

6 September 2019
Meet us at the 11th Conference of The World Mycotoxin Forum® and the XVth IUPAC International Symposium on Mycotoxins in Belfast, Northern Ireland, 14-16 October 2019

MDPI will be attending the 11th Conference of The World Mycotoxin Forum® and the XVth IUPAC International Symposium on Mycotoxins in Belfast, Northern Ireland, 14-16 October 2019.

The aim of WMFmeetsIUPAC – the world’s largest mycotoxin event – is to increase the awareness of human and animal health risks due to mycotoxin contamination. It offers a platform for the food and feed industry, science and regulatory authorities to exchange current knowledge, to promote harmonisation of food and feed safety regulations and control procedures, and to make recommendations for integrated strategies ensuring the safety and security of the food and feed supply chain.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.worldmycotoxinforum.org/welcome.php

6 August 2019
Preprints Reaches 10,000 Posted Articles Milestone

We are pleased to announce that Preprints has passed the milestone of 10,000 posted preprints. We are delighted to have reached this after just over three years of operation. Our congratulations and thanks go to our authors and advisory board who have supported growth of the platform and been crucial to its operation.

You can find further details at https://www.preprints.org/announcement/show/37.

2 August 2019
DeepGreen Partnering with Publishers and Universities in Distributing Open Access Content to Institutional Repositories

Last week, the DeepGreen initiative in Germany started into an advanced test phase with the publishing partners S. Karger AG, SAGE Publishing, MDPI, Frontiers and De Gruyter, as well as 27 universities from all over Germany, from Hamburg University of Applied Sciences to University of Konstanz.

DeepGreen aims at lowering the barriers for open access publishing by automatically delivering metadata and full text publications from participating publishers to authorized repositories at German universities.

In preparation for a later live operation, the advanced test phase serves to gain experience with extensive data deliveries from publishers and also handling different repository software (including OPUS4, DSpace, EPrints, MyCoRe). DeepGreen thereby acts as a sophisticated platform, receiving articles published by authors affiliated with German universities and depositing these articles to respective university repositories, based on the affiliation metadata. For more information about DeepGreen: https://deepgreen.kobv.de

Karger AG has been a close cooperation partner of the DeepGreen consortium since 2016. S. Karger has more than 80 subscription-based and around 20 open access journals covering a wide spectrum in health science. DeepGreen will assign S. Karger articles to authorized institutions on the legal basis of German alliance and national licenses.

SAGE Publishing  was founded by Sara Miller McCune in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE publishes more than 1,000 journals and over 600 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. SAGE Publishing has been a close cooperation partner of DeepGreen since 2016.

MDPI  is a scientific open access publisher and has been a partner of DeepGreen since 2017. MDPI comprises 205 peer-reviewed journals of various disciplines. All articles are published under a CC-BY license and are freely available without embargo period.

Frontiers  is a scientific open access publisher with 61 journals of over 600 academic disciplines. All articles are peer-reviewed and published freely available under CC-BY license.

De Gruyter  is an academic publisher with more than 700 subscription-based and open access journals of 29 disciplines. Articles provided by De Gruyter will be assigned to institutions with German alliance and national licenses.

There is promising communication with other publishers.

DeepGreen is funded by the German Research Foundation (DFG) and the consortium comprises six institutions: the Cooperative Library Network Berlin-Brandenburg, Bavarian State Library, Bavarian Library Network, University Library of the Technische Universität Berlin, University Library of Erlangen-Nuremberg and the Helmholtz Open Science Coordination Office at the GFZ German Research Centre for Geosciences.

If you would like to know in more detail which institutions take part in the advanced test phase of DeepGreen, you can find more information here.

17 July 2019
First Basel Sustainable Publishing Forum

The University of Basel and the MDPI Sustainability Foundation are organizing the First Basel Sustainable Publishing Forum on 9th September 2019.

The aim of this event is to provide background and perspectives on Plan S to Learned Societies, which have to make well-informed decisions to transition their journals to Open Access (OA).

The BSPF will bring together several representatives of Learned societies, Plan S architects as well as representatives from various publishers and publishing platforms. After getting the big picture from cOAlition S, panel discussions will allow to better understand the diverse challenges that Learned societies are facing to transition their journals to OA as well as to identify sustainable, implementable and scalable solutions for successful Open Access transition.

For program details and registration, please follow the link below:
https://sciforum.net/conference/SustainableSolutionsToOpenAccess

21 June 2019
Meet Us at WMNP 2019 in Peniche, Portugal, 1–5 September 2019


MDPI will be attending the joint conference XVI International Symposium on Marine Natural Products & XI European Conference on Marine Natural Products in Peniche, Portugal, 15 September 2019.

WMNP 2019 is this year’s the most important event in this field, especially for the European scholars studying marine natural products. It will cover all aspects in this field, hosting both experienced experts and active pioneers.

The following MDPI journals will be represented:

Marine Drugs
Toxins
Molecules

If you are also attending this conference, please feel free to stop by our booth (Booth #Near Conference Hall). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: http://wmnp2019.ipleiria.pt/.

20 June 2019
Toxins Receiving 2018 Updated Impact Factor of 3.895

We are pleased to inform that Toxins received an updated Journal Impact Factor of 3.895 in the recent release of the Journal Citation Reports®. The journal's 5-Year Impact Factor is 4.009. Toxins now ranks 14/93 (Q1) in the 'Toxicology' category and 19/135 (Q1) in 'Food Science & Technology'.


Evolution of Impact Factor, Citations and Publications for Toxins:


Source: data according to Journal Citation Reports®, 2018 release, a Clarivate Analytics product; and Scopus journal metrics.

10 May 2019
Congratulations to the Best Poster Award Winner at the 4th German Pharm-Tox Summit, Stuttgart, Germany, 2019 (Sponsored by Toxins)

The editorial team of Toxins would like to congratulate the winner of the Best Poster Award at the 4th German Pharm-Tox Summit—Stefanie Kowarschik.

The title and abstract of her work are presented below:

Title: Binding of the Yersinia pseudotuberculosis Cytotoxic Necrotizing Factor (CNFY) to its Cellular Receptor

Authors: Stefanie Kowarschik and Gudula Schmidt

Affiliation: Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany

Abstract: CNFY is one of the major virulence factors of Yersinia pseudotuberculosis. The exotoxin belongs to the AB-like toxin family and shows a high similarity (~ 68%) to the other known CNFs. Their cellular targets are RhoGTPases, which are deamidated at a single glutamine, Gln 63 in RhoA. This glutamine is crucial for GTP hydrolysis. The toxin consists of three domains, an N-terminal, translocation and C-terminal catalytic domain. CNF1 and CNFY are homologous; however, we show that they bind to different cellular receptors. CNF1 is known to bind to Lu/BCAM, but the cellular receptor for CNFY remains unknown. Additionally, CNFY shows a different binding behaviour in cell intoxication studies compared with CNF1. Our data indicate that CNFY binds to HSPGs (heparansulfate proteoglycan), which are highly abundant structures on the cell surface, and it may also bind to a yet unidentified surface protein. Furthermore, differential intoxication of human and murine cell lines correlates with the relative abundance of HSPGs in these cells.

2 April 2019
The Japanese Society of Mycotoxicology (JSMYCO) is Now an Affiliated Society Member of Toxins

In January 2019, the Japanese Society of Mycotoxicology (JSMYCO) became affiliated to Toxins. As part of this collaboration, all members of JSMYCO enjoy a discount on the article processing charges (APC) when submitting articles to Toxins.

The Japanese Society of Mycotoxicology (JSMYCO) works to increase scientific knowledge concerning toxicology, biology, and chemistry related to mycotoxins and mycotoxin-producing fungi, through membership networking, annual meetings, international symposia, seminars and publications.

JSMYCO is a professional organization whose functions are highly relevant to the scope of Toxins. We look forward to collaborating with JSMYCO and publishing state-of-the-art research from its members in this field.

20 March 2019
Fostering Open Access Publishing Worldwide: New IOAP Participants in February and March 2019

We are pleased to welcome more universities from Poland, Italy, Germany, Brazil and other parts of the world to MDPI's Institutional Open Access Program (IOAP). A warm welcome to the institutions listed below, who have joined the Program in February and March this year.


James Madison University (JMU), Harrisonburg USA
Loughborough University UK
Lublin University of Technology Poland
Marquette University, Milwaukee USA
Massey University, Palmerston North New Zealand
Medical College of Wisconsin USA
Nicolaus Copernicus University, Toruń Poland
Poznań University of Life Sciences Poland
Robert Koch-Institut, Berlin Germany
Rothamsted Research, Harpenden UK
Santa Clara University (SCU)  USA
Technical University of Applied Sciences Wildau Germany
University of Aveiro Portugal
University of Brasília Brazil
University of Duisburg-Essen Germany
University of Greifswald Germany
University of Molise Italy
University of Naples Parthenope Italy
University of São Paulo (USP) - São Carlos Institute of Physics Brazil
University of Szczecin Poland
University of Warmia and Mazury, Olsztyn Poland
University West, Trollhättan Sweden
UTP University of Science and Technology, Bydgoszcz Poland
VTT - Technical Research Centre of Finland Finland


Authors affiliated with these institutions can now enjoy a discount on the APC for papers accepted for publication in any MDPI journal. If you would like to learn more about our program, please visit: https://www.mdpi.com/about/ioap or email us at [email protected].

5 March 2019
MDPI Joins Jisc’s Publications Router Service

We are delighted to announce our participation in Jisc’s Publication Router project, as of March 2019.

Publications Router is a Jisc service that automatically sends notifications about research articles to institutions' systems such as their repositories or CRISs, since May 2015. Through this agreement, MDPI will provide Jisc with daily feeds and information regarding published articles, which will be gathered by their system and delivered to institutions also registered to this service. Nearly all of our articles are published within 15 days of acceptance, so institutions will receive them quite promptly.

The feed will include the full text of the published version of record, with no embargo, so the articles can be exposed immediately for public view. They are accompanied by rich metadata, including confirmation of the immediate CC BY licence, minimising the need for any manual intervention or checking.

For more information about Publications Router, you may contact Jisc’s central helpdesk at [email protected]. For any queries about MDPI’s institutional agreements and collaborations, you may get in touch with MDPI’s Institutional Engagement team at [email protected], which would be very happy to hear from further UK institutions.

1 February 2019
2018 MDPI Top Reviewer AwardWinners Announced


Rigorous peer-review is the cornerstone of high quality academic publishing. Over 97,000 scholars served as reviewers for MDPI journals in 2018. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list all reviewers’ names to express our gratitude. In addition, this year the “MDPI Top Reviewer Awards” are announced, to recognize the very best reviewers for their expertise, dedication, high quality, and timely review reports. We are pleased to announce the following winners of the 2018 MDPI Top Reviewer Awards:

  • Ali Behnood
  • Andrea Pezzuolo
  • Angela Gorgoglione
  • Anna D'Auria
  • Antonio D'Andrea
  • Azhar Abbas
  • Bogdan Zagajewski
  • Chunhui Chen
  • Dominika Głąbska
  • Dominika Guzek
  • Dragan Pamucar
  • Francisco J. G. Silva
  • Frank Li
  • Gianluca Serafini
  • Gyorgy Szekely
  • Haozhi Pan
  • Helvi Heinonen-Tanski
  • José Manuel Gómez-Soberón
  • Kathy Lewis
  • Klara Kosova
  • Luis N. López De Lacalle
  • M. Z. Naser
  • Malwina Tytła
  • Masoume Amirkhani
  • Matteo Ghidelli
  • Moretti Laura
  • Petra Schneider
  • Roberto Cerchione
  • Spyros Papaefthymiou
  • Ştefan Cristian Gherghina